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Metal-catalyzed alkene difunctionalization reactions have given chemists powerful 
tools to quickly increase the chemical complexity of molecules in a single step. This 
dissertation focuses on the development of new Pd-catalyzed alkene difunctionalization 
reactions for the construction of functionalized carbocycles. Specifically, treatment of 2-
allylphenyl triflate, or related acyclic 1,5-dienyl triflates, with enolate nucleophiles in the 
presence of a palladium catalyst and a base generates either four- or five-membered 
carbocyclic products. These reactions form two new bonds and a ring in a single 
transformation, with generally high levels of diastereoselectivity. The reactions described 
in this dissertation provide new and important methodology for the synthesis of 
functionalized carbocycles.  
Previous work in the Wolfe lab, as described in Chapter 1, laid the foundation for 
coupling reactions between exogenous nucleophiles and aryl or alkenyl bearing tethered 
alkenes. These studies focused on the use of nitrogen, oxygen, and indole nucleophiles, 
which were incorporated into the carbocyclic products. In Chapter 2, my work details a 
significant expansion of nucleophile scope by incorporating stabilized carbanions, 
including malonates, esters, and ketone enolates, as exogenous nucleophiles in our Pd-
catalyzed alkene difunctionalization reactions. The products of these reactions are formed 
in good yields and good diastereoselectivity, >20:1 relative to the bridging carbon when 
utilizing alkenyl triflates as the coupling partner. The mechanism of reaction is proposed 
 xxvi 
to go through a Pd(0)/Pd(II) cycle that involves oxidative addition of the aryl/alkenyl triflate 
to Pd(0), followed by anti-carbopalladation and subsequent reductive elimination.  
My work has also included development of a regiodivergent variant of our Pd-
catalyzed alkene difunctionalization reactions, as described in Chapter 3. Alkenyl triflates, 
with geminal “R” groups relative to the vinyl triflate, bearing tethered alkenes were 
coupled with malonate nucleophiles for the formation of either methylene cyclobutanes or 
methylene cyclopentanes. Two unique catalyst systems were employed to select for the 
desired regioselectivity. The mechanism governing the formation of the cyclopentane 
product appears to be analogous to our previous reported Pd(0)/Pd(II) cycle and 
described above. Preliminary mechanistic studies involving the synthesis of a deuterated 
alkene starting material and its stereoselective reaction with diethyl malonate suggest the 
four-membered ring products are formed by oxidative addition followed by a syn-
migratory insertion and subsequent stereo-retaining, reductive elimination from the metal 
center. To the best of our knowledge, this is the first example of an sp3-sp3 C-C bond 
forming reductive elimination from Pd(II) with a malonate nucleophile. 
Additional scope and studies of Pd-catalyzed alkene difunctionalizations are 
described in Chapter 4. Preliminary results incorporating exogenous nitrile nucleophiles 
as coupling partners are described. Preliminary results utilizing nitrogen nucleophiles in 
the regiodivergent Pd-catalyzed cyclization are described. Lastly, preliminary efforts to 
construct heterocycles with exogenous nucleophiles as coupling partners are described. 
 1 
Chapter 1  
Introduction to Palladium-Catalyzed Alkene Difunctionalization Reactions 
 
1.1 The Wacker Reaction 
Starting in the mid-20th century, the discovery and development of catalytic reactions 
of alkenes transformed the landscape of organic chemistry. Specifically, in 1959 the 
Wacker process (or Wacker reaction) made significant improvements upon the already 
established stoichiometric oxidation1 of ethylene to acetaldehyde by developing a 
catalytic variant (eq 1-1).2,3,4 The innovative difference between stoichiometric and 
catalytic being the incorporation of cocatalytic CuCl2 salts along with molecular oxygen to 
oxidize the palladium catalyst and thus turnover the catalytic cycle (Scheme 1-1). The 
crucial hydroxypalladation step of the Wacker reaction has been the center of controversy 
for the past six decades. The major focus of the debate is centered upon the modality of 
nucleophilic addition step; whether the reaction proceeds through a syn-addition 
hydroxypalladation (eq 1-2) or an anti-addition hydroxypalladation (eq 1-3) step. The 
following investigations into the mechanism of the Wacker reaction have proven 
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fundamental to determining which influences impact nucleopalladation and how those 
factors determine the overall course of the reaction.4 Additionally, understanding the 
Wacker reaction is an important step to understanding and manipulating similar reaction 
mechanisms and other processes sensitive to diverse reaction conditions. Understanding 
the process and factors contributing to the hydroxypalladation step in the Wacker reaction 
was, and is, one of the first steps in understanding nucleopalladation step of palladium-
catalyzed alkene difunctionalization reactions as shown in Scheme 1-2.5  
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1.2 Syn- vs Anti-Oxypalladation Pathways of the Wacker Reaction 
There has been extensive study done upon the Wacker reaction. Although improved, 
there yet remains an imperfect view of the mechanism governing the hydroxypalladation.4 
Foundational work by Henry provided strong kinetic support for a syn-addition pathway.6 
These kinetic studies found that nucleophilic attack of external hydroxide on the η2 alkene 
Pd(II) complex would require a biomolecular reaction to proceed faster than diffusion, 
ruling out such an attack. Following those studies, several groups including Stille,7  
Bäckvall and Åkermark,8 and others9 developed experiments to probe the 
stereochemistry of the oxypalladation of alkenes. These studies provided evidence for 
the anti-addition pathway; however, due to acetaldehyde being achiral, the experiments 
necessitated a fundamental change in substrate by utilizing allyl alcohols to instill chirality. 
Additionally, the authors significantly altered the overall reactions conditions from the 
original Wacker reaction by including a carbon monoxide atmosphere and high chloride 
ion concentrations. Therefore, while providing strong evidence for an anti-addition 
mechanism in their new oxypalladations, their evidence was of limited use in conclusively 
labeling the hydroxypalladation step of the original Wacker reaction as an anti-addition. 
Henry and co-workers later provided substantial evidence that showed varying reaction 
conditions from the industrial Wacker conditions (including carbon monoxide and 
increasing [Cl-]) resulted in a switch in mechanism in the hydroxypalladation.10 Henry and 
co-workers showed oxypalladation to proceed through a syn-addition pathway at low [Cl-
] and through an anti-addition pathway at high [Cl-].  
Computational studies by Goddard, Oxgaard, and co-workers have added support to 
this finding. Goddard and co-workers also proposed the energy barrier for syn-
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hydroxypalladation to be far too high to be feasible. However, as shown in Scheme 1-3, 
Goddard and co-workers presented an energetically acceptable alternative pathway to 
equilibrium deprotonation where the η2 metal complex may undergo an inner-sphere 
transfer of a water molecule while simultaneously ejecting a proton into the solvent.11 
Other experimental studies12 and computational studies13 have provided additional 
support for an anti-addition hydroxypalladation mechanism, albeit in a modified 
mechanism involving a three-water hydrogen-bond bridged chain (Scheme 1-4).12 Taken 
as a whole, the thorough investigations into oxypalladation highlight the extreme 
sensitivity of the mechanism of reaction to the employed catalyst, substrate, and overall 
reaction conditions. 
1.3 Development of Palladium-Catalyzed Alkene Difunctionalization Reactions for 
the Construction of Functionalized Carbocycles 
Since 2004 our group has developed and investigated a series of alkene 
difunctionalization reactions between aryl or alkenyl halides or triflates, and alkenes 
bearing tethered nucleophiles.14,15 As shown below (Scheme 1-5a), these 
transformations affect the formation of one carbon-heteroatom bond, one carbon-carbon 
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bond, and up to two stereocenters. The transformations afford an array of heterocyclic 
products, including tetrahydrofurans,16 pyrazolidines,17 pyrrolidines,18 cyclic ureas19 and 
cyclic guanidines,20 in good yield and high diastereoselectivity.  
We have also examined fully intramolecular variants of these transformations 
(Scheme 1-5b),21 and have demonstrated that products resulting from either syn- or anti-
addition to the alkene can be selectively obtained with suitable substrates and 
conditions.19e,21,22 These reactions proceed via a mechanism involving oxidative addition 
of the electrophile to Pd(0), followed by either syn- or anti-nucleopalladation5,23 of the 
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alkene (depending on substrate and conditions), and then C–C bond-forming reductive 
elimination.14,24  
Although the transformations described above provide a straightforward means of 
accessing several different heterocyclic ring systems, in all cases the alkene was tethered 
to the nucleophilic component of the coupling reaction. Several years ago, Dr. Derick 
White, a former Wolfe group co-worker, reasoned that by changing the arrangement of 
the pieces (alkene, nucleophile, and electrophile) such that the alkene was tethered to 
the electrophile, we could develop a new method for the synthesis of functionalized 
carbocycles. As shown in Scheme 1-6, the coupling of 2-allylphenyltriflate 1-1 (or related 
congeners) as the electrophile, combined with an external nucleophile (either anionic or 
neutral, depending on pKa considerations; nucleophiles such as amines are likely 
deprotonated after the nucleopalladation step), should provide carbocyclic products 1-2. 
Oxidative addition of the electrophile to Pd(0) would provide complex 1-3, which can 
undergo coordination of the alkene to Pd, followed by attack of 1-4 by the external 
nucleophile to afford 1-5 (which may be protonated/ charged, or neutral, depending on 
the nucleophile). Reductive elimination from 1-5 would then give 1-2. Sections 1.4-1.9 
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summarizes our progress thus far (2015-present) on the development of this new class 
of alkene difunctionalization reactions. 
1.4 Optimization of Exogenous Nitrogen Nucleophiles 
In preliminary studies, Dr. White and Dr. Hutt sought to establish proof-of-concept 
results for the general transformation outlined above. As such, they elected to examine 
the Pd-catalyzed coupling of 2-allylphenyl triflate (1-1, prepared in one step from 
commercially available 2-allylphenol) with nitrogen nucleophiles (Scheme 1-7). Initial 
attempts to couple 1.0 equiv. of benzenesulfonamide, phthalimide, or pyrrolidine-2-one 
with 1.2 equiv. of 1-1 in the presence of a Pd(OAc)2/RuPhos25 catalyst system were 
unsuccessful. However, use of pyrrolidine as the nucleophile afforded product 1-2 in 45% 
yield. After further optimization we found that the desired product 1-2 was obtained in 
essentially quantitative yield (NMR) when BrettPhos was employed as ligand with 2-
allylphenyl triflate as the limiting reagent instead of the amine nucleophile (1.0 equiv. 1-1, 
1.2 equiv. amine).26 
1.5 Enantioselective Reactions of Aryl and Alkenyl Triflates with Nitrogen 
Nucleophiles 
Once Dr. White and Dr. Hutt had successfully demonstrated the desired reactivity, they 
elected to explore enantioselective variants of this reaction, rather than simply elucidate 
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the scope of the racemic transformation. As such, they examined the coupling of naphthyl 
triflate 1-6 with pyrrolidine using a chiral palladium catalyst system (Scheme 1-8).26 They 
initially examined binaphthyl derived monodentate phosphines and obtained promising 
results of up to 87:13 er for product 1-7 but could not optimize beyond that point. After 
exploration of a few alternative ligand scaffolds, they discovered that 
phosphinooxazolines (PHOXtype ligands)27 also provided interesting levels of 
asymmetric induction, and eventually found that tert-butyl phosphinooxazoline ligand 1-
L6 provided the desired product 1-7 in 98% yield and >99: 1 er.28  
With satisfactory conditions in hand, they proceeded to explore the scope of the 
asymmetric alkene carboamination reactions. As shown in Scheme 1-9, the 
transformations were effective with both cyclic and acyclic secondary amines, providing 
good to excellent enantioselectivity. Modest yields and lower levels of asymmetric 
induction were obtained in the reactions of acyclic secondary amine nucleophiles 
(diethylamine and N-methylbenzylamine). Primary amine nucleophiles were also coupled 
in moderate to good yield and high enantioselectivity. Simple 4-substituted 2-allylphenyl 
triflates, along with alkenyl triflates derived from α-tetralone, proved to be suitable 
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substrates in addition to the naphthyl triflate. Although enantioselectivities were 
comparable for both aryl and alkenyl triflates, the chemical yields obtained in reactions of 
alkenyl triflates were generally lower than those for couplings involving aryl triflates.29 
Their current experimental evidence supports for their initial mechanistic hypothesis 
described above in Section 1.3, Scheme 1-6. In the case of amine nucleophiles, 
deprotonation likely occurs after, rather than before, the aminopalladation step in the 
catalytic cycle. Additional discussion of the mechanism and stereochemical outcomes of 
these general classes of reactions is provided below in Section 1.9. 
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1.6 Diastereoselective Reactions of Alkenyl Triflates with Nitrogen Nucleophiles 
Given the successful enantioselective reactions of alkenyl triflates described above, it 
seemed likely that several other alkenyl triflates may prove suitable substrates for these 
reactions. In addition, these reactions could potentially provide access to synthetically 
useful partially saturated carbocyclic structures. As such, Dr. White began to explore 
diastereoselective reactions of simple alkenyl triflates 1-10 generated from 2- 
allylcycloalkanones, which could be prepared in two steps from commercially available 
materials using straightforward chemistry.29  
Fortunately, very little optimization was required. The conditions employed for the 
asymmetric reactions, except using BrettPhos as ligand, provided satisfactory results in 
these transformations (Scheme 1-10). The reactions were effective with a range of 
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primary and secondary amine nucleophiles, and products 1-11 were generated with good 
to excellent levels of diastereoselectivity. The formation of both 5,5- and 6,5- fused ring 
systems was feasible, and the presence of an alkyl or ester substituent adjacent to the 
reactive allyl group was tolerated. In addition, a bis-alkenyl triflate derived from 1,3- 
cyclohexanedione was converted to aminated bicyclic alkenyl triflate product 1-11f in 67% 
yield and >20:1 dr.  
Despite having a reasonably broad scope, the reaction was sensitive to steric effects, 
as the coupling of the acyclic secondary amine diethylamine proceeded in modest yield 
(1-11d, 49%) and 2.5:1 dr. In addition, when a substrate bearing a 1,2-disubstituted 
alkene was treated with pyrrolidine, the desired product 1-11i was formed in only 36% 
yield and 5:1 dr.  
Acyclic 1,5-dienyl triflate substrates 1-12 were successfully converted to exo-
methylene cyclopentane derivatives 1-13 in moderate to good yield under the standard 
reaction conditions (Scheme 1-11).29 However, in contrast to reactions of cyclic alkenyl 
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triflates 1-10, the stereocontrol in reactions of the acyclic substrates 1-12 was sensitive 
to ligand structure. BrettPhos provided only modest diastereoselectivity, but improved 
results were obtained with the more electron-rich and less sterically bulky biaryl 
phosphine ligands CPhos or RuPhos. With these ligands the desired products were 
generated in moderate to excellent diastereoselectivity (4:1 to >20: 1). Discussion of the 
stereochemical outcome of reactions between alkenyl triflate substrates and various 
nucleophiles is provided below in Section 1.9. 
1.7 Diastereoselective Reactions of Aryl and Alkenyl Triflates with Oxygen 
Nucleophiles 
Due to the significance and synthetic utility of O-substituted indane derivatives,30 Dr. 
White and co-workers elected to explore alkene difunctionalization reactions involving 
oxygen nucleophiles, such as phenols or aliphatic alcohols.31 They initially examined 2-
allylphenyltriflate-derived substrates and investigated a broader set of aryl electrophiles 
than in our earlier studies with amine nucleophiles. Synthesis of substrates 1-14 from the 
corresponding phenols was straightforward (three steps), and only a slight change to the 
previously optimized conditions was needed. With RuPhos as the ligand for palladium (in 
place of BrettPhos), they obtained good yields of products 1-15 for most substrate 
combinations that were examined (Scheme 1-12).  
The reactions were effective with a range of phenol nucleophiles, although higher 
reaction temperatures of 130°C or 160°C were needed with electron-deficient phenols. 
The presence of an ortho-methyl group on both the aryl triflate and the phenol was 
tolerated (1-15c). In addition, a substrate bearing an allylic methyl group was coupled 
with p-methoxyphenol to afford 1-15f in 98% yield and >20 :1 dr. Interestingly, attempts 
to affect an enantioselective version of these reactions have thus far been unsuccessful. 
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The chiral ligand 1-L6, that provided excellent results with amine nucleophiles (Scheme 
1-9), failed to promote the coupling of 2-allyl-1-naphthyltriflate with p-methoxyphenol. 
Only a trace amount of product was formed, and the reasons that 1-L6 does not perform 
well in this case remain unclear. We have yet to identify a chiral catalyst system that 
provides both high yield and high enantioselectivity in reactions of oxygen nucleophiles.  
In addition to the aryl triflates described above, a broad series of alkenyl triflate 
substrates 1-16 proved to be suitable coupling partners with oxygen nucleophiles 
(Scheme 1-13). Both BrettPhos and RuPhos provided good results as ligands for these 
reactions. In some cases, one of the two was slightly superior to the other, and sometimes 
NaOtBu was slightly superior to LiOtBu. But in many instances, either of the two ligands 
and bases gave comparable yields of products 1-17.  
The transformations were capable of generating 6,5-fused, 5,5-fused, and 5,5-spiro 
ring systems in moderate to excellent yields. Diastereoselectivities were very high (>20:1) 
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in most cases, and a number of different phenols and aliphatic alcohols could be 
employed as nucleophiles. Importantly, substitution at the internal alkene carbon of the 
cyclizing alkene was tolerated. Therefore, the reactions can produce tertiary alkyl-aryl 
ethers that would be difficult to obtain with other methods. 
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1.8 Diastereoselective Reactions of Aryl and Alkenyl Triflates with Indole 
Nucleophiles 
In order to further explore the scope and limitations of this class of alkene 
difunctionalization reactions, Dr. Kirsch and co-workers elected to study reactions of 
heteroaromatic compounds.32 They were curious as to whether weak carbon 
nucleophiles, such as indoles, would participate in these reactions, and if so, whether 
they would react as carbon- or nitrogen-nucleophiles.  
During preliminary optimization studies, they found that reaction conditions 
comparable to those used with other nucleophiles described above did lead to the 
conversion of 1-2 to the desired product 1-18 (Table 1-1). However, the results were 
highly irreproducible, and chemical yields varied widely from run-to-run when conducted 
in toluene at a 0.1 M reaction concentration. They reasoned that increasing the reaction 
concentration, or increasing the equivalents of indole added, may improve yields given 
the relatively poor nucleophilicity of indoles. But, further increasing the reaction 
concentration up to 1 M did not provide significantly better results, and separation of the 
excess indole from the product was difficult.  
 16 
Ultimately, a key observation led to a solution of the reproducibility problem. In order 
to try to conduct as many reactions as possible in as short time period, the transformations 
were conducted in screw-capped vials in a metal heating block. Not every vial cap had a 
perfect seal, and in some instances the reaction solvent evaporated during the overnight 
run. Interestingly, the best results were obtained in the reactions where the solvent had 
evaporated.  
Dr. Kirsch reasoned that the extremely high concentration of indole present in the 
solvent-evaporated reaction mixtures was probably facilitating the transformations of 
these weak nucleophiles, and subsequently examined conducting reactions without 
solvent. Unfortunately, omitting solvent entirely also did not provide satisfactory 
reproducible yields.  
It seemed that the lack of success with “neat” reaction conditions may be due to 
inefficient catalyst ligation/activation, since the only liquid present in the reaction mixture 
was the aryl triflate 1-2. Based on this hypothesis, we devised a new reaction protocol, in 
which the reactions were set up using benzene as the solvent.33 The reactions were 
conducted in round-bottom flasks equipped with a short-path distillation head, and after 
reagents were mixed, the reaction flask was heated to 100 °C and the benzene solvent 
was removed via distillation. The reaction temperature was then decreased slightly to 95 
°C, and the reactions were allowed to stir for 3 h at this temperature in little or no solvent. 
These conditions proved to give satisfactory and reproducible yields.  
As shown in Scheme 1-14, several different substituted indoles were suitable 
substrates. In all cases the indole alkylation occurred at C3 and competing N-alkylation 
was not observed. The presence of the indole N-H group was essential, as N-alkyl indoles 
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did not participate in the reaction. Unfortunately, efforts to extend this method to other 
heteroaromatic systems have thus far been unsuccessful. No reaction was observed with 
benzofuran or benzothiophene. The coupling of 2,5-dimethyl pyrrole did afford the desired 
product, but yields were modest due to oxidation of the electron-rich pyrrole product 
during the course of purification.  
Both aryl and alkenyl triflates 1-19 were effective coupling partners, and products 1-
20 were formed with good to excellent diastereoselectivity. However, the transformations 
were quite sensitive to steric properties of the substrate. Aryl triflates bearing substituted 
alkenes failed to react, and a substrate with a methyl group at the allylic position was 
transformed in low yield.  
1.9 Mechanism and Stereochemistry of Palladium-Catalyzed Alkene 
Difunctionalization Reactions with Exogenous Nucleophiles 
Dr. White’s initial mechanistic hypothesis (Section 1.3, Scheme 1-6) suggested that 
the products of these reactions should result from net addition of the nucleophile and the 
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aryl (or alkenyl) group to the cyclizing double bond. In order to probe this hypothesis, Dr. 
White and co-workers examined the stereochemical outcome of the reaction between 
pyrrolidine and deuterated alkene substrate 1-21.26 As shown in Scheme 1-15, this 
reaction afforded trans-disubstituted product 1-22 as a single diastereomer (>20:1 dr). 
This result is consistent with our original hypothesis, involving oxidative addition to afford 
1-23, anti-aminopalladation of the alkene to give 1-24, and then reductive elimination to 
provide the product 1-22.  
Our working model to explain both absolute and relative stereochemistry in these 
transformations is based on the mechanistic hypothesis derived above. We believe that 
the alkene hetero- or carbo-palladation step is likely the stereodetermining step of these 
reactions, but this step may be reversible depending on the nucleophile.34 Our current 
stereochemical model does provide explanations for the origin of the major enantiomer 
or diastereomer in these transformations, but does not account for the influence of small 
changes to structure (sterics or electronics) on stereoselectivity. 
 Our working hypothesis for the origin of enantioselectivity in the Pd/t-butyl-
phosphinooxazoline catalyzed reactions is based on a model originally proposed by Guiry 
for asymmetric Heck reactions.35 As shown in Scheme 1-16,26 following oxidative addition 
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of the substrate, the alkene can bind to the metal such that the less-substituted carbon is 
relatively close to the bulky tert-butyl group (1-25), or with the more substituted and more 
hindered carbon of the alkene closer to the tert-butyl group (1-26, via rotation around the 
Pd-CAr bond axis). Reaction through the apparently less-sterically hindered and favored 
complex 1-25 leads to the observed major stereoisomer (R)-1-7. 
We believe the relative stereochemistry in transformations of alkenyl triflate substrates 
is largely controlled by reaction through an organized, chair-like, transition state during 
the alkene nucleopalladation step of the catalytic cycle. As shown in Scheme 1-17, 
binding of the alkene through transition state 1-28, in which the smaller group (RS) is 
oriented in an axial position, would afford products with the observed relative 
stereochemistry between the nucleophile and the smaller substituent adjacent to the 
cyclizing allyl group.  We cannot currently explain the influence of biaryl phosphine 
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structure on stereocontrol that was observed in reactions of acyclic alkenyl triflates 
(Scheme 1-11), although it is possible that larger phosphines (e.g., BrettPhos) may result 
in reaction through pseudoaxial orientation of the cyclizing alkene. 
1.10 Conclusion 
In conclusion, the Wolfe group has developed a new class of alkene difunctionalization 
reactions between aryl or alkenyl triflates bearing tethered alkenes, and nucleophiles 
such as amines, alcohols, and indoles. The transformations generate two bonds, 1–2 
stereocenters, and proceed in good yields and high diastereoselectivities for most cases. 
However, many important challenges remain unsolved, including the development of 
enantioselective variants of these reactions that have broad scope and generality. Many 
useful classes of nucleophiles have not yet been explored, and fully intermolecular 
reactions between an alkene, an aryl/alkenyl halide/triflate electrophile, and a nucleophile 
have not been developed. Chapter 2 will detail alkene difunctionalization reactions with 
enolate nucleophiles.  
The work described in this chapter was published in the Israel Journal of Chemistry.36 
This chapter was adapted with permission from Bornowski, E. C.; Dr. White, D. R.; and 
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Chapter 2  
Pd-Catalyzed Alkene Difunctionalization Reactions of Enolates for the Synthesis 
of Substituted Bicyclic Cyclopentanes 
2.1 Introduction  
In recent years, transition metal-catalyzed alkene difunctionalization reactions that 
form two carbon−carbon bonds have emerged as powerful tools for the construction of 
substituted alkanes, heterocycles, and carbocycles.1,2 As described in Chapter 1, our 
group has described a new series of Pd-catalyzed alkene difunctionalization reactions 
that involve the coupling of amine,3 alcohol/phenol,4 or indole5 nucleophiles with alkenes 
tethered to aryl or alkenyl triflates (2-1a). The transformations generate functionalized 
cyclopentane derivatives in good yield with high diastereoselectivity. For example, the 
Pd/BrettPhos-catalyzed coupling of 2-1a with morpholine afforded 2-2a in 76% yield with 
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>20:1 dr (eq 2-1).  Similarly, treatment of 2-1a with 3-phenylpropanol (eq 2-2) or indole 
(eq 2-3) provided 2-2b and 2-2c, respectively, in good yields with >20:1 
diastereoselectivity under appropriate conditions. 
 In order to further explore the scope of this general class of transformations, we 
elected to examine the use of stabilized carbanions as nucleophiles for alkene 
difunctionalization. We were cautiously optimistic about the chances for success at the 
outset of these studies, as enolates and related compounds have previously been 
employed as nucleophiles in a range of other palladium catalyzed reactions, including C-
arylation6 and allylic alkylation; most notably in the Tsuji-Trost reaction7 (eq 2-4). 
 As shown in Scheme 2-1, the Tsuji-Trost reaction utilizes a substrate bearing an 
allylic leaving group (2-3) coordinating to form an η2 π-allyl palladium(0) species (2-3i) 
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that undergoes oxidative addition forming an η3 π-allyl palladium(II) complex (2-3ii). A 
nucleophile then adds to the allylic group, effectively allowing the η3 π-allyl palladium (II) 
complex to undergo reductive elimination back to an η2 π-allyl palladium (0) complex (2-
3iii). The product (2-4) is liberated from the metal as the mechanistic cycle turns over.8 
The relative stereochemistry of the Tsuji-Trost reaction is determined by the “hardness” 
of the nucleophile (usually determined by the pka of the conjugate acid with pkas < 25 
categorized as “soft” and pkas > 25 as “hard”).9 As shown in Scheme 2-2, a soft 
nucleophile will give overall retention of stereochemistry due the exogenous nucleophilic 
attack of the least substituted carbon of the coordinated η3 complex. Hard nucleophiles 
give overall inversion of stereochemistry due to nucleophilic attack of the metal center 
and subsequent reductive elimination.10 Typically, malonates are employed as soft 
nucleophiles in the Tsuji-Trost reaction and recently, harder stabilized enolates have been 
utilized as overall soft nucleophiles (eq 2-5).7a  
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With this in mind, we first sought to explore the use of malonates as carbon centered 
nucleophiles in alkene aryl-alkylation or alkenyl-alkylation variants of our previous 
transformations. Harder stabilized enolates were also hypothesized to be adequate 
exogenous nucleophiles in our difunctionalization reactions. In addition, cyclopentane 
derivatives bearing malonate, ester, or ketone groups have previously shown utility as 
synthetic intermediates (select examples shown in Scheme 2-3).11,12  Importantly, the 
resulting carbonyl-substituted cyclopentane products could be further elaborated through 
manipulation of the carbonyl or functionalization of the double bond in alkenyl-triflate 
derived products. Therefore, the following describes a set of new alkene 
difunctionalization reactions of malonates, esters, and ketones that provide substituted 
cyclopentane derivatives in moderate to good yields with high levels of 
diastereoselectivity. 
The work described in this chapter is comprised of both the author’s (ECB), Derick R. 
White’s (DRW), and Elsa M. Hinds’ (EMH) contributions. DRW conducted early reaction 
optimization (eq 2-6, 0.2 mmol scale) and initial substrate scope investigations. EMH 
conducted reactions with internal olefins (Scheme 2-4: products 2-6e – 2-6h; Section 
2.4; Section 2.5) and synthesis of internal olefin starting materials. I have decided to 
include DRW’s and EMH’s results in this dissertation to give the reader the full story about 
this transformation. 
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2.2 Optimization of Reaction Conditions 
In order to probe the feasibility of alkene difunctionalization reactions involving enolate 
nucleophiles, we initially examined the coupling of diethyl malonate with 2-allylphenyl 
triflate (2-5a). We began our studies using conditions we had previously developed for 
similar reactions of alcohol or amine nucleophiles and were pleased to find that these 
conditions provided satisfactory results in this transformation (eq 2-6). The desired 
product 2-6a was formed in 93% isolated yield on a 0.2 mmol scale, 84% isolated yield 
on a 1.0 mmol scale, and 88% yield on a 1.5 g scale. 
2.3 Reaction Scope and Limitations of Aryl and Alkenyl Triflates with Malonates 
Given the successful outcome of this initial reaction, we elected not to pursue further 
optimization of conditions but instead decided to explore the scope of this transformation 
(Scheme 2-4).  Reactions between diethyl malonate and terminal alkene substrates (2-
5a–d) proceeded in good yield under our standard reaction conditions, and substrate 2-
5d was converted to 2-6d with >20:1 dr. In contrast, internal alkene substrates 2-5e–h 
were less reactive and suffered from competing base-mediated isomerization of the 
alkene and/or cleavage of the triflate to give the corresponding phenoxide. However, 
these problems could be alleviated to some extent through use of increased amounts of 
diethyl malonate (3.6 equiv) and lithium tert-butoxide (2.2 equiv) combined with a lower 
reaction temperature of 65 °C. Under these modified conditions, products 2-6e−h were 
obtained with >20:1 dr, albeit in modest isolated yields (33−46%).11 The diminished 
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reactivity of the internal alkene substrates is presumably due to their increased steric bulk, 
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which decreases the facility by which the alkene is bound to palladium. Substrate 2-5i, 
which contains a methyl group at the internal alkene carbon was transformed to 2-6i in 
only 14% yield because of competing, and somewhat surprising, 5-endo Heck-type 
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cyclization of the substrate to yield 2-6i-a. With longer reaction times, 2-6i-a isomerized 
to the internal alkene.  
We subsequently turned our attention to cyclic alkenyl triflate substrates, which can 
be prepared from the corresponding cyclic ketones in two steps (Pd-catalyzed enolate 
allylation followed by formation of the enol triflate). Transformations of cyclic alkenyl 
triflates bearing pendent terminal alkenes proceeded in good to excellent yields in most 
cases examined (Scheme 2-5). The reactions were effective with substrates derived from 
both six and five-membered-ring ketones. Products bearing fused heterocyclic rings (2-
7b, 2-7c) were formed in good yields with high dr, and the presence of a substituent on 
the carbon bearing the allyl group (2-7e, 2-7g) was tolerated. When coupling substrate 2-
1d with diethyl malonate, product 2-7d was obtained in excellent yield, with moderate 9:1 
dr, and smoothly providing a quaternary center at the functionalized carbon. The reaction 
between substrate 2-1f and diethyl 2-allylmalonate provided 2-7f, with the formation of a 
bond between two quaternary carbon atoms, in 63% yield with 19:1 dr, although use of 
the smaller RuPhos ligand was needed to obtain acceptable results.  
2.4 Reoptimization of Reaction Conditions for Alkenyl Trfilates Bearing Internal 
Olefins 
Efforts to couple alkenyl triflates bearing internal alkenes failed to provide satisfactory 
results either under these conditions (Table 2-1, entry 1), or under the re-optimized 
conditions that were modestly effective with aryl triflates.  As such, Dr. Elsa Hinds elected 
to examine the influence of precatalyst and ligand structure on the reaction between 
diethyl malonate and 1l. As shown in Table 2-1, use of other biaryl phosphines,13 including 
CPhos, RuPhos, and SPhos that are less sterically hindered than BrettPhos provided 
improved results (45-48% yield). However, use of the wide bite angle ligand Dpe-Phos 
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afforded the desired product in 65% yield when LiHMDS was employed as base. We then 
examined Pd(acac)2 as a precatalyst, as we have previously observed increased 
efficiency in other transformations when this precatalyst was used.14 The combination of 
Pd(acac)2 with SPhos provided the best results, affording 2-7p in 79% yield and >20:1 dr. 
2.5 Reaction Scope and Limitations of Alkenyl Triflates Bearing Internal Olefins 
with Malonates 
Dr. Elsa Hinds then examined the use of these newly optimized conditions with a 
number of different internal alkene substrates (Scheme 2-6). The transformations 
proceed in moderate to good yield, with generally high (>20:1) diastereoselectivity. A 
substituent (R ≠ H) on the carbon bearing the tethered alkene was tolerated, and in some 
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instances provided a significant increase in yield. For example, the coupling of 2-1l (R = 
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CO2Et) with diethyl malonate proceeded to give 2-7p in 79% yield, whereas the analogous 
substrate 2-1m (R = H) was converted to 2-7q in only 21% yield. Not surprisingly, use of 
di-tert-butyl malonate as the nucleophile provided results similar to those obtained with 
diethyl malonate. Transformations involving diethyl 2-benzyl malonate also provided 
desired products 2-7j, 2-7n, and 2-7s in >20:1 dr, although higher reaction temperatures 
were required (110 °C), and chemical yields were lower than those obtained with the 
unsubstituted diethyl malonate nucleophile. 
2.6 Reaction Scope and Limitations of Acyclic Alkenyl Triflates with Malonates 
In prior studies involving amine or alcohol nucleophiles, we found that acyclic alkenyl 
triflates are also viable substrates in related alkene difunctionalization reactions.3b,4 As 
such, we briefly examined the reactivity of two acyclic substrates with diethyl malonate. 
As shown in eq 2-7, the coupling of 2-8 with diethyl malonate proceeded smoothly under 
standard conditions to afford spirocycle 2-9 in 82% and >20:1 dr. However, when gem-
diester substrate 2-10 was treated with di-tert-butyl malonate under analogous conditions, 
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we obtained a 4:1 mixture of 2-11a:2-11b in 53% yield (eq 2-8). A preliminary screen of 
several other phosphine ligands, including X-Phos, dpe-Phos, and P(2-furyl)3, provided 
similar mixtures of 2-11a:2-11b (ranging from 2:1 to 1:2.5) in good yields (up to 90% for 
the mixture). Chapter 3 is directed towards improving the regioselectivity in these 
transformations and exploring the scope of the reaction.  
2.7 Reaction Scope and Limitations of Alkenyl and Aryl Triflates with Other 
Stabilized Carbanions 
In addition to symmetrical malonate esters, these transformations are also effective 
with other stabilized carbanion nucleophiles. For example, the reaction between 2-1a and 
ethyl acetoacetate afforded 2-12a in 83% yield as a 1:1 mixture of stereoisomers epimeric 
at the stereocenter adjacent to the carbonyl group (Scheme 2-7, eq 2-9). Use of triethyl 
phosphonoacetate as the nucleophile, combined with LiHMDS as base, provided 2-12b 
in 55% yield on a 1.85 mmol scale (Scheme 2-7, eq 2-10). However, reactions involving 
other activated nucleophiles were more challenging. Ethyl cyanoacetate was much less 
reactive than diethyl malonate, and only small amounts of desired product were formed 
under standard conditions. Nonetheless, after some experimentation we were able to 
produce 2-12c in 50% yield by using (BrettPhos)Pd(allyl)Cl as the precatalyst15 along with 
Cs2CO3 as base (Scheme 2-7, eq 2-11). These conditions were also effective for the 
coupling of 2-allylphenyl triflate 2-5a with ethyl cyanoacetate to afford 2-13a in 47% yield 
(Scheme 2-7, eq 2-12). Efforts to employ 2,4-pentanedione (acac) as the nucleophile 
provided only trace amounts of product, possibly due to inhibition of catalysis by acac 
acting as a ligand for Pd. In contrast, 2-5a was successfully coupled with 2-acetyltetralone 
under modified conditions in which an excess (2.6 equiv) of LiHMDS was employed as 
base. In this case the alkylation occurred on the methyl group rather than the carbon 
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between the carbonyls, presumably via the dianion derived from 2-acetyltetralone, to 
afford 2-13b (Scheme 2-7, eq 2-13) in 40% yield.16 The modest yield results from 
competing arylation6 of the methyl ketone with 2-allylphenyl triflate, rather than alkene 
difunctionalization. Although these other nucleophiles proved to be viable with terminal 
alkene substrates, efforts to couple them with internal alkene derivatives have thus far 
been unsuccessful.  
 39 
2.8 Reaction Scope and Limitations of Alkenyl and Aryl Triflates with Esters 
Given the successful transformations of malonates and related nucleophiles, we 
sought to further expand the scope of this method by employing other carbonyl-containing 
nucleophiles. As such, we surveyed the reactivity of a few aryl and alkenyl triflate 
substrates towards several different esters. Efforts to employ acetate esters gave poor 
results, as represented by the formation of 2-14a in only 24% yield. The main side reaction 
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in this case is identical to that observed with 2-acetyltetralone – competing α-arylation of 
the ester with the aryl triflate substrate. In contrast, much better results were obtained 
with more highly substituted esters. For example, the sterically hindered methyl 
isobutyrate was coupled with terminal alkene substrates 2-5a and 2-1a to afford 2-14b 
and 2-14g in high yield. This hindered ester was also successfully coupled with substrates 
bearing a methyl group on the internal alkene carbon (2-1d, 2-1f, 2-5i, and 2-5j) when 
RuPhos was used as the ligand for Pd. These reactions afforded 2-14h, 2-14i, 2-14d, and 
2-14c in 52%, 50%, 24%, and 23% yield, respectively. Although the yields in these 
particular transformations are modest, the reactions do affect the formation of a C–C bond 
between two quaternary carbon atoms, and products 2-14h and 2-14i17 were formed with 
high diastereoselectivity (11:1 dr and >20:1 dr, respectively). Acyclic alkenyl triflate 15 
was also successfully coupled with methyl isobutyrate using the Pd(OAc)2/RuPhos 
catalyst to afford 16 in 52% yield and >20:1 dr (eq 2-14).  Reactions between 2-1a or 2-
5a and methyl 2-phenyl acetate afforded 2-14e and 2-14f in moderate to good yield, but 
2-14f was obtained as a 2:1 mixture of diastereomers epimeric at the stereocenter 
adjacent to the ester. 
2.9 Reaction Scope and Limitations of Alkenyl and Aryl Triflates with Ketones  
The coupling of 2-1a or 2-5a with several different ketones also proceeded smoothly, 
and this series of reactions exhibited the same general trends that were observed with 
ester nucleophiles. Low to moderate yields were obtained with methyl ketones (2-17a; 
24% and 2-17h; 52%), and in the case of 1,1-diphenyl acetone, reaction selectively 
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occurred at the less hindered carbon, rather than through the more highly substituted, 
thermodynamic enolate. However, reactions of several other ketones, including α-
phenylacetophenone, α-tetralone, 6-methoxy-α-tetralone, and cyclohexanone, 
proceeded smoothly. In all cases examined, products were generated with essentially 
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complete control of relative stereochemistry around the bicyclic ring system. Products 2-
17i, 2-17j, and 2-17k, which contain a base-epimerizable stereocenter, were formed as 
essentially 1:1 mixtures of diastereomers epimeric at the carbonyl-bearing stereocenter. 
However, the reaction of 2-methyl-α-tetralone to produce 2-17l, which lacks a base-
epimerizable proton, also proceeded with 1:1 dr. Interestingly, cyclohexanone underwent 
selective monoalkylation (using 2.6 equiv of cyclohexanone) to provide 2-17c and 2-17i; 
bis-alkylation products were not observed. This is likely due to the use of excess 
cyclohexanone, along with the fact that the thermodynamic enolates derived from 
products 2-17c and 2-17i are sterically encumbered. These hindered enolates should 
react much more slowly than the enolate of cyclohexanone itself, and the less-substituted 
“kinetic” enolates of the monoalkylated cyclohexanone products should be present in 
relatively low concentration under these conditions. 
2.10 Mechanism and Stereochemical Model 
Based on the stereochemical outcome of transformations involving internal alkenes, 
in which products result from anti-addition of the nucleophile and the aryl or alkenyl group 
to the pendant alkene, the mechanism of these transformations is probably similar to 
those of related reactions of amine, alcohol, or indole nucleophiles.3,4,5 As illustrated in 
Scheme 2-10, the reactions are likely initiated by oxidative addition of the aryl or alkenyl 
triflate (2-1) to a Pd(0) complex generated by ligation and reduction of the Pd(II) 
precatalyst. After oxidative addition, the alkene in intermediate 2-18 is poised to bind to 
the Pd(II) center, which activates it for attack by the exogenous nucleophile in 
intermediate 2-19. This intermediate then undergoes anti-carbopalladation to provide 2-
20, which is transformed to the desired product with regeneration of the Pd(0) catalyst 
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through reductive elimination. The observed major product stereochemistry is consistent 
with carbopalladation through a chair-like conformation in which non-bonding interactions 
are minimized. Although control of relative stereochemistry of the substituents on the 
bicyclic ring system is generally quite high, we currently are unable to control the relative 
stereochemistry of stereocenters adjacent to the carbonyl of the nucleophilic component. 
For products such as 2-14f and 2-17i-k, which contain an acidic proton at the carbonyl α-
stereocenter, the poor stereocontrol is easily ascribed to epimerization under the strongly 
basic reaction conditions. However, the poor selectivity in the formation of 2-17l, which 
does not contain an epimerizable α-stereocenter, reveals a second problem in 
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stereocontrol. In this case the 1:1 dr must result from inherently low relative face 
selectivity when the enolate approaches intermediate 2-19 (Scheme 2-10).  
2.11 Conclusion 
In conclusion, we have developed a series of new alkene difunctionalization reactions 
between alkenes bearing pendant aryl or alkenyl triflates, and enolate nucleophiles 
derived from esters, ketones, and malonates. Reactions of terminal alkene substrates are 
reasonably general, and transformations involving internal alkenes provide moderate 
yields when malonate nucleophiles are used. The reactions generate a ring and two C–
C bonds, and provide products that contain up to three stereocenters with high 
diastereoselectivity in most cases examined. The product stereochemistry implicates a 
mechanism involving anti-carbopalladation of the alkene, which occurs with high 
diastereoselectivity. The transformations afford several different fused-bicyclic products, 
including heterocycles, although reactions that generate simple monocyclic cyclopentane 
derivatives are currently limited in scope due to the formation of regioisomeric 
cyclobutene products. 
The work described in this chapter was published in Organic Letters18 and Organic 
Process Research & Development.19 This chapter was adapted with permission from 
Bornowski, E. C.; Dr. Hinds, E. M.; Dr. White, D. R.; Nakamura, Y.; and Dr. Wolfe, J. P. 
Org. Lett. 2019, 21, 3813–3816 Copyright (2019) American Chemical Society and Org. 
Process Res. Dev. 2019, 23, 1610–1630 Copyright (2019) American Chemical Society. 
2.12 Experimental 
General Considerations: All reactions were carried out under a nitrogen atmosphere in 
flame-dried glassware. All reagents, palladium precatalysts, and ligands were purchased 
from commercial sources and were used without purification unless otherwise noted. The 
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substrates 2-1a-e,3b 2-1f,4 2-1g,3a 2-5a,3a 2-5c,3a 2-5d,3b 2-8,3b 2-10,3b 2-15,3b 
(Brettphos)Pd(allyl)(Cl),15 N-(2-pyridyl)triflimide,20 4-tert-butyl-2-allylphenol,21 and ally 1-
methyl-2-oxocyclohexane-1-carboxylate22 were prepared by previously published 
methods. Alkenyl triflate starting materials were stored in a freezer under nitrogen. Bulk 
quantities of cesium carbonate, lithium tert-butoxide, and lithium hexamethyldisilazide 
were stored in nitrogen-filled glove box, and small amounts were removed and used 
within a few days, during which time they were stored in a desiccator. Toluene, 
tetrahydrofuran, dichloromethane, and diethyl ether were purified using a GlassContour 
solvent purification system. Anhydrous 1,4 dioxane was purchased from Sigma-Aldrich 
and was used without purification. Structural and stereochemical assignments were made 
on the basis of 2-D COSY and NOESY experiments. Ratios of diastereomers were 
determined by 1H NMR analysis. Yields refer to isolated yields of compounds estimated 
to be ≥95% pure as determined by 1H NMR analysis unless otherwise noted. The yields 
reported in the experimental section describe the result of a single experiment, whereas 
yields reported in Schemes 2-4 – 2-10 and equations 2-6 – 2-14 are average yields of 
two or more experiments. Thus, the yields reported in the experimental section may differ 
from those shown in Schemes 2-4 – 2-10 and equations 2-6 – 2-14.  
Preparation and Characterization of Substrates 
 
2-Allyl-4-(tert-butyl)phenyl trifluoromethanesulfonate (2-5b). A flame-dried flask 
equipped with a stir bar was cooled under a stream of nitrogen and charged with 2-allyl-
4-tert-butylphenol (0.231 g, 1.21 mmol, 1.0 equiv) and dichloromethane (1.3 mL, 1 M). 
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Pyridine (0.117 mL, 1.48 mmol, 1.2 equiv) was added, and the reaction was cooled to 0 
°C. Trifluoromethanesulfonic anhydride (0.225 mL, 1.34 mmol, 1.1 equiv) was added, the 
ice bath was removed, and the reaction was stirred for 15 h at rt. The mixture was 
quenched with ammonium chloride and extracted with DCM (x3). The organic layer was 
dried with MgSO4 and concentrated in vacuo to yield a brown oil. The crude material was 
purified via column chromatography on silica gel using 99:1 hexanes:ethyl acetate as the 
eluent.  This procedure afforded 0.334 g (85%) of the title compound as a colorless oil. 
1H NMR (500 MHz, CDCl3)  7.32 – 7.25 (m, 2H), 7.19 – 7.14 (m, 1H), 5.98 – 5.87 (m, 
1H), 5.18 – 5.09 (m, 2H), 3.47 (d, J = 6.6 Hz, 2H), 1.31 (s, 9H). 13C NMR (126 MHz, 
CDCl3)  151.5, 145.7, 134.9, 131.9, 128.3, 125.1, 120.7, 118.5 (q, JC-F = 321 Hz) 117.2, 
77.2, 34.7, 34.3, 31.2. IR (film) 2967, 1491 cm-1. HRMS (ESI+ TOF) m/z: [M + H+]+ calcd 
for C14H17F3O3S 323.0850; found 323.0565 
 
2-Cinnamylphenol (2-S1). A flame-dried 2-neck flask equipped with a stir bar and a 
condenser was cooled under a stream of nitrogen and charged with phenol (2.0 g, 21.2 
mmol, 1.0 equiv) and diethyl ether (22 mL, 0.1 M). Sodium hydride (60% in mineral oil, 
1.7 g, 42.4 mmol, 2.0 equiv) was added, and the reaction stirred at rt for 30 min. Cinnamyl 
chloride was added and the reaction heated to 37 °C with stirring for 6 h. The reaction 
was cooled to rt, and the mixture was transferred to an Erlenmeyer flask containing 
aqueous HCl (0.1 M, 75 mL). The mixture was stirred briefly then transferred to a 
separatory funnel. The layers were separated, and the aqueous layer was extracted with 
diethyl ether (3 x 20 mL). The combined organic layers were washed with brine, dried 
over MgSO4, filtered and concentrated in vacuo to yield a yellow oil. The crude material 
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was purified via column chromatography on silica gel using 95:5 -> 90:10 hexanes:ethyl 
acetate as the eluent. This procedure afforded 2.52 g (57%) of the title compound as a 
yellow semisolid, mp 57-58 °C. 1H NMR (500 MHz, CDCl3)  7.28 (d, J = 18.1 Hz, 4H), 
7.25 – 7.11 (m, 3H), 6.91 (s, 1H), 6.82 (d, J = 8.0 Hz, 1H), 6.51 (d, J = 15.9 Hz, 1H), 6.44 
– 6.34 (m, 1H), 4.89 (s, 1H), 3.58 (d, J = 6.5 Hz, 2H). 13C NMR (126 MHz, CDCl3)  154.0, 
137.1, 131.5, 130.5, 128.5 (2 peaks), 127.9 (2 peaks), 127.3, 126.2, 121.0, 115.8, 34.1. 
IR (film) 3531.5, 1591.7, cm-1. HRMS (ESI- TOF) m/z: [M - H+]- calcd for C15H14O 
209.0966; found 209.0972.  
 
2-Cinnamylphenyl trifluoromethanesulfonate (2-5e). A flame-dried flask equipped 
with a stir bar was cooled under a stream of nitrogen and charged with 2-cinnamylphenol 
(2-S1) (0.934 g, 4.45 mmol, 1.0 equiv) and dichloromethane (20 mL, 0.2 M). Pyridine 
(0.72 mL, 8.9 mmol, 2.0 equiv) was added, and the reaction was cooled to 0 °C. 
Trifluoromethanesulfonic anhydride (1.5 mL, 8.9 mmol, 2.0 equiv) was added, the ice bath 
was removed, and the reaction was stirred for 15 h at rt. The purple mixture was filtered 
through a pad of celite, eluting with ethyl acetate. The purple filtrate was concentrated in 
vacuo to yield a purple oil.  The crude material was purified via column chromatography 
on silica gel using 98:2 hexanes:ethyl acetate as the eluent. This procedure afforded 1.18 
g (78%) of the title compound as a colorless oil. 1H NMR (500 MHz, CDCl3)  7.46 – 7.13 
(m, 9H), 6.51 (d, J = 15.8 Hz, 1H), 6.35 – 6.22 (m, 1H), 3.65 (d, J = 6.8 Hz, 2H). 13C NMR 
(126 MHz, CDCl3)  147.9, 137.0, 133.1, 132.7, 131.4, 128.5, 128.2, 127.4, 126.2, 126.1, 
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121.4, 118.5 (q, JC-F = 319 Hz), 33.2, 29.7. IR (film) 1595.3, cm-1. HRMS (ESI+ TOF) m/z: 
[M + H+]+ calcd for C16H13F3O3S 342.0538; found 342.0538.  
 
2-Cinnamyl-4-fluorophenol (2-S2).  The title compound was synthesized via a similar 
procedure described above for the preparation of 2-cinnamylphenol (2-S1), except using 
4-fluorophenol (2.9 g, 17.86 mmol, 1.0 equiv), cinnamyl chloride (2.5 mL, 17.86 mmol, 
1.0 equiv), and sodium hydride (60% in mineral oil, 1.428 g, 35.7 mmol, 2.0 equiv). The 
crude material was purified via column chromatography on silica gel using 95:5 -> 90:10 
hexanes:ethyl acetate as the eluent. This procedure afforded 2.617 g (64%) of the title 
compound as a yellow solid, mp 51-52 °C. 1H NMR (500 MHz, CDCl3)  7.41 – 7.16 (m, 
5H), 6.90 (d, J = 9.0 Hz, 1H), 6.83 (d, J = 13.6 Hz, 1H), 6.75 (d, J = 13.4 Hz, 1H), 6.51 (d, 
J = 15.9 Hz, 1H), 6.35 (d, J = 15.9 Hz, 1H), 4.78 (s, 1H), 3.54 (d, J = 6.6 Hz, 2H). 13C 
NMR (126 MHz, CDCl3)  158.1, 156.2, 149.8 (d, J = 2.5 Hz), 136.9, 132.0, 128.6, 127.4 
(d, J = 7.5 Hz), 127.0, 126.2, 116.6 (d, J = 31 Hz), 116.5 (d, J = 18 Hz), 113.9 (d, J = 23 
Hz),  34.0. IR (film) 3411.7, 1619.3 cm-1. HRMS (ESI- TOF) m/z: [M - H+]- calcd for 
C15H13FO 227.0872; found 227.0878.  
 
2-Cinnamyl-4-fluorophenyl trifluoromethanesulfonate (2-5f). The title compound was 
synthesized via a similar procedure described above for the preparation of 2-
cinnamylphenyl trifluoromethanesulfonate (2-5e), except using 2-cinnamyl-4-
fluorophenol (2-S2) (0.79 g, 3.47 mmol, 1.0 equiv), trifluoromethanesulfonic anhydride 
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(1.16 mL, 6.94 mmol, 2.0 equiv), and pyridine (0.56 mL, 6.94 mmol, 2.0 equiv). The crude 
material was purified via column chromatography on silica gel using 100:1 -> 98:2 
hexanes:ethyl acetate as the eluent. This procedure afforded 0.8474 g (68%) of the title 
compound as a colorless oil. 1H NMR (500 MHz, CDCl3)  7.52 – 7.22 (m, 6H), 7.15 (d, J 
= 8.7 Hz, 1H), 7.04 (s, 1H), 6.60 (d, J = 15.8 Hz, 1H), 6.31 (dd, J = 15.8, 7.0 Hz, 1H), 3.69 
(d, J = 7.0 Hz, 2H). 13C NMR (126 MHz, CDCl3)  162.6, 160.6, 143.5 (d, J = 4 Hz), 136.8, 
135.9 (d, J = 8 Hz), 133.5, 127.7, 126.3, 125.1, 123.1 (d, J = 9 Hz), 118.7 (q, J = 319 Hz), 
117.9 (d, J = 24 Hz), 115.0 (d, J = 24 Hz), 33.3. IR (film) 1592.3, cm-1. HRMS (ESI+ TOF) 
m/z: [M + H+]+ calcd for C16H12F4O3S 361.0522; found 361.0516. 
 
2-Cinnamyl-4-methoxyphenol (2-S3). The title compound was synthesized via a similar 
procedure described above for the preparation of 2-cinnamylphenol (2-S1), except using 
4-methoxyphenol (1.9 g, 14.4 mmol, 1.0 equiv), cinnamyl chloride (2.0 mL, 14.4 mmol, 
1.0 equiv), and sodium hydride (60% in mineral oil, 1.15 g, 28.8 mmol, 2.0 equiv)). The 
crude material was purified via column chromatography on silica gel using 95:5 -> 90:10 
hexanes:ethyl acetate as the eluent. This procedure afforded 1.516 g (44%) of the title 
compound as an orange solid, mp 74–76 °C. 1H NMR (500 MHz, CDCl3)  7.46 – 7.10 
(m, 5H), 6.83 – 6.61 (m, 3H), 6.50 (d, J = 15.9 Hz, 1H), 6.37 (d, J = 15.8 Hz, 1H), 4.59 (s, 
1H), 3.76 (s, 3H), 3.54 (d, J = 6.3 Hz, 2H). 13C NMR (126 MHz, CDCl3)  153.8, 137.0, 
131.6, 128.6 (2 peaks), 128.5, 127.7, 126.8, 126.2, 116.5, 116.0, 112.6, 55.7, 34.3. IR 
(film) 3384.8, 1598.5, cm-1. HRMS (ESI- TOF) m/z: [M - H+]- calcd for C16H16O2 239.1072; 
found 239.1078.  
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2-Cinnamyl-4-methoxyphenyl trifluoromethanesulfonate (2-5g). The title compound 
was synthesized via a similar procedure described above for the preparation of 2-
cinnamylphenyl trifluoromethanesulfonate (2-5e), except using 2-cinnamyl-4-
methoxyphenol (2-S3) (1.0 g, 4.17 mmol, 1.0 equiv), trifluoromethanesulfonic anhydride 
(1.4 mL, 8.33 mmol, 2.0 equiv), and pyridine (0.67 mL, 8.33 mmol, 2.0 equiv). The crude 
material was purified via column chromatography on silica gel using 98:2 -> 95:5 
hexanes:ethyl acetate as the eluent. This procedure afforded 1.18 g (76%) of the title 
compound as a colorless oil. 1H NMR (500 MHz, CDCl3)  7.44 – 7.13 (m, 6H), 6.87 (s, 
1H), 6.79 (d, J = 9.0 Hz, 1H), 6.51 (d, J = 15.8 Hz, 1H), 6.34 – 6.18 (m, 1H), 3.80 (s, 3H), 
3.60 (d, J = 6.9 Hz, 2H). 13C NMR (126 MHz, CDCl3)  159.0, 141.3, 137.0, 134.4, 132.8, 
128.5, 127.4, 126.2, 126.0, 122.4, 118.7 (q, JC-F = 305 Hz), 116.3, 112.8, 55.7, 33.5. IR 
(film) 1587.1 cm-1. HRMS (ESI+ TOF) m/z: [M + NH4+]+ calcd for C17H15F3O4S 390.0987; 
found 390.0981.  
 
2-Cinnamyl-4-methylphenol (2-S4). The title compound was synthesized via a similar 
procedure described above for the preparation of 2-cinnamylphenol (2-S1), except using 
4-methylphenol (2.3 mL, 22.0 mmol, 1.0 equiv), cinnamyl chloride (3.0 mL, 22.0 mmol, 
1.0 equiv), and sodium hydride (60% in mineral oil, 1.80 g, 44.0 mmol, 2.0 equiv). The 
crude material was purified via column chromatography on silica gel using 95:5 -> 90:10 
hexanes:ethyl acetate as the eluent. This procedure afforded 2.68 g (54%) of the title 
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compound as a yellow wax. 1H NMR (500 MHz, CDCl3)  7.44 – 7.14 (m, 5H), 7.04 – 6.88 
(m, 2H), 6.72 (d, J = 8.0 Hz, 1H), 6.56 – 6.46 (m, 1H), 6.44 – 6.33 (m, 1H), 4.75 (s, 1H), 
3.54 (dd, J = 6.5, 1.4 Hz, 2H), 2.28 (s, 3H). 13C NMR (126 MHz, CDCl3)  151.7, 137.1, 
131.4, 131.0, 130.2, 128.5, 128.2, 128.1, 127.3, 126.2, 125.4, 115.6, 34.1, 20.5. IR (film) 
3214.4, 2750.3, 1495.7, 1405.2, 1275.7 cm-1. HRMS (Electron Impact Ionization TOF) 
m/z: [M + H+]+ calcd for C16H16O 224.1201; found 224.1201.  
 
2-Cinnamyl-4-methylphenyl trifluoromethanesulfonate (2-5h). The title compound 
was synthesized via a similar procedure described above for the preparation of 2-
cinnamylphenyl trifluoromethanesulfonate (2-5e), except using 2-cinnamyl-4-
methylphenol (2-S4) (1.02 g, 4.46 mmol, 1.0 equiv), trifluoromethanesulfonic anhydride 
(1.5 mL, 8.93 mmol, 2.0 equiv), and pyridine (0.72 mL, 8.93 mmol, 2.0 equiv). The crude 
material was purified via column chromatography on silica gel using 100:0 -> 98:2 
hexanes:ethyl acetate as the eluent. This procedure afforded 1.20 g (76%) of the title 
compound as a colorless oil. 1H NMR (500 MHz, CDCl3)  7.38 (d, J = 7.0 Hz, 2H), 7.32 
(t, J = 7.6 Hz, 2H), 7.28 – 7.20 (m, 1H), 7.20 – 7.13 (m, 2H), 7.10 (dd, J = 8.4, 2.2 Hz, 
1H), 6.51 (d, J = 15.7 Hz, 1H), 6.35 – 6.21 (m, 1H), 3.61 (dd, J = 7.0, 1.5 Hz, 2H), 2.35 
(s, 3H). 13C NMR (126 MHz, CDCl3)  145.8, 138.5, 137.1, 132.6, 132.5, 131.9, 128.7, 
128.5, 128.4, 127.4, 126.3, 118.6 (q, JC-F = 321 Hz), 121.1, 33.2, 20.9. IR (film) 3028.5, 
2924.4, 1599.3, 1490.7, 1417.7 cm-1. HRMS (ESI+ TOF) m/z: [M + NH4+]+ calcd for 
C17H15F3O3S 374.1038; found 374.1032.  
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4-(tert-Butyl)-2-(2-methylallyl)phenyl trifluoromethanesulfonate (2-5i). A flame-dried 
thick-walled sealable glass pressure flask equipped with a stir bar was cooled under a 
stream of nitrogen and charged with 1-(tert-butyl)-4-[(2-methylallyl)oxy]benzene (5.33g, 
26 mmol) and dimethylformamide (5 mL, 5.2 M). The solution was heated to 200°C for 12 
h, then was cooled to rt and ethyl acetate (20 mL) was added. The mixture was transferred 
to a separatory funnel, washed with water (3 x 20 mL), then was dried with anhydrous 
MgSO4 and concentrated in vacuo to yield a brown oil. The crude material was purified 
via column chromatography on silica gel using 80:20 hexanes:dichloromethane as the 
eluent. This procedure afforded 4.05 g (76%) of 4-(tert-butyl)-2-(2-methylallyl)phenol as 
a colorless oil with ca 3% of a side product resulting from isomerization of the alkene. 1H 
NMR (401 MHz, CDCl3)  7.14 (dd, J = 8.4, 2.5 Hz, 1H), 7.07 (d, J = 2.5 Hz, 1H), 6.75 
(d, J = 8.4 Hz, 1H), 4.97 (s, 1H), 4.90 (s, 1H), 4.83 (s, 1H), 3.36 (s, 2H), 1.74  (s, 3H), 
1.28 (s, 9H). 
A flame-dried flask equipped with a stir bar was cooled under a stream of nitrogen and 
charged with 4-(tert-butyl)-2-(2-methylallyl)phenol (1.4 g, 6.85 mmol, 1.0 equiv) and 
dichloromethane (7 mL, 1 M). Pyridine (1.4 mL, 8.22 mmol, 1.2 equiv) was added, and 
the mixture was cooled to 0 °C. Trifluoromethanesulfonic anhydride (0.7 mL, 8.22 mmol, 
1.2 equiv) was added, the ice bath was removed, and the reaction was stirred at rt for 15 
h. The mixture was quenched with saturated aqueous ammonium chloride (10 mL) and 
then transferred to a separatory funnel. The mixture was extracted with dichloromethane 
(3 x 10 mL), then the organic layers were combined, dried with anhydrous MgSO4, and 
concentrated in vacuo to yield a brown oil. The crude material was purified via column 
chromatography on silica gel using 99:1 hexanes:ethyl acetate as the eluent.  This 
procedure afforded 2.06 g (89%) of the title compound as a colorless oil that contained 
ca 6% of a side product resulting from alkene isomerization. Data are for the major 
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isomer. 1H NMR (500 MHz, CDCl3)  7.32 – 7.27 (m, 2H), 7.20 – 7.14 (m, 1H), 4.89 (s, 
1H), 4.66 (s, 1H), 3.40 (s, 2H), 1.72 (s, 3H), 1.31 (s, 9H); 13C NMR (126 MHz, CDCl3)  
151.34, 146.09, 142.74, 131.42, 128.76, 125.07, 120.58, 118.5 (q, JC-F = 321 Hz), 113.05, 
38.29, 34.63, 31.23, 22.22. IR (film) 2951, 2700, 1480, 1415, 1208, 729 cm-1; HRMS 
(ESI+ TOF) m/z: [M + H+]+ calcd for C15H19F3O3S 337.1080; found 337.1077. 
 
Ethyl 1-cinnamyl-2-oxocyclopentane-1-carboxylate (2-S5). A flame-dried flask 
equipped with a stir bar was cooled under a stream of nitrogen and charged with sodium 
hydride (60% in mineral oil, 0.534 g, 13.35 mmol, 0.89 equiv) and THF (6 mL). The 
mixture was cooled to 0 °C and a solution of ethyl-2-oxocyclopentanecarboxylate (1.9 
mL, 15 mmol, 1 equiv) in THF (10 mL) was added dropwise over the course of 90 min. 
The reaction mixture was warmed to rt and stirred for 90 min, then a solution of cinnamyl 
bromide (2.6 mL, 17.25 mmol, 1.15 equiv) in THF (5 mL) was added and the mixture was 
stirred at rt for 16 h.  The reaction was quenched with saturated aqueous ammonium 
chloride (20 mL) and transferred to a separatory funnel. The layers were separated and 
the aqueous layer was extracted with ethyl acetate (3 x 20 mL). The combined organic 
layers were washed with brine (1 x 20 mL) and then dried over Na2SO4, filtered and 
concentrated in vacuo to afford a yellow oil. The crude material was purified via column 
chromatography on silica gel using 90:10 hexanes:ethyl acetate as the eluent. This 
procedure afforded 1.84 g (45%) of the title compound as a colorless oil. 1H NMR (500 
MHz, CDCl3)  7.40 – 7.25 (m, 4H), 7.21 (d, J = 14.2 Hz, 1H), 6.45 (d, J = 15.8 Hz, 1H), 
6.16 – 6.01 (m, 1H), 4.25 – 4.10 (m, 2H), 2.89 – 2.73 (m, 1H), 2.59 – 2.37 (m, 3H), 2.31 
– 2.16 (m, 1H), 2.04 (d, J = 14.0 Hz, 2H), 1.90 (d, J = 17.0 Hz, 1H), 1.25 (t, J = 7.1 Hz, 
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3H). 13C NMR (126 MHz, CDCl3)  214.6, 170.9, 137.0, 134.1, 128.5, 127.4, 126.2, 124.5, 
61.5, 60.2, 38.1, 37.0, 32.3, 19.6, 14.1. IR (film) 1750.4, 1719.9, 1448.4 cm-1. HRMS (ESI+ 
TOF) m/z: [M + H+]+ calcd for C17H20O3 272.1413; found 273.1485.  
 
Ethyl 1-cinnamyl-2-{[(trifluoromethyl)sulfonyl]oxy}cyclopent-2-ene-1-carboxylate 
(2-1l).  A flame-dried flask equipped with a stir bar was cooled under a stream of nitrogen 
and charged with THF (10 mL) and diisopropylamine (1.0 mL, 7.29 mmol, 1.7 equiv). The 
mixture was cooled to 0 °C, n-BuLi (2.5 M in hexanes, 2.9 mL, 7.29 mmol, 1.7 equiv) was 
added dropwise, and the resulting mixture was stirred at 0 °C for 30 min. The mixture was 
cooled to -78 °C and a solution of ethyl 1-cinnamyl-2-oxocyclopentane-1-carboxylate (2-
S5, 1.17 g, 4.29 mmol, 1 equiv) in THF (10 mL) was added dropwise over the course of 
90 min. The reaction mixture was stirred at -78 °C for 2.5 h, then N-(2-pyridyl)triflamide 
(2.61 g, 7.29 mmol, 1.7 equiv) in THF (5 mL) was added and the mixture was warmed to 
rt and stirred for 16 h. The reaction was quenched with water (20 mL) and the mixture 
was transferred to a separatory funnel. The layers were separated and the aqueous layer 
was extracted with ethyl acetate (3 x 20 mL). The combined organic layers were washed 
with brine (1 x 20 mL) and then dried over Na2SO4, filtered and concentrated in vacuo to 
afford a yellow oil. The crude material was purified via column chromatography on silica 
gel using 98:2 -> 95:5 hexanes:ethyl acetate as the eluent. This procedure afforded 1.18 
g (68%) of the title compound as a yellow oil. 1H NMR (500 MHz, CDCl3)  7.42 – 7.14 
(m, 5H), 6.50 (d, J = 15.7 Hz, 1H), 6.14 – 6.00 (m, 1H), 5.80 (s, 1H), 4.32 – 4.11 (m, 2H), 
2.78 (d, J = 8.0 Hz, 1H), 2.63 (d, J = 14.1 Hz, 1H), 2.48 (d, J = 9.3 Hz, 2H), 2.35 (d, J = 
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5.5 Hz, 1H), 2.15 – 1.93 (m, 1H), 1.29 (t, J = 7.2 Hz, 3H). 13C NMR (126 MHz, CDCl3)  
172.5, 147.9, 137.0, 134.5, 128.5, 127.5, 126.2, 123.6, 121.6 (q, JC-F = 375 Hz), 118.3, 
61.6, 57.6, 38.0, 31.2, 26.2, 14.0. IR (film) 1728.6, 1602.5, 1422.8 cm-1. HRMS (ESI+ 
TOF) m/z: [M + H+]+ calcd for C18H19F3O5S 405.0984; found 405.0978.  
 
2-Cinnamylcyclopentan-1-one (2-S6). A flame-dried flask equipped with a stir bar was 
cooled under a stream of nitrogen and charged with palladium allyl chloride dimer (0.146 
g, 0.4 mmol, 0.02 equiv), dppf (0.665 g, 1.2 mmol, 0.06 mmol), and methanol (80 mL). 
The mixture was stirred at rt for 60 min, then cinnamyl alcohol (2.8 mL, 22 mmol, 1.1 
equiv) was added to the orange mixture, and the resulting mixture was stirred at rt for 30 
min. Cyclopentanone (2.1 mL, 20 mmol, 1 equiv) and pyrrolidine (0.33 mL, 4 mmol, 0.2 
equiv) were added, and the mixture was then heated to 45 °C with stirring for 16 h. The 
reaction was quenched with cold saturated aqueous ammonium chloride (20 mL). The 
mixture was transferred to a separatory funnel, the layers were separated, and the 
aqueous layer was extracted with diethyl ether (3 x 20 mL). The combined organic layers 
were washed with brine (1 x 20 mL) and then dried over Na2SO4, filtered, and 
concentrated in vacuo to afford yellow oil. The crude material was purified via column 
chromatography on silica gel using 98:2 -> 95:5 hexanes:ethyl acetate as the eluent. This 
procedure afforded 3.38 g (83%) of the title compound as a colorless oil. 1H NMR (500 
MHz, CDCl3)  7.39 – 7.13 (m, 5H), 6.43 (d, J = 15.6 Hz, 1H), 6.24 – 6.08 (m, 1H), 2.65 
(d, J = 10.0 Hz, 1H), 2.41 – 2.16 (m, 4H), 2.11 (d, J = 8.8 Hz, 1H), 2.01 (s, 1H), 1.81 (dddt, 
J = 14.7, 8.5, 4.3, 2.3 Hz, 1H), 1.63 (s, 1H). 13C NMR (126 MHz, CDCl3)  220.4, 137.4, 
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131.8, 128.5, 127.6, 127.1, 126.0, 49.0, 38.2, 33.1, 29.0, 20.7. IR (film) 1732.7, 1597.2 
cm-1. HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C14H16O 201.1280; found 201.1274.  
 
5-Cinnamylcyclopent-1-en-1-yl trifluoromethanesulfonate (2-1m). A flame-dried flask 
equipped with a stir bar was cooled under a stream of nitrogen and charged with THF (20 
mL) and diisopropylamine (1.05 mL, 7.5 mmol, 1.5 equiv). The mixture was cooled to 0 
°C, n-BuLi (2.5 M in hexanes, 3.0 mL, 7.5 mmol, 1.5 equiv) was added dropwise, and the 
resulting solution was stirred at 0 °C for 30 min. The mixture was then cooled to -78 °C 
and a solution of 2-cinnamylcyclopentan-1-one (2-S6, 1.0 g, 5.0 mmol, 1 equiv) in THF 
(20 mL) was added dropwise over the course of 70 min. The reaction mixture was then 
stirred for 2 h at -78 °C, then a solution of N-(2-pyridyl)triflamide (2.61 g, 7.29 mmol, 1.2 
equiv) in THF (10 mL) was added. The resulting mixture was warmed to -41 °C in 
CH3CN/dry ice bath and stirred for 2 h. The reaction was quenched with water (20 mL) 
and the mixture was transferred to a separatory funnel. The layers were separated and 
the aqueous layer was extracted with ethyl acetate (3 x 20 mL). The combined organic 
layers were washed with brine (1 x 20 mL) and then dried over Na2SO4, filtered, and 
concentrated in vacuo to afford a yellow oil. The crude material was purified via column 
chromatography on silica gel using 100:0 -> 98:2 hexanes:ethyl acetate as the eluent. 
This procedure afforded 0.8675 g (52%) of the title compound as a colorless oil. 1H NMR 
(500 MHz, CDCl3)  7.35 (d, J = 18.6 Hz, 4H), 7.26 (s, 1H), 6.49 (d, J = 15.8 Hz, 1H), 6.18 
(d, J = 15.7 Hz, 1H), 5.71 (s, 1H), 3.04 (s, 1H), 2.57 (ddt, J = 11.1, 5.8, 2.9 Hz, 1H), 2.45 
– 2.26 (m, 3H), 2.20 (s, 1H), 1.80 (d, J = 6.2 Hz, 1H). 13C NMR (126 MHz, CDCl3)  151.3, 
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137.3, 132.6, 128.5, 127.2, 126.3, 126.1, 121.1 (q, JC-F = 315 Hz), 117.4, 43.0, 35.7, 26.7, 
26.6. IR (film) 1656.6, 1495.7 cm-1. HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for 
C15H15F3O3S 333.0772; found 333.0767.  
 
Ethyl 1-cinnamyl-2-oxocyclohexane-1-carboxylate (2-S7). The title compound was 
synthesized via a similar procedure described above for the preparation of ethyl 1-
cinnamyl-2-oxocyclopentane-1-carboxylate (2-S5), except using ethyl-2-
oxocyclohexanecarboxylate (3.2 mL, 20 mmol, 1 equiv), cinnamyl bromide (3.4 mL, 23.0 
mmol, 1.15 equiv), and sodium hydride (0.712 g, 17.8 mmol, 0.89 equiv). The crude 
material was purified via column chromatography on silica gel using 95:5 -> 90:10 
hexanes:ethyl acetate as the eluent. This procedure afforded 3.58 g (63%) of the title 
compound as a yellow oil. 1H NMR (500 MHz, CDCl3)  7.39 – 7.12 (m, 5H), 6.37 (d, J = 
15.8 Hz, 1H), 6.24 – 6.09 (m, 1H), 4.16 (q, J = 7.1 Hz, 2H), 2. 73 (tdd, J = 11.5, 7.1, 1.4 
Hz, 1H), 2.56 – 2.41 (m, 3H), 2.01 (ddt, J = 9.2, 6.2, 3.1 Hz, 1H), 1.81 – 1.57 (m, 4H), 
1.57 – 1.49 (m, 1H), 1.21 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3)  207.6, 171.5, 
137.2, 133.2, 128.4, 127.2, 126.1, 125.1, 61.3, 41.2, 38.6, 36.1, 27.9, 27.5, 22.5, 14.2. IR 
(film) 1709.8 (2 overlapping peaks), 1597.9, 1495.7, cm-1. HRMS (ESI+ TOF) m/z: [M + 
H+]+ calcd for C18H22O3 287.1647; found 287.1642.  
 
Ethyl 1-cinnamyl-2-{[(trifluoromethyl)sulfonyl]oxy}cyclohex-2-ene-1-carboxylate 
(2-1h). The title compound was synthesized a similar procedure described above for the 
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preparation of ethyl 1-cinnamyl-2-{[(trifluoromethyl)sulfonyl]oxy}cyclopent-2-ene-1-
carboxylate (2-1l), except using ethyl 1-cinnamyl-2-oxocyclohexane-1-carboxylate (2-S7) 
(1.13 g, 4.0 mmol, 1 equiv), LDA (6.73 mmol, 1.7 equiv), and N-(2-pyridyl)triflamide (2.409 
g, 6.73 mmol, 1.7 equiv). The crude material was purified via column chromatography on 
silica gel using 100:0 -> 98:2 hexanes:ethyl acetate as the eluent. This procedure afforded 
1.06 g (64%) of the title compound as a colorless oil. 1H NMR (500 MHz, CDCl3)  7.46 – 
7.12 (m, 5H), 6.49 (d, J = 15.7 Hz, 1H), 6.12 (t, J = 15.4 Hz, 1H), 5.92 (s, 1H), 4.36 – 4.11 
(m, 2H), 2.82 – 2.64 (m, 2H), 2.38 – 2.10 (m, 3H), 1.82 – 1.53 (m, 3H), 1.31 (t, J = 7.1 Hz, 
3H). 13C NMR (126 MHz, CDCl3)  172.6, 148.1, 137.0, 134.5, 128.5, 127.5, 126.2, 123.8, 
120.3, 118.3 (q, JC-F = 318 Hz), 61.8, 50.5, 38.7, 32.3, 24.4, 18.6, 14.0. IR (film) 1730.3, 
1677.1 cm-1. HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C19H21F3O5S 419.1140; found 
419.1135.  
 
2-Cinnamylcyclohexan-1-one (2-S8). The title compound was synthesized via a similar 
procedure described above for the preparation of 2-cinnamylcyclopentan-1-one (2-S5), 
except using cyclohexanone (2.1 mL, 20 mmol, 1 equiv), cinnamyl alcohol (2.8 mL, 2.2 
mmol, 1.1 equiv), palladium allyl chloride dimer (0.146 g, 0.4 mmol, 0.02 equiv), dppf 
(0.665 g, 1.2 mmol, 0.06 mmol), and pyrrolidine (0.33 mL, 4.0 mmol, 0.2 equiv). The crude 
material was purified via column chromatography on silica gel using 95:5 hexanes:ethyl 
acetate as the eluent. This procedure afforded 2.74 g (63%) of the title compound as a 
yellow oil. 1H NMR (500 MHz, CDCl3)  7.44 – 7.23 (m, 4H), 7.19 (s, 1H), 6.39 (d, J = 
15.8 Hz, 1H), 6.20 (t, J = 15.2 Hz, 1H), 2.73 – 2.60 (m, 1H), 2.43 (d, J = 15.8 Hz, 2H), 
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2.32 (d, J = 19.2 Hz, 1H), 2.25 – 2.00 (m, 3H), 1.88 (s, 1H), 1.67 (s, 2H), 1.41 (d, J = 12.4 
Hz, 1H). 13C NMR (126 MHz, CDCl3)  212.4, 137.5, 131.6, 128.5, 128.4, 128.3, 127.0, 
126.0, 50.7, 42.1, 33.6, 27.9, 25.0. IR (film) 1705.24, 1597.9 cm-1. HRMS (ESI+ TOF) m/z: 
[M + H+]+ calcd for C15H18O 215.1436; found 215.1430.  
 
6-Cinnamylcyclohex-1-en-1-yl trifluoromethanesulfonate (2-1i). The title compound 
was synthesized via a similar procedure to 5-cinnamylcyclopent-1-en-1-yl 
trifluoromethanesulfonate (2-1k), except using 2-cinnamylcyclohexan-1-one (2-S8) 
(0.544 g, 2.54 mmol, 1 equiv), LDA (3.82 mmol, 1.5 equiv), and N-(2-pyridyl)triflamide 
(1.09 g, 3.05 mmol, 1.2 equiv). The crude material was purified via column 
chromatography on silica gel using 100:0 -> 98:2 -> 95:5 hexanes:ethyl acetate as the 
eluent. This procedure afforded 0.660 g (75%) of the title compound as a colorless oil. 1H 
NMR (500 MHz, CDCl3)  7.43 – 7.13 (m, 5H), 6.45 (d, J = 15.6 Hz, 1H), 6.23 – 6.04 (m, 
1H), 5.83 (s, 1H), 2.62 (d, J = 10.1 Hz, 2H), 2.40 – 2.26 (m, 1H), 2.18 (s, 2H), 1.88 (s, 
1H), 1.62 (dd, J = 49.8, 6.2 Hz, 3H). 13C NMR (126 MHz, CDCl3)  151.7, 137.3, 132.7, 
128.5, 127.2, 126.7, 126.1, 119.5, 118.5 (q, JC-F = 319 Hz), 37.6, 35.1, 27.8, 24.3, 19.0. 
IR (film) 1680.2, 1494.3 cm-1. HRMS (ESI+ TOF) m/z: [M + NH4+]+ calcd for C16H17F3O3S 
364.1194; found 364.1189.  
 
Ethyl 1-cinnamyl-2-oxocyclohexane-1-carboxylate (2-S9). The title compound was 
synthesized via a similar procedure described above for the preparation of ethyl 1-
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cinnamyl-2-oxocyclopentane-1-carboxylate (2-S4), except using ethyl-2-
oxocyclohexanecarboxylate (3.4 mL, 21.1 mmol, 1 equiv), crotyl bromide (2.5 mL, 24.3 
mmol, 1.15 equiv), and sodium hydride (0.75 g, 18.8 mmol, 0.89 equiv). The crude 
material was purified via column chromatography on silica gel using 98:2 hexanes:ethyl 
acetate as the eluent. This procedure afforded 2.26 g (48%) of the title compound as a 
brown oil. 1H NMR (500 MHz, CDCl3)  5.54 – 5.22 (m, 2H), 4.26 – 4.04 (m, 2H), 2.60 – 
2.28 (m, 4H), 2.28 – 2.13 (m, 1H), 1.96 (ddd, J = 14.1, 5.2, 2.9 Hz, 1H), 1.81 – 1.51 (m, 
6H), 1.42 (d, J = 16.2 Hz, 1H), 1.21 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3)  
207.7, 171.6, 128.8, 125.6, 61.1, 41.1, 38.0, 35.7, 27.5, 22.5, 22.4, 17.9, 14.1. IR (film) 
1710.4 (2 overlapping peaks), 1438.0 cm-1. HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for 
C13H20O3 225.1491; found 225.1485.  
 
(E)-Ethyl-1-(but-2-en-1-yl)-2-{[(trifluoromethyl)sulfonyl]oxy}cyclohex-2-ene-1-
carboxylate (2-1j). The title compound was synthesized via a similar procedure 
described above for the preparation of ethyl 1-cinnamyl-2-
{[(trifluoromethyl)sulfonyl]oxy}cyclohex-2-ene-1-carboxylate (2-1l), except using ethyl 1-
cinnamyl-2-oxocyclohexane-1-carboxylate (2-S9) (0.98 g, 4.46 mmol, 1 equiv), LDA (7.6 
mmol, 1.7 equiv), and N-(2-pyridyl)triflamide (2.66 g, 7.6 mmol, 1.7 equiv). The crude 
material was purified via column chromatography on silica gel using 100:0 -> 98:2 
hexanes:ethyl acetate as the eluent. This procedure afforded 0.623 g (40%) of the title 
compound as a colorless oil. 1H NMR (500 MHz, CDCl3)  5.86 (s, 1H), 5.57 – 5.45 (m, 
1H), 5.28 (d, J = 15.0 Hz, 1H), 4.15 (d, J = 16.3 Hz, 2H), 2.47 (s, 2H), 2.29 – 2.08 (m, 
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3H), 1.63 (d, J = 15.5 Hz, 6H), 1.27 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3)  
172.8, 148.2, 130.2, 124.5, 120.0, 118.3 (q, JC-F = 318 Hz), 61.5, 50.3, 38.3, 32.0, 31.9, 
24.4, 18.7, 13.9. IR (film) 1731.2, 1677.4, 1414.4 cm-1. HRMS (ESI+ TOF) m/z: [M + H+]+ 
calcd for C14H19F3O5S 357.0984; found 357.0978.  
 
(±)-Cinnamyl 1-methyl-2-oxocyclohexane-1-carboxylate (2-S10). A flame-dried flask 
equipped with a stir bar was cooled under a stream of nitrogen and charged with allyl 1-
methyl-2-oxocyclohexane-1-carboxylate (1.169 g, 5.97 mmol, 1 equiv), Grubbs II catalyst 
(0.203 g, 0.239 mmol, 0.04 equiv), and copper iodide (68.1 mg, 0.358 mmol, 0.06 equiv). 
The flask was evacuated and backfilled with nitrogen, then and diethyl ether (30 mL, 0.2 
M) and styrene (2.05 mL, 17.9 mmol, 3.0 equiv) were added to the mixture. The septum 
was replaced with a condenser and the mixture was heated to 40 °C with stirring for 15 
h. The reaction mixture was cooled to rt, and concentrated in vacuo to yield a purple 
colored crude product. The crude product was purified via column chromatography on 
silica gel using 95:5 hexanes:ethyl acetate as the eluent. This procedure afforded 0.904 
g (63%) of the title compound as a colorless oil. 1H NMR (500 MHz, CDCl3)  7.42 – 7.21 
(m, 5H), 6.71 – 6.58 (m, 1H), 6.31 – 6.18 (m, 1H), 4.87 – 4.72 (m, 2H), 2.57 – 2.41 (m, 
2H), 2.09 – 1.95 (m, 1H), 1.83 (m, 1H), 1.78 – 1.58 (m, 2H), 1.54 – 1.42 (m, 1H), 1.32 (s, 
3H), 1.04 (m, 1H). 13C NMR (126 MHz, CDCl3)  208.2, 172.9, 136.0, 134.8, 134.0, 128.6, 
126.7, 122.4, 65.8, 57.2, 40.7, 38.2, 27.5, 22.6, 21.3. IR (film) 2935.8, 2867.1, 1709.7 (the 
two carbonyls are incidentally equivalent), 1495.5, 1449.5 cm-1. HRMS (ESI+ TOF) m/z: 
[M + Na+]+ calcd for C17H20O3Na 295.1305; found 295.1305. 
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2-Cinnamyl-2-methylcyclohexan-1-one (2-S11). A flame-dried Schlenk flask equipped 
with a stir bar was cooled under a stream of nitrogen and charged with palladium acetate 
(27.8 mg, 0.124 mmol, 0.10 equiv), and triphenylphosphine (0.812 g, 3.10 mmol, 2.5 
equiv). The flask was evacuated and backfilled with nitrogen, then tetrahydrofuran (25 
mL, 0.1 M) and cinnamyl 1-methyl-2-oxocyclohexane-1-carboxylate (2-S10) (0.337 g, 
1.24 mmol, 1.0 equiv) were added. The septum was replaced with a condenser and the 
reaction mixture was heated to 30 °C with stirring for 15 h. The mixture was then cooled 
to rt, diluted with diethyl ether, filtered through a pad of silica gel, and concentrated in 
vacuo to yield a yellow oil. The crude material was purified via column chromatography 
on silica gel using 98:2 -> 95:5 hexanes:ethyl acetate as the eluent. This procedure 
afforded 33.9 mg (12%) of the title compound as a colorless oil. 1H NMR (500 MHz, 
CDCl3)  7.36 – 7.25 (m, 5H), 7.19 (d, J = 7.2 Hz, 1H), 6.40 (d, J = 15.7 Hz, 1H), 6.18 – 
6.06 (m, 1H), 2.47 (d, J = 15.0 Hz, 4H), 1.91 – 1.68 (m, 4H), 1.68 – 1.56 (m, 1H), 1.13 (s, 
3H). 13C NMR (126 MHz, CDCl3)  215.4, 137.4, 133.0, 128.4, 127.1, 126.0, 125.7, 48.9, 
38.8, 38.6, 29.7, 27.4, 22.9, 21.1. IR (film) 3026.3, 2931.9, 2863.5, 1704.1, 1598.2, 
1495.1 cm-1. HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C16H21O 229.1587; found 
229.1586.  
 
6-Cinnamyl-6-methylcyclohex-1-en-1-yl trifluoromethanesulfonate (2-1k). The title 
compound was synthesized via a similar procedure to ethyl 1-cinnamyl-2-
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{[(trifluoromethyl)sulfonyl]oxy}cyclohex-2-ene-1-carboxylate (2-1l), except using 2-
cinnamyl-2-methylcyclohexan-1-one (2-S11) (1.13 g, 4.0 mmol, 1 equiv), LDA (6.73 
mmol, 1.7 equiv), and N-(2-pyridyl)triflamide (2.409 g, 6.73 mmol, 1.7 equiv). The crude 
material was purified via column chromatography on silica gel using 100:0 –> 98:2 
hexanes:ethyl acetate as the eluent. This procedure afforded 1.06 g (64%) of a colorless 
oil. 1H NMR (500 MHz, CDCl3)  7.45 – 7.13 (m, 5H), 6.43 (d, J = 15.7 Hz, 1H), 6.14 (ddd, 
J = 15.4, 8.1, 7.0 Hz, 1H), 5.76 (t, J = 4.1 Hz, 1H), 2.46 (ddd, J = 13.9, 7.0, 1.4 Hz, 1H), 
2.31 (ddd, J = 13.9, 8.1, 1.2 Hz, 1H), 2.17 (ddd, J = 9.6, 5.7, 3.9 Hz, 2H), 1.82 (td, J = 9.6, 
4.6 Hz, 1H), 1.73 – 1.58 (m, 2H), 1.59 – 1.48 (m, 1H), 1.20 (s, 3H). 13C NMR (126 MHz, 
CDCl3)  154.8, 137.3, 133.6, 128.5, 127.2, 126.1, 125.1, 118.4 (q, JC-F = 313 Hz), 117.3, 
42.0, 38.7, 35.4, 24.7, 24.5, 18.2. IR (film) 3027.8, 2938.4, 1495.6, 1457.0, 1410.0 cm-1. 
HRMS (Electron Ionization Impact TOF) m/z: [M]+ calcd for C17H19F3O3S 360.1007; found 
360.1024. 
Preparation and Characterization of Products 
General Procedure for Pd-catalyzed Alkene Dialkylation Reactions on terminal 
alkenes, General Procedure A. 
A flame-dried 4 mL vial equipped with a stir bar was cooled under a stream of nitrogen 
and charged with Pd(OAc)2 (0.008 mmol, 0.04 equiv), Brettphos (0.012 mmol, 0.06 
equiv), and lithium tert-butoxide (0.28 mmol, 1.4 equiv). The aryl or alkenyl triflate (0.2 
mmol, 1.0 equiv) was weighed in a separate 1 dram vial and diluted with toluene (1 mL, 
0.2 M). This mixture was added to the reaction vessel and the appropriate nucleophile 
(0.24 mmol, 1.2 equiv) was added. Toluene (1 mL, 0.2M) was used to rinse the 1 dram 
vial and the solution was transferred to the reaction vessel. The vial was flushed with 
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nitrogen, capped, and heated to 95 °C with stirring overnight until the starting material 
had been consumed. The mixture was then cooled to rt and quenched with saturated 
aqueous ammonium chloride (1 mL). The aqueous layer was extracted with ethyl acetate 
(3 x 1 mL), dried over MgSO4, filtered and concentrated in vacuo. The crude product was 
purified via flash chromatography on silica gel to afford the desired product. 
General procedure for Pd-catalyzed alkene dialkylation reactions on internal alkene 
substrates, General procedure B 
A flame-dried 4 mL vial equipped with a stir bar and was cooled under a stream of nitrogen 
and charged with the appropriate triflate (0.2 mmol, 1.0 equiv), the appropriate palladium 
pre-catalyst (0.008 mmol, 0.04 equiv), the appropriate ligand (0.012 mmol, 0.06 equiv), 
lithium tert-butoxide (0.44 mmol, 2.2 equiv). The vial was purged with nitrogen and 
charged with toluene (0.8 M) and the appropriate malonate derivative (0.6 mmol, 3.6 
equiv). The vial was capped and heated to the appropriate temperature with stirring until 
the starting material had been consumed. The mixture was cooled to rt, charged with 
phenanthrene (1 equiv; NMR internal standard), diluted with dichloromethane (1 mL), and 
quenched with saturated ammonium chloride (1 mL). The aqueous layer was extracted 
with dichloromethane (3 x 1 mL), dried over Na2SO4, filtered, and concentrated in vacuo. 
The crude product was purified via flash chromatography on silica gel to afford the desired 
product. 
 
Diethyl 2-(2,3-dihydro-1H-inden-2-yl)malonate (2-6a). The title compound was 
prepared from 2-allylphenyl triflate (53.5 mg, 0.2 mmol) and diethyl malonate (37 µL, 0.24 
mmol) using General Procedure A. The crude material was purified via column 
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chromatography on silica gel using 95:5 hexanes:ethyl acetate as the eluent. This 
procedure afforded 51.7 mg (93%) of the title compound as a colorless solid (mp 33 – 
35°C). 1H NMR (500 MHz, CDCl3)  7.22 – 7.15 (m, 2H), 7.16 – 7.13 (m, 2H), 4.22 (qd, J 
= 7.1, 2.7 Hz, 4H), 3.45 (d, J = 9.3 Hz, 1H), 3.25 – 3.03 (m, 3H), 2.83 – 2.69 (m, 2H), 1.28 
(t, J = 7.1 Hz, 6H). 13C NMR (126 MHz, CDCl3)  168.8, 142.1, 126.4, 124.4, 61.4, 56.8, 
39.0, 37.3, 14.1; IR (film) 2980, 2840, 1744, 1727, 1476 cm-1; HRMS (ESI+ TOF) m/z: [M 
+ H+]+ calcd for C16H20O4 277.1362; found 277.1434. 
 
Diethyl 2-(2,3-dihydro-1H-inden-2-yl)malonate (2-6a). The title compound was 
prepared from 2-allylphenyl triflate (267 mg, 1.0 mmol) and diethyl malonate (183 µL, 1.2 
mmol) using General Procedure A. The crude material was purified via column 
chromatography on silica gel using 95:5 hexanes:ethyl acetate as the eluent. This 
procedure afforded 232 mg (84%) of the title compound as a white solid (mp 33 – 35°C). 
Characterization data were identical to those listed above. 
 
Diethyl 2-(2,3-dihydro-1H-inden-2-yl)malonate (2-6a). The title compound was 
prepared from 2-allylphenyl triflate (1.50 g, 5.63 mmol) and diethyl malonate (1.03 mL, 
6.76 mmol) using General Procedure A. The crude material was purified via column 
chromatography on silica gel using 95:5 hexanes:ethyl acetate as the eluent. This 
procedure afforded 1.36 g (88%) of the title compound as a white solid (mp 33 – 35°C). 
Characterization data were identical to those listed above. 
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(±)-Diethyl 2-[5-(tert-butyl)-2,3-dihydro-1H-inden-2-yl]malonate (2-6b). The title 
compound was prepared from 2-allyl-4-tert-butylphenyl triflate (64.5 mg, 0.2 mmol) and 
diethyl malonate (37 µL, 0.24 mmol) using General Procedure A. The crude material was 
purified via column chromatography on silica gel using 95:5 hexanes:ethyl acetate as the 
eluent. This procedure afforded 48.3 mg (77%) of the title compound as a colorless oil. 
1H NMR (400 MHz, CDCl3)  7.24 (s, 1H), 7.20 (dd, J = 7.9, 1.9 Hz, 1H), 7.13 (d, J = 7.9 
Hz, 1H), 4.28 – 4.16 (m, 4H), 3.46 (d, J = 8.9 Hz, 1H), 3.23 – 3.08 (m, 3H), 2.86 – 2.66 
(m, 2H), 1.32 (s, 9H), 1.31 – 1.27 (m, 6H). 13C NMR (126 MHz, CDCl3)  168.9, 149.7, 
142.1, 139.3, 124.0, 123.7, 121.4, 61.4, 57.1, 39.4, 37.6, 37.0, 34.7, 31.68, 14.3; IR (film) 
1748, 1729, 1467 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C20H28O4 333.199; 
found 333.206. 
 
(±)-Diethyl 2-(5-fluoro-2,3-dihydro-1H-inden-2-yl)malonate (2-6c). The title compound 
was prepared from 2-allyl-4-fluorophenyl triflate (56.8 mg, 0.2 mmol) and diethyl malonate 
(37 µL, 0.24 mmol) using General Procedure A. The crude material was purified via 
column chromatography on silica gel using 95:5 hexanes:ethyl acetate as the eluent. This 
procedure afforded 46.5 mg (79%) of the title compound as a colorless oil. 1H NMR (500 
MHz, CDCl3)  7.09 (dd, J = 8.3, 5.2 Hz, 1H), 6.89 – 6.83 (m, 1H), 6.82 (td, J = 8.9, 2.4 
Hz, 1H), 4.25 – 4.16 (m, 4H), 3.44 (d, J = 9.1 Hz, 1H), 3.24 – 3.04 (m, 3H), 2.86 – 2.65 
(m, 2H), 1.27 (t, J = 7.2 Hz, 6H). 13C NMR (126 MHz, CDCl3)  168.8, 163.2, 161.2, 144.2 
(d, J = 8.2 Hz), 137.4 (d, J = 2.5 Hz), 125.1 (d, J = 8.8 Hz), 113.2 (d, J = 22.6 Hz), 111.4 
(d, J = 21.9 Hz), 61.6, 56.8, 39.7, 37.5, 37.5, 36.6, 14.2; IR (film) 2982, 1745, 1727, 1614, 
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1599, 1483 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C16H19FO4 295.1267; found 
295.134. 
 
(±)-(1S,2R)-Diethyl 2-(1-methyl-2,3-dihydro-1H-inden-2-yl)malonate (2-6d). The title 
compound was prepared from 2-(but-3-en-2-yl)phenyl triflate (56.0 mg, 0.2 mmol), and 
diethyl malonate (37 µL, 0.24 mmol) using General Procedure A, except with 
(Brettphos)Pd(allyl)(Cl) (8.6 mg, 0.04 equiv) in place of Pd(OAc)2. The crude material was 
purified via column chromatography on silica gel using 95:5 hexanes:ethyl acetate as the 
eluent. This procedure afforded 43.1 mg (75%) of the title compound as a colorless oil. 
The compound was obtained as a >20:1 mixture of diastereomers as judged by 1H NMR 
analysis. Data are for the major isomer. 1H NMR (401 MHz, CDCl3)  7.23 – 7.10 (m, 4H), 
4.24 – 4.15 (m, 4H) 3.51 (d, J = 8.2 Hz, 1H), 3.24 (dd, J = 16.1, 8.1 Hz, 1H), 3.08 (p, J = 
6.8 Hz, 1H), 2.81 (dd, J = 16.1, 7.3 Hz, 1H), 2.69 (p, J = 8.0 Hz, 1H), 1.32 – 1.22 (m, 9H); 
13C NMR (176 MHz, CDCl3)  169.1, 168.8, 147.0, 141.4, 126.7, 126.66, 124.5, 123.6, 
61.51, 61.45, 55.6, 46.9, 43.4, 35.8, 19.8, 14.3, 14.2; IR (film) 1741, 1728, 1464 cm-1; 
HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C17H22O4 291.1518; found 291.1591. 
 
(1S,2S)-Diethyl 2-(1-phenyl-2,3-dihydro-1H-inden-2-yl)malonate (2-6e). The title 
compound was prepared from 2-cinnamylphenyl trifluoromethanesulfonate (75.2 mg, 
0.22 mmol) and diethyl malonate (0.1 mL, 0.6 mmol), Pd(OAc)2 (1.8 mg, 0.008 mmol, 
0.04 equiv), Brettphos (6.4 mg, 0.012 mmol, 0.06 equiv), with a reaction temperature of 
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65 °C for five hours using General Procedure B. The crude material was purified via 
column chromatography on silica gel using 98:2 -> 95:5 hexanes:ethyl acetate as the 
eluent. This procedure afforded 39.8 mg (51%) of the title compound as a colorless oil. 
The compound was obtained as a >20:1 mixture of diastereomers as judged by 1H NMR 
analysis. Data are for the major isomer. 1H NMR (500 MHz, Benzene-d6)  7.22 – 6.97 
(m, 7H), 6.93 (t, J = 7.4 Hz, 1H), 6.75 (d, J = 7.5 Hz, 1H), 4.27 (d, J = 9.0 Hz, 1H), 3.92 – 
3.79 (m, 2H), 3.73 – 3.52 (m, 3H), 3.45 (dd, J = 15.7, 7.9 Hz, 1H), 3.32 – 3.22 (m, 1H), 
2.96 (dd, J = 15.8, 8.9 Hz, 1H), 0.83 (t, J = 7.1 Hz, 3H), 0.73 (t, J = 7.1 Hz, 3H). 13C NMR 
(126 MHz, Benzene-d6)  168.1, 167.9, 145.9, 143.4, 142.0, 127.8, 127.7, 127.6, 127.5, 
126.6, 124.9, 124.2, 60.7, 60.6, 55.0 (2 peaks), 48.9, 36.0, 13.7, 13.4. IR (film) 1730.5, 
1601.2 cm-1. HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C22H24O4 353.1753; found 
353.1747. 
  
(±)-(1S,2S)-Diethyl 2-(5-fluoro-1-phenyl-2,3-dihydro-1H-inden-2-yl)malonate (2-6f). 
The title compound was prepared from 2-cinnamyl 4-fluorophenyl 
trifluoromethanesulfonate (64.7 mg, 0.18 mmol) and diethyl malonate (0.1 mL, 0.6 mmol), 
palladium acetate (1.8 mg, 0.008 mmol, 0.04 equiv), Brettphos (6.4 mg, 0.012 mmol, 0.06 
equiv), with a reaction temperature of 65 °C for five hours using General Procedure B. 
The crude material was purified via column chromatography on silica gel using 98:2 -> 
95:5 hexanes:ethyl acetate as the eluent. This procedure afforded 31.0 mg (47%) of the 
title compound as a colorless oil. The compound was obtained as a >20:1 mixture of 
diastereomers as judged by 1H NMR analysis. Data are for the major isomer. 1H NMR 
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(500 MHz, C6D6)  7.16 – 6.94 (m, 5H), 6.69 (dd, J = 9.0, 2.4 Hz, 1H), 6.60 (t, J = 8.7 Hz, 
1H), 6.45 (d, J = 8.2 Hz, 1H), 4.13 (d, J = 8.4 Hz, 1H), 3.95 – 3.76 (m, 2H), 3.65 (dd, J = 
10.8, 7.1 Hz, 1H), 3.61 – 3.46 (m, 2H), 3.29 – 3.17 (m, 2H), 2.80 (dd, J = 15.1, 8.0 Hz, 
1H), 0.84 (t, J = 7.1 Hz, 3H), 0.73 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, C6D6)  168.0 
(d, J = 34 Hz), 163.5 161.5, 144.1 (d, J = 9 Hz), 143.1, 141.3 (d, J = 1 Hz), 128.8, 127.9, 
126.7, 126.0, 113.5 (d, J = 25 Hz), 111.1 (d, J = 23 Hz), 60.8 (d, J = 14 Hz), 54.5, 54.1, 
49.2, 35.8 (2 peaks), 13.7, 13.4. IR (film) 1728.0, 1600.2, 1483.7 cm-1. HRMS (ESI+ TOF) 
m/z: [M + H+]+ calcd for C22H23FO4 371.1659; found 371.1653.  
  
(±)-(1S,2S)-Diethyl 2-(5-methoxy-1-phenyl-2,3-dihydro-1H-inden-2-yl)malonate (2-
6g). The title compound was prepared from 2-cinnamyl 4-methoxyphenyl 
trifluoromethanesulfonate (81.6 mg, 0.23 mmol), diethyl malonate (0.1 mL, 0.6 mmol), 
palladium acetate (1.8 mg, 0.008 mmol, 0.04 equiv), Brettphos (6.4 mg, 0.012 mmol, 0.06 
equiv), with a reaction temperature of 65 °C for five hours using General Procedure B. 
The crude material was purified via column chromatography on silica gel using 98:2 -> 
95:5 hexanes:ethyl acetate as the eluent. This procedure afforded 29.2 mg (35%) of the 
title compound as a colorless oil. The compound was obtained as a >20:1 mixture of 
diastereomers as judged by 1H NMR analysis. Data are for the major isomer. 1H NMR 
(500 MHz, C6D6)  7.19 (d, J = 7.2 Hz, 2H), 7.10 (s, 3H), 7.01 (s, 1H), 6.69 (d, J = 19.9 
Hz, 2H), 6.61 (d, J = 10.3 Hz, 1H), 4.26 (d, J = 8.5 Hz, 1H), 3.97 – 3.78 (m, 2H), 3.76 – 
3.53 (m, 3H), 3.49 – 3.36 (m, 1H), 3.30 (s, 3H), 3.04 – 2.87 (m, 1H), 0.84 (t, J = 7.1 Hz, 
3H), 0.74 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, C6D6)  168.2, 167.2, 159.5, 143.9, 
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143.4, 137.8, 128.8, 128.3, 127.9, 127.8, 126.5, 125.6, 113.0, 109.5, 60.7, 54.8, 54.6, 
54.3, 49.4, 36.1, 13.7. IR (film) 1727.7, 1608.5, 1588.8, cm-1. HRMS (ESI+ TOF) m/z: [M 
+ H+]+ calcd for C23H26O5 383.1859; found 383.1853.  
 
(±)- (1S,2S)-Diethyl 2-(5-methyl-1-phenyl-2,3-dihydro-1H-inden-2-yl)malonate (2-
6h). The title compound was prepared from 2-cinnamyl 4-methylphenyl 
trifluoromethanesulfonate (5h) (81.6 mg, 0.23 mmol) and diethyl malonate (0.1 mL, 0.6 
mmol) using General Procedure B. The crude material was purified via column 
chromatography on silica gel using 95:5 hexanes:ethyl acetate as the eluent. This 
procedure afforded 29.2 mg (35%) of the title compound as a colorless oil. The compound 
was obtained as a >20:1 mixture of diastereomers as judged by 1H NMR analysis. Data 
are for the major isomer. 1H NMR (500 MHz, C6D6)  7.23 – 7.14 (m, 1H), 7.09 (dd, J = 
15.1, 7.6 Hz, 3H), 7.04 – 6.97 (m, 1H), 6.87 (s, 1H), 6.78 (d, J = 7.7 Hz, 1H), 6.70 (d, J = 
7.7 Hz, 1H), 4.28 (d, J = 8.7 Hz, 1H), 3.96 – 3.78 (m, 2H), 3.73 – 3.53 (m, 3H), 3.44 (dd, 
J = 15.7, 7.9 Hz, 1H), 3.37 – 3.25 (m, 1H), 2.97 (dd, J = 15.7, 8.7 Hz, 1H), 2.11 (s, 3H), 
0.84 (t, J = 7.2 Hz, 3H), 0.74 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, C6D6)  168.2, 167.9, 
143.7, 142.9, 142.1, 136.2, 128.9, 128.3, 127.5, 126.5, 124.9, 124.7, 60.7, 60.6, 54.8, 
54.7, 49.2, 35.9, 20.9, 13.7, 13.6. IR (film) 2980.6, 1728.9, 1602.0, 1493.5, 1453.4 cm-1. 
HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C23H26O4 367.1909; found 367.1904.  
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Diethyl 2-[5-(tert-butyl)-2-methyl-2,3-dihydro-1H-inden-2-yl]malonate (2-6i). The title 
compound was prepared from 4-tert-butyl-2-(2-methylallyl)phenyl triflate (67.3 mg, 0.2 
mmol) and diethyl malonate (37 µL, 0.24 mmol) using General Procedure A. The crude 
material was purified via column chromatography on silica gel using 99:1 hexanes:ethyl 
acetate as the eluent. This procedure afforded 9.7 mg (14%) of the title compound as a 
colorless oil.1H NMR (401 MHz, CDCl3)  7.21 – 7.15 (m, 2H), 7.12 – 7.06 (m, 2H), 4.25 
– 4.12 (m, 4H), 3.56 (s, 1H), 3.24 – 3.12 (m, 2H), 2.86 – 2.74 (m, 2H), 1.30 (s, 9H), 1.29 
– 1.24 (m, 9H); 13C NMR (100 MHz, CDCl3)  168.53, 149.43, 141.54, 138.71, 124.11, 
123.37, 121.54, 61.01, 60.38, 45.55, 44.97, 44.44, 34.49, 31.55, 24.41, 14.08; IR (film) 
2955, 1721, 1727, 1033 cm-1. HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for 
C21H30O4 347.2217; found 347.2220. 
 
5-(tert-butyl)-2-methylene-2,3-dihydro-1H-indene (2-6i-a). The title compound was 
prepared from 4-tert-butyl-2-(2-methylallyl)phenyl triflate (67.3 mg, 0.2 mmol) and diethyl 
malonate (37 µL, 0.24 mmol) using General Procedure A. The crude material was purified 
via column chromatography on silica gel using 99:1 hexanes:ethyl acetate as the eluent. 
This procedure afforded 23 mg (61%) of the title compound as a colorless oil.1H NMR 
(401 MHz, CDCl3)  7.219 – 7.26 (m, 1H), 7.26 – 7.21 (m, 1H), 7.19 – 7.14 (m, 1H), 5.13 
– 5.06 (m, 2H), 3.75 – 3.69 (m, 2H), 3.69 – 3.64 (m, 2H), 1.34 (s, 9H). 
 
(±)-(2S,3aR)-Diethyl 2-(2,3,3a,4,5,6-hexahydro-1H-inden-2-yl)malonate (2-7a). The 
title compound was prepared from 6-allylcyclohex-1-en-1-yl triflate (54.1 mg, 0.2 mmol) 
and diethyl malonate (37 µL, 0.24 mmol) using General Procedure A. The crude material 
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was purified via column chromatography on silica gel using 98:2 hexanes:ethyl acetate 
as the eluent. This procedure afforded 45.4 mg (84%) of the title compound as a colorless 
oil. The compound was obtained as a >20:1 mixture of diastereomers as judged by 1H 
NMR analysis. Data are for the major isomer. 1H NMR (500 MHz, CDCl3)  5.37 (s, 1H), 
4.19 (qd, J = 7.1, 3.1 Hz, 4H), 3.17 (d, J = 9.9 Hz, 1H), 2.70 – 2.52 (m, 2H), 2.22 (br s, 
1H), 2.11 – 2.01 (m, 1H), 2.03 – 1.91 (m, 4H), 1.77 (ddd, J = 12.3, 6.0, 3.2 Hz, 1H), 1.43 
(m, 1H), 1.26 (td, J = 7.1, 1.9 Hz, 6H), 0.99 (m, 1H), 0.88 (q, J = 11.5 Hz, 1H); 13C NMR 
(125 MHz, CDCl3)  169.1, 169.0, 142.8, 118.1, 61.4, 57.8, 41.0, 38.6, 37.1, 35.3, 28.9, 
25.3, 22.5, 14.3; IR (film) 1730, 1029 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for 
C16H24O4 281.1675; found 281.1747. 
 
(±)-(6S,7aR)-Diethyl 2-(1,3,5,6,7,7a-hexahydrocyclopenta[c]pyran-6-yl)malonate (2-
7b). The title compound was prepared from 3-allyl-3,6-dihydro-2H-pyran-4-yl triflate (54.4 
mg, 0.2 mmol) and diethyl malonate (37 µL, 0.24 mmol) using General Procedure A. The 
crude material was purified via column chromatography on silica gel using 95:5 -> 90:10 
hexanes:ethyl acetate as the eluent.  This procedure afforded 53.6 mg (95%) of the title 
compound as a colorless oil. The compound was obtained as a >20:1 mixture of 
diastereomers as judged by 1H NMR analysis. Data are for the major isomer. 1H NMR 
(500 MHz, CDCl3)  5.40 (s, 1H), 4.25 – 4.09 (m, 6H), 4.09 – 3.99 (m, 1H), 3.19 (d, J = 
9.2 Hz, 1H), 3.03 (t, J = 10.2 Hz, 1H), 2.75 – 2.63 (m, 2H), 2.56 (br s, 1H), 2.11 – 1.96 
(m, 2H), 1.26 (t, J = 7.1 Hz, 6H), 0.87 (q, J = 11.5 Hz, 1H); 13C NMR (101 MHz, CDCl3)  
168.8, 140.8, 116.8, 69.3, 65.1, 61.5, 57.4, 39.8, 37.1, 34.7, 34.0, 14.3; IR (film) 1750, 
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cyclopenta[c]pyridin-6-yl]malonate (2-7c). The title compound was prepared from tert-
butyl 3-allyl-4-{[(trifluoromethyl)sulfonyl]oxy}-3,6-dihydropyridine-1(2H)-carboxylate (67.1 
mg, 0.2 mmol) and diethyl malonate (37 µL, 0.24 mmol) using General Procedure A. The 
crude material was purified via column chromatography on silica gel using 25:75 
hexanes:dichloromethane as the eluent. This procedure afforded 52.3 mg (76%) of the 
title compound as a colorless oil. Characterization data are for a mixture of rotamers; 
broadening is due to slow interconversion on the NMR time scale. 1H NMR (500 MHz, 
C6D6)  5.09 (s, 1H), 4.57 – 4.15 (m, 2H), 4.11 – 3.82 (br m, 4H), 3.43 – 3.37 (m, 1H), 
3.18 – 3.15 (m, 1H), 2.81 – 2.53 (m, 2H), 2.25 (br s, 1H), 2.21 – 2.12 (m, 1H), 2.07 – 1.95 
(br m, 1H), 1.94 – 1.81 (m, 1H), 1.55 – 1.38 (m, 9H), 1.04 – 0.90 (m, 6H), 0.86 – 0.74 (m, 
1H). 13C NMR (100 MHz, CDCl3)  168.7, 79.7, 61.5, 57.3, 40.2, 37.5, 35.1, 34.8, 28.6, 
28.4, 14.2; IR (film) 1751, 1729, 1693 cm-1; HRMS (ESI+ TOF) m/z: 404.2044 (404.2044 
calcd for C20H31NO6, M+Na+). HRMS (ESI+ TOF) m/z: [M + Na+]+ calcd for C20H31NO6 
404.2044; found 404.2044. 
 
(±)-(6S,7aR)-diethyl 2-(2,3,5,6,7,7a-hexahydro-1H-cyclopenta[c]pyridin-6-
yl)malonate (2-S12). In order to confirm the connectivity and stereochemistry of 2-7c, 
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the boc group was cleaved by addition of trifluoroacetic acid (3 drops) to a solution of 2-
7c in dichloromethane; the resulting solution was stirred for 1 hour at rt. The solvent and 
excess trifluoroacetic acid were removed under reduced pressure and the product was 
washed with NaHCO3, brine, and dried with MgSO4. This procedure afforded 34.3 mg 
(89%) of the title compound as a colorless oil. This material was judged to be a >20:1 
mixture of diastereomers by 1H NMR analysis. Data are for the major isomer. 1H NMR 
(400 MHz, CDCl3)  5.38 (s, 1H), 4.18 (q, J = 7.1 Hz, 4H), 3.37 - 3.29 (m, 2H), 3.18 (d, J 
= 9.5 Hz, 1H), 2.73 - 2.59 (m, 2H), 2.40 (br s, 1H), 2.33 – 2.23 (m, 1H), 2.11 – 1.97 (m, 
2H), 1.49 – 1.37 (m, 1 H), 1.26 (t, J = 7.1 Hz, 6H), 0.88 (q, J = 11.3 Hz, 1H); 13C NMR 
(100 MHz, CDCl3)  168.9, 168.8, 141.8, 116.8, 61.4, 57.5, 48.3, 44.5, 40.4, 36.9, 35.7, 
35.0, 14.2; IR (film) 2983, 1782, 1730, 1148 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd 
for C15H23NO4 282.1700; found 282.1706.  
 
(±)-(2S,3aR)-Diethyl 2-(2-methyl-2,3,3a,4,5,6-hexahydro-1H-inden-2-yl)malonate (2-
7d). The title compound was prepared from 6-(2-methylallyl)cyclohex-1-en-1-yl triflate 
(54.1 mg, 0.2 mmol) and diethyl malonate (37 µL, 0.24 mmol) using General Procedure 
A. The crude material was purified via column chromatography on silica gel using 95:5 
hexanes:ethyl acetate as the eluent. This procedure afforded 55.6 mg (94%) of the title 
compound as a colorless oil. The compound was obtained as a 9:1 mixture of 
diastereomers as judged by 1H NMR analysis. Data are for the major isomer. 1H NMR 
(500 MHz, CDCl3)  5.35 (s, 1H), 4.17 (q, J = 7.1 Hz, 4H), 3.32 (s, 1H), 2.48 (d, J = 17.0 
Hz, 1H), 2.39 (br s, 1H), 2.28 (d, J = 17.0 Hz, 1H), 2.02 - 1.90 (m, 3H), 1.87 – 1.73 (m, 
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2H), 1.45 (tddd, J = 13.4, 10.3, 7.5, 2.9 Hz, 1H), 1.28 – 1.21 (m, 10H), 1.03 – 0.92 (m, 
1H); 13C NMR (126 MHz, CDCl3)  168.8, 143.1, 118.1, 61.7, 61.3, 61.04, 61.03, 45.9, 
44.1, 41.6, 38.7, 38.6, 29.0, 28.9, 25.3, 24.9, 22.6, 22.5, 14.3; IR (film) 1753, 1729 cm-1; 
HRMS (ESI+ TOF) m/z: [M + Na+]+ calcd for C17H26O4 317.1723; found 317.1729. 
 
(±)-(2S,3aS)-Diethyl 2-(3a-allyl-1,2,3,3a,4,5-hexahydropentalen-2-yl)malonate (2-
7e). The title compound was prepared from 5,5-diallylcyclopent-1-en-1-yl triflate (60 mg, 
0.2 mmol) and diethyl malonate (37 µL, 0.24 mmol) using General Procedure A. The 
crude material was purified via column chromatography on silica gel using 95:5 
hexanes:ethyl acetate as the eluent. This procedure afforded 56.6 mg (92%) of the title 
compound as a colorless oil. The compound was obtained as a >20:1 mixture of 
diastereomers as judged by 1H NMR analysis. Data are for the major isomer. 1H NMR 
(700 MHz, CDCl3)  5.79 (dddd, J = 16.9, 10.1, 7.9, 6.6 Hz, 1H), 5.22 (s, 1H), 5.05 (d, J 
= 17.0 Hz, 1H), 5.02 (d, J = 10.1 Hz, 1H), 4.22 – 4.12 (m, 4H), 3.25 (d, J = 10.3 Hz, 1H), 
3.09 (qt, J = 10.3, 6.4 Hz, 1H), 2.63 – 2.50 (m, 2H), 2.42 – 2.36 (m, 2H), 2.12 (dd, J = 
13.8, 6.6 Hz, 1H), 2.07 (dd, J = 13.8, 8.0 Hz, 1H), 1.98 – 1.92 (m, 2H), 1.56 (dt, J = 12.4, 
9.5 Hz, 1H), 1.25 (td, J = 7.1, 4.4 Hz, 6H), 1.03 (dd, J = 12.0, 10.5 Hz, 1H); 13C NMR (176 
MHz, CDCl3)  168.9, 168.8, 153.9, 136.1, 119.1, 116.9, 61.41, 61.37, 59.3, 58.2, 41.5, 
40.3, 39.9, 36.9, 36.1, 28.2, 14.3; IR (film) 1732, 1150 cm-1; HRMS (ESI+ TOF) m/z: [M + 




yl)malonate (2-7f). The title compound was prepared from (methylallyl)cyclopent-1-en-
1-yl triflate (54.0 mg, 0.2 mmol), and diethyl allylmalonate (48 µL, 0.24 mmol) using 
General Procedure A, except with RuPhos (5.6 mg, 0.012 mmol) as ligand. The crude 
material was purified via column chromatography on silica gel using 95:5 hexanes:ethyl 
acetate as the eluent. This procedure afforded 40.8 mg (63%) of the title compound as a 
colorless oil. The compound was obtained as a 19:1 mixture of diastereomers as judged 
by 1H NMR analysis. NOTE: The alkene was observed to isomerize in CDCl3 to a 4:1 
mixture of regioisomers. Data are for the major isomer. 1H NMR (401 MHz, CDCl3)  5.90 
(ddt, J = 17.1, 10.1, 7.1 Hz, 1H), 5.22 (s, 1H), 5.14 – 4.92 (m, 2H), 4.15 (m, 4H), 3.12 – 
2.95 (br m, 1H), 2.82 – 2.38 (m, 5H), 2.10 (dtd, J = 12.0, 6.8, 1.2 Hz, 1H), 1.98 (ddd, J = 
17.4, 4.5, 2.3 Hz, 1H), 1.83 – 1.60 (m, 2H), 1.50 – 1.33 (m, 1H), 1.24 (q, J = 7.3 Hz, 6H), 
1.15 (s, 3H); 13C NMR (126 MHz, CDCl3)  170.83, 170.79, 152.5, 135.2, 118.0, 117.5, 
110.0, 65.5, 60.7, 51.9, 49.4, 43.2, 37.7, 37.3, 37.0, 32.4, 26.5, 14.1; IR (film) 1741, 1723, 
1206 cm-1; HRMS (ESI+ TOF) m/z: [M + Na+]+ calcd for C19H28O4 343.199; found 343.188. 
 
(±)-(1R,2S,3aR)-Diethyl 3a-(ethoxycarbonyl)-1,2,3,3a,4,5-hexahydropentalen-2-
yl)malonate (2-7g). The title compound was prepared from ethyl 1-allyl-2-
{[(trifluoromethyl)sulfonyl]oxy}cyclopent-2-ene-1-carboxylate (69.9 mg, 0.213 mmol) and 
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diethyl malonate (36 μL, 0.24 mmol), Pd(OAc)2 (1.8 mg, 0.008 mmol, 0.04 equiv), 
BrettPhos (4.9 mg, 0.012 mmol, 0.06 equiv), at 95 °C for 14 h using General Procedure 
B. The crude material was purified via column chromatography on silica gel using 98:2 -
> 95:5 hexanes:ethyl acetate as the eluent. This procedure afforded 48.2 mg (67%) of 
the title compound as a colorless oil. The compound was obtained as a >20:1 mixture of 
diastereomers as judged by 1H NMR analysis. Data are for the major isomer. 1H NMR 
(500 MHz, CDCl3)  5.44 (s, 1H), 4.22–4.09 (m, 6H), 3.27 (d, J = 9.7 Hz, 1H), 3.17 (qd, J 
= 10.3, 5.0 Hz, 1H), 2.80 (dt, J = 14.9, 8.0 Hz, 1H), 2.66 – 2.53 (m, 1H), 2.46 (m, 4H), 
2.04 (dd, J = 16.4, 6.0 Hz, 1H), 1.75 (dt, J = 12.8, 9.6 Hz, 1H), 1.27–1.23 (m, 9H). 13C 
NMR (126 MHz, CDCl3)  175.6, 168.5, 168.5, 149.6, 122.9, 65.5, 61.3, 60.7, 60.6, 57.6, 
40.8, 40.6, 37.6, 36.9, 36.8, 28.8, 14.2, 14.1. IR (film) 2980.3, 2933.2, 2855.3, 1724.2, 




inden-2-yl] malonate (2-7h). The title compound was prepared from ethyl 1-cinnamyl-2-
{[(trifluoromethyl)sulfonyl]oxy}cyclohex-2-ene-1-carboxylate (2-1i) (83.0 mg, 0.20 mmol) 
and diethyl malonate (0.1 mL, 0.6 mmol), Pd(acac)2 (2.4 mg, 0.008 mmol, 0.04 equiv), 
SPhos (4.9 mg, 0.012 mmol, 0.06 equiv), at 95 °C for fourteen hours using General 
Procedure B. The crude material was purified via column chromatography on silica gel 
using 95:5 -> 90:10 hexanes:ethyl acetate as the eluent. This procedure afforded 62.5 
mg (73%) of the title compound as a colorless oil. The compound was obtained as a >20:1 
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mixture of diastereomers as judged by 1H NMR analysis. Data are for the major isomer. 
1H NMR (500 MHz, C6D6)  7.64 (d, J = 7.6 Hz, 2H), 7.21 – 7.09 (m, 2H), 7.02 (t, J = 7.3 
Hz, 1H), 5.33 (q, J = 3.2 Hz, 1H), 4.06 – 3.78 (m, 4H), 3.59 (dq, J = 10.5, 7.0 Hz, 1H), 
3.49 (d, J = 6.9 Hz, 1H), 3.44 (dq, J = 10.8, 7.2 Hz, 1H), 3.14 – 2.95 (m, 2H), 2.37 (dt, J 
= 12.6, 3.5 Hz, 1H), 1.94 – 1.82 (m, 1H), 1.73 (dtd, J = 18.3, 7.4, 3.8 Hz, 1H), 1.61 – 1.38 
(m, 3H), 1.37 – 1.22 (m, 1H), 1.12 (td, J = 13.1, 3.8 Hz, 1H), 1.01 – 0.91 (m, 3H), 0.84 
(dt, J = 17.9, 7.1 Hz, 3H), 0.70 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, C6D6)  175.1, 
167.9, 167.6, 144.5, 143.3, 129.4, 129.3, 127.5, 126.3, 123.8, 60.8, 60.6, 54.2, 53.5, 53.4, 
44.6, 41.9, 33.0, 24.5, 19.2, 13.9, 13.7, 13.3. IR (film) 1724.1, 1605.6, 1446.6 cm-1. HRMS 
(ESI+ TOF) m/z: [M + H+]+ calcd for C25H32O6 429.2277; found 429.2272.  
 
(±)-(1R,2S,3aR)-Diethyl 2-(1-phenyl-2,3,3a,4,5,6-hexahydro-1H-inden-2-yl)malonate 
(2-7i). The title compound was prepared from 6-cinnamylcyclohex-1-en-1-yl 
trifluoromethanesulfonate (2-1i) (69.0 mg, 0.20 mmol) and diethyl malonate (0.1 mL, 0.6 
mmol), Pd(acac)2 (2.4 mg, 0.008 mmol, 0.04 equiv), SPhos (4.9 mg, 0.012 mmol, 0.06 
equiv), at 95 °C for fourteen hours using General Procedure B. The crude material was 
purified via column chromatography on silica gel using 98:2 hexanes:ethyl acetate as the 
eluent. This procedure afforded 54.1 mg (76%) of the title compound as a colorless oil. 
The compound was obtained as a >20:1 mixture of diastereomers as judged by 1H NMR 
analysis. Data are for the major isomer. 1H NMR (500 MHz, CDCl3)  7.32 – 7.21 (m, 2H), 
7.21 – 7.11 (m, 3H), 5.23 (p, J = 2.9 Hz, 1H), 4.15 (p, J = 7.0 Hz, 2H), 3.82 (dq, J = 10.7, 
7.1 Hz, 1H), 3.63 (dq, J = 10.8, 7.2 Hz, 1H), 3.40 (dt, J = 9.6, 2.6 Hz, 1H), 3.34 (d, J = 8.1 
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Hz, 1H), 2.78 – 2.66 (m, 1H), 2.58 – 2.45 (m, 1H), 2.31 (dt, J = 12.0, 6.1 Hz, 1H), 2.09 – 
1.88 (m, 3H), 1.79 (dt, J = 12.7, 3.9 Hz, 1H), 1.51 – 1.38 (m, 1H), 1.24 (t, J = 7.1 Hz, 3H), 
1.16 – 0.95 (m, 5H). 13C NMR (126 MHz, CDCl3)  168.6, 168.3, 147.6, 145.2, 128.2, 
128.1, 126.1, 120.3, 61.2, 61.0, 55.5, 53.1, 46.4, 41.3, 37.5, 28.8, 25.1, 22.2, 14.1, 13.7. 
IR (film) 1730.9, 1601.5 cm-1. HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C22H28O4 
357.2066; found 357.2060.  
 
(±)-(1S,2S,3aS)-Diethyl 2-benzyl-2-[3a-(ethoxycarbonyl-1-phenyl-2,3,3a,4,5,6-
hexahydro-1H-inden-2-yl]malonate (2-7j). The title compound was prepared from ethyl 
1-cinnamyl-2-{[(trifluoromethyl)sulfonyl]oxy}cyclohex-2-ene-1-carboxylate (2-1h) (85.4 
mg, 0.20 mmol) and benzyl diethyl malonate (0.1 mL, 0.43 mmol), Pd(acac)2 (2.4 mg, 
0.008 mmol, 0.04 equiv), SPhos (4.9 mg, 0.012 mmol, 0.06 equiv), for 14 hours using 
General Procedure B, except with xylenes as solvent at 110 °C. The crude material was 
purified via column chromatography on silica gel using 98:2 -> 95:5 hexanes:ethyl acetate 
as the eluent. This procedure afforded 53.3 mg (51%) of the title compound as a colorless 
oil. The compound was obtained as a >20:1 mixture of diastereomers as judged by 1H 
NMR analysis. Data are for the major isomer. 1H NMR (500 MHz, CDCl3)  7.38 – 7.21 
(m, 4H), 7.16 – 7.08 (m, 3H), 7.04 (dd, J = 7.1, 2.4 Hz, 2H), 5.43 (d, J = 2.5 Hz, 1H), 4.15 
(dd, J = 29.8, 7.1 Hz, 2H), 4.03 – 3.84 (m, 2H), 3.70 (s, 2H), 3.10 (d, J = 13.9 Hz, 1H), 
3.01 (d, J = 14.1 Hz, 1H), ), 2.83 (dd, J = 12.6, 6.2 Hz, 1H), 2.27 (dt, J = 12.7, 3.5 Hz, 
1H), 2.18 – 1.90 (m, 2H), 1.73 – 1.46 (m, 2H), 1.25 (dt, J = 14.2, 8.3 Hz, 5H), 1.11 (t, J = 
7.1 Hz, 3H), 0.97 (t, J = 7.2 Hz, 3H), 0.88 (t, J = 6.7 Hz, 3H). 13C NMR (126 MHz, CDCl3) 
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 175.9, 170.0, 169.9, 144.9, 144.5, 137.0, 130.2, 128.6, 128.0, 127.8, 126.6, 123.4, 62.2, 
60.9, 60.8, 52.4, 51.8, 48.2, 40.9, 40.4, 33.6, 31.6, 24.5, 22.6, 18.9, 14.1, 13.9, 13.7. IR 
(film) 1720.8, 1601.5, 1495.7 cm-1. HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C32H38O6 
519.2747; found 519.2741.  
 
(±)-(1R,2S,3aS)-Diethyl 2-[3a-(ethoxycarbonyl)-1-methyl-2,3,3a,4,5,6-hexahydro-
1H-inden-2-yl]malonate (2-7k). The title compound was prepared from ethyl (E)-1-(but-
2-en-1-yl)-2-{[(trifluoromethyl)sulfonyl]oxy}cyclohex-2-ene-1-carboxylate (2-1j) (73.5 mg, 
0.21 mmol) and diethyl malonate (0.1 mL, 0.6 mmol), Pd(acac)2 (2.4 mg, 0.008 mmol, 
0.04 equiv), SPhos (4.9 mg, 0.012 mmol, 0.06 equiv), at 95 °C for fourteen hours using 
General Procedure B. The crude material was purified via column chromatography on 
silica gel using 98:2 -> 95:5  hexanes:ethyl acetate as the eluent. This procedure afforded 
40.1 mg (52%) of the title compound as a colorless oil. The compound was obtained as 
a >20:1 mixture of diastereomers as judged by 1H NMR analysis. Data are for the major 
isomer. 1H NMR (500 MHz, CDCl3)  5.54 (q, J = 3.1 Hz, 1H), 4.17 (ddt, J = 11.1, 7.6, 4.4 
Hz, 6H), 3.39 – 3.30 (m, 1H), 3.26 (d, J = 6.0 Hz, 1H), 2.44 – 2.31 (m, 2H), 2.23 (dt, J = 
12.5, 3.4 Hz, 1H), 2.18 – 2.07 (m, 1H), 1.98 (ddq, J = 14.6, 7.1, 3.5 Hz, 2H), 1.76 – 1.59 
(m, 2H), 1.53 (ddd, J = 13.9, 6.9, 3.5 Hz, 1H), 1.26 (t, J = 7.1 Hz, 9H), 1.12 (d, J = 6.7 Hz, 
3H). 13C NMR (126 MHz, CDCl3)  175.5, 169.0, 168.4, 141.8, 114.8, 114.4, 61.3, 61.1 
(2 peaks), 60.6, 54.8, 51.0, 49.7, 37.9, 31.7, 24.2, 19.6, 16.3, 14.1, 14.0. IR (film) 1725.2 
(2 peaks), 1446.7 cm-1. HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C20H30O6 367.2121; 




hexahydro-1H-inden-2-yl]malonate (2-7l). The title compound was prepared from ethyl 
1-cinnamyl-2-{[(trifluoromethyl)sulfonyl]oxy}cyclohex-2-ene-1-carboxylate (2-1h) (83.6 
mg, 0.20 mmol) and di-tert-butyl malonate (0.1 mL, 0.4 mmol) using General Procedure 
B. The crude material was purified via column chromatography on silica gel using 95:5 
hexanes:ethyl acetate as the eluent. This procedure afforded 64.1 mg (66%) of the title 
compound as a colorless oil. The compound was obtained as a >20:1 mixture of 
diastereomers as judged by 1H NMR analysis. Data are for the major isomer. 1H NMR 
(500 MHz, CDCl3)  7.44 – 7.35 (m, 2H), 7.27 (t, J = 7.4 Hz, 2H), 7.22 – 7.13 (m, 1H), 
5.44 (q, J = 3.2 Hz, 1H), 4.20 (q, J = 7.2 Hz, 2H), 3.53 (dt, J = 11.0, 2.9 Hz, 1H), 3.20 (d, 
J = 5.8 Hz, 1H), 2.67 (dd, J = 12.2, 5.5 Hz, 1H), 2.63 – 2.49 (m, 1H), 2.34 (dt, J = 12.4, 
3.3 Hz, 1H), 2.11 (ddd, J = 14.1, 7.2, 3.4 Hz, 1H), 2.03 (dq, J = 11.2, 3.8 Hz, 1H), 1.77 – 
1.56 (m, 3H), 1.47 (m, 11H), 1.39 – 1.22 (m, 11H). 13C NMR (126 MHz, CDCl3)  176.0, 
167.8, 167.7, 144.4, 143.2, 128.9, 128.2, 126.3, 123.8, 81.5, 81.3, 60.8, 55.1, 53.4, 52.9, 
44.2, 40.8, 33.3, 28.0, 27.7, 24.5, 19.1, 14.3. IR (film) 2977.9, 2934.0, 1722.4 (2 peaks), 
1496.0, 1453.7 cm-1. HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C29H40O6 485.2903; 




yl)malonate (2-7m). The title compound was prepared from 6-cinnamylcyclohex-1-en-1-
yl trifluoromethanesulfonate (2-1i) (73.1 mg, 0.21 mmol) and di-tert-butyl malonate (0.1 
mL, 0.4 mmol) using General Procedure B. The crude material was purified via column 
chromatography on silica gel using 98:2 hexanes:ethyl acetate as the eluent. This 
procedure afforded 53.9 mg (62%) of the title compound as a white solid, mp: 79-81 °C. 
The compound was obtained as a >20:1 mixture of diastereomers as judged by 1H NMR 
analysis. Data are for the major isomer. 1H NMR (500 MHz, CDCl3)  7.32 – 7.10 (m, 5H), 
5.26 (m, 1H), 3.43 (dt, J = 9.2, 2.4 Hz, 1H), 3.19 (d, J = 7.0 Hz, 1H), 2.69 – 2.56 (m, 1H), 
2.56 – 2.43 (m, 1H), 2.31 (dt, J = 12.2, 6.3 Hz, 1H), 2.09 – 1.92 (m, 3H), 1.78 (dt, J = 13.0, 
3.7 Hz, 1H), 1.47 (d, J = 1.2 Hz, 9H), 1.26 (s, 9H), 1.22 – 1.10 (m, 2H), 1.07 (dt, J = 12.6, 
2.6 Hz, 1H). 13C NMR (126 MHz, CDCl3)  168.0, 167.96, 147.7, 145.5, 128.3, 128.0, 
126.0, 120.0, 81.4, 81.2, 56.8, 53.1, 46.1, 41.1, 36.8, 29.0, 28.0, 27.7, 25.1, 22.3. IR (film) 
2977.9, 2929.2, 1720.2 (2), 1601.8, 1477.5, 1452.7 cm-1. HRMS (ESI+ TOF) m/z: [M + 
H+]+ calcd for C26H36O4 413.2692; found 413.2686.  
 
(±)-(1R,2S,3aR)-Diethyl 2-benzyl-2-(1-phenyl-2,3,3a,4,5,6-hexahydro-1H-inden-2-
yl)malonate (2-7n). The title compound was prepared from 6-cinnamylcyclohex-1-en-1-
yl  trifluoromethanesulfonate (2-1i) (57.6 mg, 0.17 mmol) and benzyl diethyl malonate (0.1 
mL, 0.43 mmol) using General Procedure B, except that the reaction was run in xylenes 
at 110 °C. The crude material was purified via column chromatography on silica gel using 
98:2 hexanes:ethyl acetate as the eluent. This procedure afforded 39.0 mg (51%) of the 
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title compound as a colorless oil. The compound was obtained as a >20:1 mixture of 
diastereomers as judged by 1H NMR analysis. Data are for the major isomer. 1H NMR 
(500 MHz, CDCl3)  7.41 – 7.06 (m, 9H), 6.95 (dd, J = 6.6, 3.0 Hz, 1H), 5.27 (q, J = 2.7 
Hz, 1H), 4.05 – 3.87 (m, 3H), 3.88 – 3.76 (m, 1H), 3.70 – 3.61 (m, 1H), 3.20 – 3.14 (m, 
2H), 3.09 (d, J = 14.0 Hz, 1H), 2.94 (dt, J = 10.6, 7.2 Hz, 1H), 2.40 (dt, J = 12.2, 7.2 Hz, 
1H), 2.04 (ddt, J = 12.4, 5.3, 3.4 Hz, 1H), 1.98 – 1.85 (m, 1H), 1.74 (ddd, J = 12.2, 6.1, 
2.9 Hz, 1H), 1.52 – 1.34 (m, 2H), 1.32 – 1.18 (m, 1H), 1.19 – 1.04 (m, 4H), 1.02 (q, J = 
7.0 Hz, 3H). 13C NMR (126 MHz, CDCl3)  170.4, 148.1, 147.5, 136.9, 130.2, 128.3, 
127.8, 126.5, 119.2, 62.8, 60.8, 54.7, 51.9, 50.3, 40.5, 39.9, 36.0, 34.6, 29.2, 25.08, 22.1, 
13.9. IR (film) 3027.9, 2979.3, 2929.1, 2854.1, 1725.4, 1602.4, 1495.3 cm-1. HRMS (ESI+ 
TOF) m/z: [M + H+]+ calcd for C29H35O4 447.2530; found 447.2530.  
 
(±)-(1R,2S,3aR)-Diethyl 2-(3a-methyl-1-phenyl-2,3,3a,4,5,6-hexahydro-1H-inden-2-
yl)malonate (2-7o) The title compound was prepared from 6-cinnamyl-6-methylcyclohex-
1-en-1-yl trifluoromethanesulfonate (2-1k) (44.6 mg, 0.12 mmol) and benzyl diethyl 
malonate (0.1 mL, 0.43 mmol) using General Procedure B. The crude material was 
purified via column chromatography on silica gel using 98:2 -> 95:5 hexanes:ethyl acetate 
as the eluent. This procedure afforded 28.4 mg (62%) of the title compound as a colorless 
oil. The compound was obtained as a >20:1 mixture of diastereomers as judged by 1H 
NMR analysis. Data are for the major isomer. 1H NMR (500 MHz, CDCl3)  7.30 – 7.11 
(m, 5H), 5.19 (td, J = 3.6, 2.1 Hz, 1H), 4.24 – 4.07 (m, 2H), 3.77 (dq, J = 10.8, 7.1 Hz, 
1H), 3.58 (dq, J = 10.8, 7.2 Hz, 1H), 3.47 (dq, J = 9.0, 2.8 Hz, 1H), 3.35 (d, J = 8.1 Hz, 
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1H), 2.98 (dddd, J = 11.9, 10.1, 8.1, 5.8 Hz, 1H), 2.11 – 1.90 (m, 3H), 1.82 – 1.60 (m, 
3H), 1.38 – 1.15 (m, 8H), 1.02 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3)  168.6, 
168.3, 150.4, 144.3, 128.3, 128.2, 126.1, 120.6, 61.1, 61.0, 55.7, 53.5, 45.7, 43.6, 40.2, 
36.8, 25.5, 24.5, 18.1, 14.1, 13.7. IR (film) 2977.3, 2933.5, 1731.4, 1492.9, 1452.0 cm-1. 
HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C23H31O4 371.2217; found 371.2217.  
 
(±)-(1S,2S,3aS)-Diethyl 2-[3a-(Ethoxycarbonyl)-1-phenyl-1,2,3,3a,4,5-
hexahydropentalen-2-yl] malonate (2-7p). The title compound was prepared from ethyl 
1-cinnamyl-2-{[(trifluoromethyl)sulfonyl]oxy}cyclopent-2-ene-1-carboxylate (2-1l) (70.9 
mg, 0.18 mmol) and diethyl malonate (0.1 mL, 0.6 mmol), Pd(acac)2 (2.4 mg, 0.008 mmol, 
0.04 equiv), SPhos (4.9 mg, 0.012 mmol, 0.06 equiv), at 95 °C for fourteen hours using 
General Procedure B. The crude material was purified via column chromatography on 
silica gel using 95:5 -> 90:10 hexanes:ethyl acetate as the eluent. This procedure afforded 
53.8 mg (72%) of the title compound as a yellow oil. The compound was obtained as a 
>20:1 mixture of diastereomers as judged by 1H NMR analysis. Data are for the major 
isomer. 1H NMR (500 MHz, CDCl3)  7.32 – 7.08 (m, 4H), 5.58 (dt, J = 3.5, 1.7 Hz, 1H), 
4.27 – 4.01 (m, 4H), 4.01 – 3.90 (m, 1H), 3.90 – 3.77 (m, 1H), 3.66 – 3.57 (m, 1H), 3.48 
(d, J = 7.3 Hz, 1H), 3.24 (ddt, J = 8.8, 7.1, 1.8 Hz, 1H), 3.01 – 2.87 (m, 1H), 2.77 (dd, J = 
12.1, 6.3 Hz, 1H), 2.52 (ddd, J = 15.8, 8.7, 3.4 Hz, 1H), 2.33 (dd, J = 12.6, 6.5 Hz, 1H), 
1.93 – 1.78 (m, 1H), 1.45 (t, J = 11.7 Hz, 1H), 1.23 (ddt, J = 25.1, 10.9, 7.2 Hz, 7H), 1.15 
– 1.01 (m, 3H). 13C NMR (126 MHz, CDCl3)  175.8, 168.2, 166.6, 153.3, 142.8, 128.3, 
127.7, 126.3, 125.9, 64.9, 61.5, 61.4, 60.7, 55.1, 54.3, 50.2, 47.1, 41.7, 39.5, 37.1, 29.7, 
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14.1. IR (film) 1725.0 (2 peaks), 1597.5 cm-1. HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for 
C24H30O6 415.2121; found 415.2115.  
 
(±)-(1R,2S,3aR)-Diethyl 2-(1-phenyl-1,2,3,3a,4,5-hexahydropentalen-2-yl)malonate 
(2-7q). The title compound was prepared from 5-cinnamylcyclopent-1-en-1-yl 
trifluoromethanesulfonate (2-1m) (62.4 mg, 0.19 mmol) and diethyl malonate (0.1 mL, 0.6 
mmol), Pd(acac)2 (2.4 mg, 0.008 mmol, 0.04 equiv), SPhos (4.9 mg, 0.012 mmol, 0.06 
equiv), at 95 °C for fourteen hours using General Procedure B. The crude material was 
purified via column chromatography on silica gel using 98:2 -> 95:5 hexanes:ethyl acetate 
as the eluent. This procedure afforded 18.8 mg (30%) of the title compound as a colorless 
oil. The compound was obtained as a >20:1 mixture of diastereomers as judged by 1H 
NMR analysis. Data are for the major isomer. 1H NMR (500 MHz, CDCl3)  7.33 – 7.22 
(m, 3H), 7.22 – 7.10 (m, 3H), 5.25 (tt, J = 3.2, 1.7 Hz, 1H), 4.23 – 4.05 (m, 2H), 3.98 – 
3.84 (m, 1H), 3.84 – 3.71 (m, 1H), 3.47 (dd, J = 21.1, 8.3 Hz, 2H), 3.20 (d, J = 6.6 Hz, 
1H), 3.10 – 2.97 (m, 1H), 2.59 (ddd, J = 7.0, 3.4, 1.7 Hz, 1H), 2.49 (dd, J = 9.7, 6.2 Hz, 
1H), 2.29 (dt, J = 12.3, 6.4 Hz, 1H), 2.15 (dt, J = 13.2, 6.9 Hz, 2H), 1.24 (t, J = 7.1 Hz, 
3H), 1.05 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3)  168.5, 168.4, 155.7, 144.6, 
128.3, 127.6, 126.2, 120.2, 61.2, 61.1, 55.7, 52.3, 51.5, 47.2, 37.2, 36.7, 32.1, 14.1, 13.7. 
IR (film) 2932.7, 2849.4, 1730.9, 1600.8, 1495.7, 1452.3 cm-1. HRMS (ESI+ TOF) m/z: [M 




hexahydropentalen-2-yl]malonate (2-7r). The title compound was prepared from ethyl 
1-cinnamyl-2-{[(trifluoromethyl)sulfonyl]oxy}cyclopent-2-ene-1-carboxylate (2-1l) (80.8 
mg, 0.2 mmol) and di-tert-butyl malonate (0.1 mL, 0.4 mmol) using General Procedure B. 
The crude material was purified via column chromatography on silica gel using 95:5 
hexanes:ethyl acetate as the eluent. This procedure afforded 54.5 mg (58%) of the title 
compound as a pale yellow oil. The compound was obtained as a >20:1 mixture of 
diastereomers as judged by 1H NMR analysis. Data are for the major isomer. 1H NMR 
(500 MHz, CDCl3)  7.29 – 7.21 (m, 4H), 7.16 (p, J = 3.5, 2.8 Hz, 1H), 5.63 – 5.55 (m, 
1H), 4.09 (q, J = 7.2 Hz, 2H), 3.64 (d, J = 8.4 Hz, 1H), 3.33 (dd, J = 6.8, 1.5 Hz, 1H), 3.20 
– 3.08 (m, 1H), 2.94 (t, J = 8.5 Hz, 1H), 2.79 (dd, J = 12.3, 6.5 Hz, 1H), 2.53 (ddd, J = 
15.7, 9.0, 2.8 Hz, 1H), 2.35 (dd, J = 12.6, 6.5 Hz, 1H), 1.95 – 1.81 (m, 1H), 1.56 – 1.40 
(m, 10H), 1.31 (d, J = 1.6 Hz, 9H), 1.17 (td, J = 7.1, 1.5 Hz, 3H). 13C NMR (126 MHz, 
CDCl3)  175.9, 167.8, 167.7, 153.3, 143.0, 128.3, 127.7, 126.2, 125.7, 81.6, 81.5, 64.8, 
60.6, 56.9, 49.9, 47.0, 39.4, 39.1, 37.1, 28.0, 27.7, 14.1. IR (film) 2977.8, 2933.2, 1721.1 
(the carbonyl peaks are incidentally equivalent), 1596.3, 1497.0, 1454.5 cm-1. HRMS 




hexahydro pentalen-2-yl]malonate (2-7s). The title compound was prepared from ethyl 
1-cinnamyl-2-{[(trifluoromethyl)sulfonyl]oxy}cyclopent-2-ene-1-carboxylate (2-1l) (89.2 
mg, 0.22 mmol) and benzyl diethyl malonate (0.1 mL, 0.43 mmol) using General 
Procedure B, except that the reaction was run in xylenes at 110 °C. The crude material 
was purified via column chromatography on silica gel using 98:2 -> 95:5 hexanes:ethyl 
acetate as the eluent. This procedure afforded 45.4 mg (41%) of the title compound as a 
colorless oil. The compound was obtained as a >20:1 mixture of diastereomers as judged 
by 1H NMR analysis. Data are for the major isomer. 1H NMR (500 MHz, CDCl3)  7.30 – 
7.02 (m, 10H), 5.54 (dt, J = 3.2, 1.5 Hz, 1H), 4.14 – 3.96 (m, 3H), 3.98 – 3.82 (m, 3H), 
3.73 – 3.61 (m, 1H), 3.52 (dt, J = 10.3, 7.2 Hz, 1H), 3.19 (s, 2H), 3.02 – 2.81 (m, 2H), 
2.52 (ddd, J = 15.6, 8.8, 3.3 Hz, 1H), 2.30 (dd, J = 12.7, 6.8 Hz, 1H), 1.84 (dt, J = 12.7, 
9.4 Hz, 1H), 1.62 – 1.49 (m, 1H), 1.17 (t, J = 7.1 Hz, 3H), 1.09 (t, J = 7.2 Hz, 3H), 0.89 (t, 
J = 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3)  176.2, 170.3, 170.2, 153.8, 143.7, 136.6, 
130.2, 128.2, 127.9, 127.5, 126.7, 125.9, 124.4, 64.0, 63.0, 61.0, 60.8, 60.6, 52.4, 46.0, 
40.6, 39.6, 37.9, 37.2, 14.0 (2 peaks), 13.5. IR (film) 2980.3, 1719.6, 1602.1, 1495.9, 
1454.1 cm-1. HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C31H36O6 505.2590; found 
505.2585.  
 
(±)-(5S,7R)-Diethyl 2-(9-methylene-1-oxaspiro[4.4]nonan-7-yl)malonate (2-9). The 
title compound was prepared from 1-(2-allyltetrahydrofuran-2-yl)vinyl triflate (57.3 mg, 0.2 
mmol) and diethyl malonate (37 µL, 0.24 mmol) using General Procedure A. The crude 
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material was purified via column chromatography on silica gel using 95:5 -> 90:10 
hexanes:ethyl acetate as the eluent. This procedure afforded 49.0 mg (82%) of the title 
compound as a colorless oil. The compound was obtained as a >20:1 mixture of 
diastereomers as judged by 1H NMR analysis. Data are for the major isomer. 1H NMR 
(500 MHz, C6D6)  4.96 (s, 1H), 4.88 (s, 1H), 4.07 – 3.84 (m, 4H), 3.75 – 3.59 (m, 2H), 
3.31 – 3.18 (m, 1H), 3.23 – 3.09 (m, 1H), 2.89 (dd, J = 16.4, 7.8 Hz, 1H), 2.29 (dd, J = 
12.9, 6.5 Hz, 1H), 2.16 (ddt, J = 16.3, 9.5, 2.6 Hz, 1H), 1.87 – 1.76 (m, 1H), 1.71 – 1.52 
(m, 3H), 1.46 (dd, J = 12.9, 10.7 Hz, 1H), 0.91 (t, J = 7.1 Hz, 6H). 13C NMR (126 MHz, 
C6D6)  168.12, 168.09, 154.1, 106.3, 88.0, 66.3, 60.63, 60.62, 57.0, 43.8, 36.8, 35.7, 
34.4, 26.0, 13.7; IR (film) 1749, 1728, 1445, 1025 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ 
calcd for C16H24O5 297.1624; found 297.1697.  
  
(±)-Diethyl 4-(1,3-di-tert-butoxy-1,3-dioxopropan-2-yl)-2-methylenecyclopentane-
1,1-dicarboxylate (11) and (±)-Diethyl 3-(3-(tert-butoxy)-2-(tert-butoxycarbonyl)-3-
oxopropyl)-2-methylenecyclobutane-1,1-dicarboxylate (2-11a and 2-11b). The title 
compounds were prepared from diethyl 2-allyl-2-(1-
{[(trifluoromethyl)sulfonyl]oxy}vinyl)malonate (37.3 mg, 0.1 mmol) and di-tert-butyl 
malonate (26.7 µL, 0.12 mmol) using General Procedure A except XPhos (6 mol %) was 
used as ligand, 1,4-dioxane was used as solvent, and the reaction was conducted for 1 
hr. The crude material was purified via column chromatography on silica gel using 95:5 
hexanes:ethyl acetate as the eluent. This procedure afforded 33.4 mg (76%) combined 
yield of [2-11a] and [2-11b] in a 1:2.5 regioisomeric mixture which was determined by 1H 
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NMR analysis. Characterization data are for the mixture. 1H NMR (500 MHz, CDCl3)  
5.35 – 5.3 (ddd, J = 12.4, 2.9, 1.3 Hz, 1.4H), 5.25 (t, J = 2.0 Hz, 0.43H), 5.14 (dd, J = 2.4, 
1.2 Hz, 1H), 4.30 – 4.15 (m, J = 14.2, 7.2, 5.9, 3.2 Hz, 5.7H), 3.16 (t, J = 7.6 Hz, 1H), 3.09 
– 2.95 (m, 1.4H), 2.75 – 2.55 (m, 2.3H), 2.31 – 2.18 (m, 1.4H), 2.15 (ddd, J = 13.9, 7.8, 
6.1 Hz, 1H), 2.09 – 2.00 (m, 0.8H), 1.94 (ddd, J = 13.9, 9.4, 7.4 Hz, 1H), 1.50 – 1.41 (m, 
26H), 1.25 (td, J = 7.2, 6.1 Hz, 9.7H); 13C NMR (126 MHz, CDCl3)  169.6, 169.1, 168.7, 
168.6, 147.8, 146.5, 112.8, 110.6, 81.75, 81.73, 81.72, 61.84, 61.78, 61.76, 61.7, 59.3, 
58.6, 51.8, 40.0, 38.5, 36.9, 32.9, 32.1, 29.8, 28.1, 19.0, 14.19, 14.14, 14.12. 
 
(±)-Ethyl (2S,3aR)-2-(2,3,3a,4,5,6-hexahydro-1H-inden-2-yl)-3-oxobutanoate (2-12a). 
The title compound was prepared from 6-allylcyclohex-1-en-1-yl triflate (54.1 mg, 0.2 
mmol) and ethyl acetoacetate (31 µL, 0.24 mmol) using the General Procedure A. The 
crude material was purified via column chromatography on silica gel using 99:1 -> 95:5 
hexanes:ethyl acetate as the eluent. This procedure afforded 40.5 mg (81%) of the title 
compound. The compound was obtained as a 1:1 mixture of diastereomers, epimeric at 
the stereocenter between the carbonyl groups as indicated by the structure above, as 
judged by 1H NMR analysis. Data are for the mixture. 1H NMR (401 MHz, CDCl3)  5.35 
(s, 0.5H), 5.32 (s, 0.5H), 4.28 – 4.10 (m, 2H), 3.25 (dd, J = 10.1, 8.2 Hz, 1H), 2.75 – 2.50 
(m, 2H), 2.22 (d, J = 3.1 Hz, 4H), 2.10 – 1.71 (m, 6H), 1.51 – 1.34 (m, 1H), 1.29 – 1.25 
(m, 3H), 1.05 – 0.89 (m, 1H), 0.88 – 0.71 (m, 1H); 13C NMR (126 MHz, CDCl3)  203.1, 
202.9, 169.33, 169.28, 142.7, 142.5, 118.3, 118.2, 66.4, 66.2, 61.4, 41.1, 40.8, 38.6, 
38.59, 36.9, 35.2, 35.2, 29.3, 29.0, 28.9, 25.30, 25.29, 22.5, 22.4, 14.3; IR (film) 1735, 
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yl)acetate (2-12b). The title compound was prepared from 6-allylcyclohex-1-en-1-yl 
triflate (500 mg, 1.85 mmol), and triethyl phosphonoacetate (440 µL, 2.22 mmol) using 
General Procedure A except with lithium hexamethyldisilazide (774 mg, 4.625 mmol) as 
base. The crude material was purified via column chromatography on silica gel using 
50:50 -> 15:85 hexanes:ethyl acetate as the eluent. This procedure afforded 332 mg 
(52%) of the title compound as a yellow oil. The compound was obtained as a 1:1 mixture 
of diastereomers, epimeric at the stereocenter adjacent to the ester group as indicated 
by the structure above, as judged by 1H NMR analysis. Data are for the mixture 1H NMR 
(401 MHz, CDCl3)  5.39 (s, 0.5H), 5.35 (s, 0.5H), 4.35 – 3.98 (m, 6H), 2.84 – 2.54 (m, 
2.5H), 2.35 – 2.09 (m, 2H), 2.07 – 1.86 (m, 4H), 1.85 – 1.71 (m, 1H), 1.50 – 1.37 (m, 1H), 
1.41 – 1.14 (m, 9H), 1.14 – 0.73 (m, 2.5H); 13C NMR (126 MHz, CDCl3)  169.21, 169.06, 
142.83, 142.20, 117.97, 62.46, 61.21, 52.14, 51.09, 41.32, 40.64, 39.63, 39.51, 39.42, 
36.28, 36.24, 36.15, 36.11, 35.92, 35.79, 35.43, 28.65, 28.58, 25.19, 25.14, 22.32, 22.30, 
16.40, 16.36, 14.17; IR (film) 1731 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for 
C17H29O5P 345.1753; found 345.1825. 
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(±)-(2S, 3aR)-Ethyl 2’-cyano-2-2,3,3a,4,5,6-hexahydro-1H-inden-2-yl acetate (2-12c). 
The title compound was prepared from 6-allylcyclohex-1-en-1-yl triflate (54.1 mg, 0.2 
mmol), ethyl cyanoacetate (26 µL, 0.24 mmol), using General Procedure A, except with 
Pd(allyl)BrettphosCl (8.6 mg, 0.012 mmol), as catalyst, BrettPhos was added (6.4 mg, 
0.012 mmol), cesium carbonate (91.2 mg, 0.28 mmol) as base, and 1,4 dioxane (2 mL, 
0.1M) as solvent. The crude material was purified via column chromatography on silica 
gel using 65:35 -> 50:50 hexanes:dichloromethane as the eluent. This procedure afforded 
22.8 mg (50%) of the title compound as a colorless oil. The compound was obtained as 
a 1:1 mixture of diastereomers, epimeric at the CN-bearing stereocenter, as judged by 1H 
NMR analysis. Data are for the mixture. 1H NMR (401 MHz, CDCl3)  5.43 (s, 1H), 4.26 
(q, J = 7.1 Hz, 2H), 3.48 (dd, J = 11.3, 6.5 Hz, 1H), 2.69 – 2.50 (m, 2H), 2.35 – 1.91 (m, 
6H), 1.85 – 1.71 (m, 1H), 1.51 – 1.34 (m, 1H), 1.32 (t, J = 7.1 Hz, 3H), 1.16 – 0.97 (m, 
2H); 13C NMR (126 MHz, CDCl3)  166.0, 141.3, 141.1, 119.32, 119.27, 115.9, 62.8, 
42.70, 42.65, 41.1, 41.0, 38.5, 37.9, 37.7, 34.8, 34.0, 28.7, 25.2, 22.3, 14.2; IR (film) 2248, 
1743, 1453 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C14H19NO2 234.1416; found 
234.1493. 
 
(±)-Ethyl 2-cyano-2-(2,3-dihydro-1H-inden-2-yl)acetate (2-13a). The title compound 
was prepared from 2-allylphenyl triflate (53.3 mg, 0.2 mmol), ethyl cyanoacetate (26 µL, 
0.24 mmol), using General Procedure A, except with Pd(allyl)BrettphosCl (8.6 mg, 0.012 
mmol) as catalyst, additional BrettPhos (6.4 mg, 0.012 mmol), Cs2CO3 (91.2 mg, 0.28 
mmol) as base, and dioxane (2 mL, 0.1M) as solvent. The crude material was purified via 
column chromatography on silica gel using 95:5 hexanes:ethyl acetate as the eluent. This 
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procedure afforded 22.0 mg (47%) of the title compound as a colorless oil. The compound 
was obtained as a 1:1 mixture of diastereomers, epimeric at the CN-bearing stereocenter, 
as judged by 1H NMR analysis. Data are for the mixture. 1H NMR (500 MHz, CDCl3)  
7.25 – 7.15 (m, 4H), 4.28 (q, J = 7.2 Hz, 2H), 3.64 (dd, J = 6.8, 1.7 Hz, 1H), 3.25 – 3.08 
(m, 3H), 2.99 (dd, J = 15.5, 7.4 Hz, 1H), 2.92 (dd, J = 14.5, 6.7 Hz, 1H), 1.34 (t, J = 7.2, 
3H); 13C NMR (126 MHz, CDCl3)  165.59, 140.95, 140.93, 126.91, 126.87, 124.54, 
124.46, 115.72, 62.85, 42.08, 42.04, 39.96, 37.07, 36.56, 14.02; IR (film) 2908, 2242, 




13b). The title compound was prepared from 2-allylphenyl triflate (53.5 mg, 0.2 mmol) and 
2-acetyl-1-tetralone (45.2 mg, 0.24 mmol) using General Procedure A, except with 
LiHMDS (87.0 mg, 0.52 mmol) as the base, and xylenes (2 mL) as the solvent, and a 
reaction temperature of 130 °C. The crude material was purified via column 
chromatography on silica gel using 65:35 hexanes:dichloromethane as the eluent. This 
procedure afforded 24.5 mg (40%) of the title compound as a yellow solid, mp 77–80 °C, 
that contained ca 5% of inseparable impurities. 1H NMR (401 MHz, CDCl3)  7.95 – 7.91 
(m, 1H), 7.37 (td, J = 7.4, 1.5 Hz, 1H), 7.33 – 7.26 (m, 1H), 7.20 – 7.14 (m, 3H), 7.14 – 
7.08 (m, 2H), 3.15 (dd, J = 15.6, 7.7 Hz, 2H), 3.01 – 2.91 (m, 1H), 2.85 – 2.79 (m, 2H), 
2.73 – 2.61 (m, 4H), 2.58 (dd, J = 8.3, 6.3 Hz, 2H); 13C NMR (100 MHz, CDCl3)  194.95, 
177.67, 142.75, 140.82, 131.88, 131.30, 127.51, 126.85, 126.26, 125.90, 124.50, 106.06, 
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41.46, 39.10, 36.22, 28.28, 22.52; IR (film) 3062, 2926, 2833, 1712, 1666, 1586, 1554, 
1294 cm-1; HRMS (ESI+ TOF) m/z: [M + Na+]+ calcd for C21H20O2 327.1356; found 
327.1360. 
 
tert-Butyl 2-(2,3-dihydro-1H-inden-2-yl)acetate (2-14a). The title compound was 
prepared from 2-allylphenyl triflate (266.5 mg, 1 mmol) and tert-butyl acetate (165 µL, 1.4 
mmol) using General Procedure A, except with LiHMDS (368 mg, 2.2 mmol) as the base. 
The crude material was purified via column chromatography on silica gel using 95:5 
hexanes:ethyl acetate as the eluent to afford a mixture of the desired product and a side 
product resulting from C-arylation of the ester. In order to separate these compounds, the 
material was further reacted with 0.5 g of AD-alpha-mix in a 1:1 solution of tert-butyl 
alcohol and water (1.6 mL: 1.6 mL) for 12 h at rt to oxidize the alkene in the undesired 
product. The oxidation reaction was then quenched with sodium sulfite and stirred at rt 
for 30 min. The aqueous layer was extracted with ethyl acetate (3 x 5 mL), dried with 
MgSO4, and concentrated in vacuo. The crude material was purified via column 
chromatography on silica gel using 80:20 hexanes:dichloromethane. This procedure 
afforded 24.5 mg (24%) of the title compound as a colorless oil.1H NMR (401 MHz, CDCl3) 
 7.22 – 7.16 (m, 2H), 7.16 – 7.10 (m, 2H), 3.12 (dd, J = 15.5, 7.8 Hz, 2H), 2.85 (p, J = 
7.6 Hz, 1H), 2.64 (dd, J = 15.5, 7.4 Hz, 2H), 2.41 (d, J = 7.5 Hz, 1H), 1.47 (s, 9H); 13C 
NMR (126 MHz, CDCl3)  172.27, 142.80, 126.20, 124.44, 80.22, 41.41, 38.92, 36.34, 
28.13; IR (film) 2248, 1743, 1453 cm-1; IR (film) 2969, 2921, 1724, 1480 cm-1; HRMS 
(ESI+ TOF) m/z: [M + Na+]+ calcd for C15H20O2 255.1356; found 255.1360. 
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Methyl 2-(2,3-dihydro-1H-inden-2-yl)-2-methylpropanoate (2-14b). The title 
compound was prepared from 2-allylphenyl triflate (53.3 mg, 0.2 mmol) and methyl 
isobutyrate (28 µL, 0.24 mmol) using General Procedure A, except with LiHMDS (73.6 
mg, 0.44 mmol) as the base. The crude material was purified via column chromatography 
on silica gel using 95:5 hexanes:ethyl acetate as the eluent. This procedure afforded 37.1 
mg (85%) of the title compound as a colorless oil.1H NMR (500 MHz, CDCl3)  7.20 – 
7.15 (m, 2H), 7.14 – 7.10 (m, 2H), 3.68 (s, 3H), 2.96 – 2.86 (m, 2H), 2.85 – 2.74 (m, 3H), 
1.23 (s, 6H); 13C NMR (126 MHz, CDCl3)  178.11, 142.89, 126.33, 124.45, 77.41, 77.16, 
76.91, 51.85, 47.83, 44.52, 34.56, 23.09; IR (film) 1726 cm-1; HRMS (ESI+ TOF) m/z: [M 
+ H+]+ calcd for C14H18O2 219.3180; found 219.1380. 
 
(±)-Methyl 2-(5-fluoro-2-methyl-2,3-dihydro-1H-inden-2-yl)-2-methylpropanoate (2-
14c). The title compound was prepared from 4-fluoro-2-(2-methylallyl)phenyl triflate (56.8 
mg, 0.2 mmol) and methyl isobutyrate (28 µL, 0.24 mmol) using General Procedure A, 
except with LiHMDS (73.6 mg, 0.44 mmol) as the base and RuPhos (5.6 mg, 0.012 mmol) 
as the ligand. The crude material was purified via column chromatography on silica gel 
using 80:20 hexanes:dichloromethane as the eluent. This procedure afforded 11.5 mg 
(23%) of the title compound as a colorless oil. 1H NMR (401 MHz, CDCl3)  7.08 (dd, J = 
8.2, 5.3 Hz, 1H), 6.90 – 6.75 (m, 2H), 3.65 (s, 3H), 3.23 (dd, J = 25.1, 16.1 Hz, 2H), 2.48 
(dd, J = 16.0, 11.5 Hz, 2H), 1.25 (s, 6H), 1.03 (s, 3H); 13C NMR (176 MHz, CDCl3)  
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177.52, 162.65, 161.27, 144.36 (d, J = 8.0 Hz), 137.55, 125.58 (d, J = 8.7 Hz), 112.94 (d, 
J = 22.2 Hz), 111.71 (d, J = 21.8 Hz), 51.51, 48.95, 47.81, 47.56, 42.50, 42.49, 41.50, 
29.69, 23.75, 22.09, 22.07, 19.01; IR (film) 2929, 1723, 1141 cm-1; HRMS (ESI+ TOF) 
m/z: [M + Na+]+ calcd for C15H19FO2 273.1369; found 273.1267. 
 
(±)-Methyl 2-[5-(tert-butyl)-2-methyl-2,3-dihydro-1H-inden-2-yl]-2-
methylpropanoate (2-14d). The title compound was prepared from 4-tert-butyl-2-(2-
methylallyl)phenyl triflate (67.3 mg, 0.2 mmol) and methyl isobutyrate (28 µL, 0.24 mmol) 
using General Procedure A except with LiHMDS (73.6 mg, 0.44 mmol) as the base and 
RuPhos (5.6 mg, 0.012 mmol) as the ligand. The crude material was purified via column 
chromatography on silica gel using 99:1 hexanes:ethyl acetate as the eluent. This 
procedure afforded 13.7 mg (24%) of the title compound as a colorless oil. 1H NMR (401 
MHz, CDCl3)  7.22 – 7.15 (m, 2H), 7.10 (d, J = 7.8 Hz, 1H), 3.65 (s, 3H), 3.31 – 3.20 (m, 
2H), 2.54 – 2.43 (m, 2H), 1.31 (s, 9H), 1.26 (s, 6H), 1.04 (s, 3H); 13C NMR (126 MHz, 
CDCl3)  177.71, 149.22, 142.08, 139.24, 124.23, 123.15, 121.69, 51.44, 48.47, 47.61, 
42.47, 41.89, 34.49, 31.59, 23.94, 22.14; IR (film) 2952, 1728, 1144 cm-1; HRMS (ESI+ 
TOF) m/z: [M + Na+]+ calcd for C19H28O2 306.2428; found 306.2436. 
 
(±)-Methyl 2-(2,3-dihydro-1H-inden-2-yl)-2-phenylacetate (2-14e). The title compound 
was prepared from 2-allylphenyl triflate (53.3 mg, 0.2 mmol) and methyl 2-phenylacetate 
(35 µL, 0.24 mmol) using General Procedure A, except with LiHMDS (73.6 mg, 0.44 
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mmol) as the base. The crude material was purified via column chromatography on silica 
gel using 80:20 hexanes:dichloromethane -> 65:35 hexanes:dichloromethane as the 
eluent. This procedure afforded 45.8 mg (86%) of the title compound as a white solid, mp 
70–71 °C. 1H NMR (400 MHz, CDCl3)  7.41 – 7.28 (m, 4H), 7.24 – 7.19 (m, 1H), 7.18 – 
7.06 (m, 3H), 3.70 (s, 3H), 3.56 (d, J = 10.5 Hz, 1H), 3.34 – 3.15 (m, 2H), 2.84 – 2.66 (m, 
2H), 2.50 (dd, J = 15.7, 7.6 Hz, 1H); 13C NMR (100 MHz, CDCl3)  174.03, 142.53, 142.33, 
138.30, 128.70, 128.28, 127.45, 126.32, 126.29, 124.48, 124.34, 56.98, 51.96, 42.92, 
38.19, 37.06; IR (film) 2941, 1725, 1577, 1451, 1433 cm-1; HRMS (ESI+ TOF) m/z: [M + 
Na+]+ calcd for C18H18O2 289.1199; found 289.1203. 
 
(±)-(2S,3aR)-Methyl 2-(2,3,3a,4,5,6-hexahydro-1H-inden-2-yl)-2-phenylacetate (2-
14f). The title compound was prepared from 6-allylcyclohex-1-en-1-yl triflate (54.1 mg, 
0.2 mmol) and methyl 2-phenylacetate (35 µL, 0.24 mmol) using General Procedure A, 
except with LiHMDS (73.6 mg, 0.44 mmol) as the base. The crude material was purified 
via column chromatography on silica gel using 80:20 hexanes:dichloromethane -> 65:35 
hexanes:dichloromethane as the eluent. This procedure afforded 29.2 mg (54%) of the 
title compound as a colorless oil. The compound was obtained as a 2:1 mixture of 
diastereomers epimeric at the stereocenter alpha to the carbonyl group, as judged by 1H 
NMR analysis. Data are for the mixture. 1H NMR (500 MHz, CDCl3)  7.38 – 7.30 (m, 4H), 
7.30 – 7.24 (m, 1H), 5.40 (m, 0.67H), 5.30 (s, 0.34H), 3.66 (s, 3H), 3.29 (d, J = 10.6 Hz, 
1H), 2.84 – 2.61 (m, 1.67H), 2.28 (br s, 0.33H), 2.24 – 2.09 (m, 1.35H), 2.05 – 1.94 (m, 
3H), 1.92 – 1.83 (m, 0.67H), 1.83 – 1.70 (m, 1.34H), 1.66 – 1.55 (m, 1H), 1.51 – 1.34 (m, 
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1H), 1.09 – 0.86 (m, 1.34H), 0.67 (q, J = 11.6 Hz, 0.67H); 13C NMR (126 MHz, CDCl3)  
174.15, 143.38, 143.06, 138.54, 128.51, 128.19, 128.14, 127.25, 127.22, 117.78, 117.75, 
58.17, 57.91, 51.86, 51.83, 41.21, 40.88, 40.82, 40.74, 39.42, 38.66, 35.92, 35.01, 28.91, 
28.83, 25.19, 25.17, 22.38, 22.35; IR (film) 2914, 2833, 1731, 1430 cm-1; HRMS (ESI+ 
TOF) m/z: [M + H+]+ calcd for C18H22O2 271.1693; found 271.1695. 
 
(±)-(2S,3aR)-Methyl 2-(2,3,3a,4,5,6-hexahydro-1H-inden-2-yl)-2-methylpropanoate 
(2-14g). The title compound was prepared from 6-allylcyclohex-1-en-1-yl triflate (54.1 mg, 
0.2 mmol) and methyl isobutyrate (28 µL, 0.24 mmol) using General Procedure A, except 
with LiHMDS (73.6 mg, 0.44 mmol) as the base. The crude material was purified via 
column chromatography on silica gel using 80:20 hexanes:dichloromethane -> 65:35 
hexanes:dichloromethane as the eluent. This procedure afforded 39.1 mg (88%) of the 
title compound as a colorless oil. The compound was obtained as a >20:1 mixture of 
diastereomers as judged by 1H NMR analysis. Data are for the major isomer. 1H NMR 
(500 MHz, CDCl3)  5.34 (s, 1H), 3.65 (s, 3H), 2.38 – 2.12 (m, 3H), 2.09 – 1.90 (m, 4H), 
1.87 – 1.70 (m, 2H), 1.50 – 1.36 (m, 1H), 1.13 (s, 3H), 1.12 (s, 3H), 1.06 – 0.95 (m, 1H), 
0.94 – 0.83 (m, 1H); 13C NMR (126 MHz, CDCl3)  178.47, 143.62, 117.60, 77.41, 77.16, 
76.91, 51.72, 45.66, 44.10, 41.42, 35.44, 31.85, 28.98, 25.39, 22.74, 22.61, 22.57; IR 





yl)propanoate (2-14h). The title compound was prepared from 6-(2-methylallyl)cyclohex-
1-en-1-yl triflate (56.9 mg, 0.2 mmol) and methyl isobutyrate (28 µL, 0.24 mmol) using 
General Procedure A, except with LiHMDS (73.6 mg, 0.44 mmol) as the base and RuPhos 
(5.6 mg, 0.012 mmol) as the ligand. The crude material was purified via column 
chromatography on silica gel using 95:5 hexanes:ethyl acetate as the eluent. This 
procedure afforded 24.7 mg (52%) of the title compound as a colorless oil. The compound 
was obtained as an 11:1 mixture of diastereomers as judged by 1H NMR analysis. Data 
are for the major isomer. 1H NMR (401 MHz, CDCl3)  5.32 (s, 1H), 3.63 (s, 3H), 2.65 – 
2.54 (m, 1H), 2.38 (br s, 1H), 2.05 – 1.88 (m, 4H), 1.82 – 1.72 (m, 1H), 1.52 (dd, J = 12.1, 
7.0 Hz, 1H), 1.48 – 1.37 (m, 1H), 1.33 (t, J = 12.1 Hz, 1H), 1.14 (s, 6H), 1.01 (s, 3H), 1.00 
– 0.94 (m, 1H); 13C NMR (126 MHz, CDCl3)  177.90, 143.91, 117.22, 51.28, 47.96, 45.16, 
42.34, 40.66, 38.95, 29.04, 25.17, 24.87, 22.47, 21.61, 21.58; IR (film) 1922, 1726, 1432, 




yl)propanoate (2-14i). The title compound was prepared from 5-(2-methylallyl)cyclopent-
1-en-1-yl triflate (54.0 mg, 0.2 mmol) and methyl isobutyrate (28 µL, 0.24 mmol) using 
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General Procedure A, except with LiHMDS (73.6 mg, 0.44 mmol) as the base and RuPhos 
(5.6 mg, 0.012 mmol) as the ligand. The crude material was purified via column 
chromatography on silica gel using 95:5 hexanes:ethyl acetate as the eluent. This 
procedure afforded 22.2 mg (50%) of the title compound as a colorless oil. The compound 
was obtained as a >20:1 mixture of diastereomers as judged by 1H NMR analysis. Data 
are for the major isomer. NMR spectra were acquired in C6D6, as some (ca 5%) 
isomerization of the alkene occurred when spectra were acquired in CDCl3. 1H NMR (401 
MHz, C6D6)  5.24 (s, 1H), 3.31 (s, 3H), 2.95 (br s, 1H), 2.80 – 2.67 (m, 1H), 2.66 – 2.53 
(m, 1H), 2.51 – 2.38 (m, 1H), 2.11 – 2.05 (m, 1H), 1.84 – 1.74 (m, 1H), 1.52 – 1.29 (m, 
4H), 1.14 (s, 6H), 1.03 (s, 3H); 13C NMR (126 MHz, C6D6)  176.54, 152.91, 117.81, 
52.08, 50.53, 49.78, 48.01, 41.82, 37.24, 34.74, 32.35, 25.21, 21.47, 21.43; IR (film) 
2943, 2839, 1726, 1132 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C14H22O2 
223.1693; found 223.1690. 
 
(±)-(1S,4R)-Methyl 2-methyl-2-(1-methyl-3-methylene-4-
phenylcyclopentyl)propanoate (2-16). The title compound was prepared from 5-
methyl-3-phenylhexa-1,5-dien-2-yl triflate (64.1 mg, 0.2 mmol) and methyl isobutyrate (28 
µL, 0.24 mmol) using General Procedure A, except with LiHMDS (73.6 mg, 0.44 mmol) 
as the base and RuPhos (5.6 mg, 0.012 mmol) as the ligand. The crude material was 
purified via column chromatography on silica gel using 80:20 hexanes:dichloromethane 
as the eluent. This procedure afforded 28 mg (52%) of the title compound as a colorless 
oil. The compound was obtained as a >20:1 mixture of diastereomers as judged by 1H 
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NMR analysis. Data are for the major isomer. 1H NMR (500 MHz, CDCl3)  7.33 – 7.27 
(m, 2H), 7.23 – 7.17 (m, 3H), 5.00 (s, 1H), 4.59 (s, 1H), 3.79 – 3.70 (m, 1H), 3.67 (s, 3H), 
2.83 (d, J = 16.4 Hz, 1H), 2.21 (d, J = 16.3 Hz, 1H), 2.03 – 1.94 (m, 1H), 1.92 – 1.84 (m, 
1H), 1.23 (s, 3H), 1.22 (s, 3H) 1.06 (s, 3H); 13C NMR (126 MHz, CDCl3)  177.64, 155.32, 
145.32, 128.35, 128.14, 126.05, 108.75, 51.39, 48.86, 47.74, 45.59, 44.87, 43.20, 22.23, 
21.63, 21.60; IR (film) 2968, 1726, 1142 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for 
C18H24O2 273.1849; found 273.1847. 
 
3-(2,3-Dihydro-1H-inden-2-yl)-1,1-diphenylpropan-2-one (2-17a). The title compound 
was prepared from 2-allylphenyl triflate (533 mg, 2.0 mmol) and 1,1-diphenylacetone (505 
mg, 2.4 mmol) using General Procedure A, except with LiHMDS (736 mg, 4.4 mmol) as 
the base. The crude material was purified via column chromatography on silica gel using 
99:1 hexanes:ethyl acetate as the eluent to afford a mixture of the desired product and a 
side product resulting from C-arylation of the ester. In order to separate these 
compounds, the material was further reacted with 1.2 g of AD-alpha-mix in a 1:1 solution 
of tertbutyl alcohol and water (4 mL: 4 mL) for 12 h at rt to oxidize the alkene in the 
undesired product. The oxidation reaction was then quenched with sodium sulfite and 
stirred at rt for 30 min. The aqueous layer was extracted with ethyl acetate (3 x 8 mL), 
dried with MgSO4, and concentrated in vacuo. The crude material was purified via column 
chromatography on silica gel using 99:1 hexanes:ethyl acetate. This procedure afforded 
158 mg (24%) of the title compound as a colorless oil. 1H NMR (401 MHz, CDCl3)  7.34 
– 7.27 (m, 4H), 7.26 – 7.19 (m, 6H), 7.14 – 7.05 (m, 4H), 5.10 (s, 1H), 3.08 (dd, J = 15.6, 
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7.8 Hz, 2H), 2.90 (dt, J = 14.9, 7.5 Hz, 1H), 2.74 (d, J = 7.1 Hz, 2H), 2.46 (dd, J = 15.5, 
7.3 Hz, 2H); 13C NMR (126 MHz, CDCl3)  207.95, 142.79, 138.35, 129.01, 128.78, 
127.30, 126.28, 124.48, 64.35, 48.73, 39.07, 35.10; IR (film) 3020, 2902, 2833, 1713, 
1492, 903 cm-1; HRMS (ESI+ TOF) m/z: [M + Na+]+ calcd for C24H22O 349.1563; found 
349.1566. 
 
(±)-2-(2,3-Dihydro-1H-inden-2-yl)-1,2-diphenylethan-1-one (2-17b). The title 
compound was prepared from 2-allylphenyl triflate (53.3 mg, 0.2 mmol) and deoxybenzoin 
(47.1 mg, 0.24 mmol) using General Procedure A, except with LiHMDS (73.6 mg, 0.44 
mmol) as the base. The crude material was purified via column chromatography on silica 
gel using 80:20 hexanes:dichloromethane as the eluent. This procedure afforded 50.1 mg 
(81%) of the title compound as a colorless oil. 1H NMR (401 MHz, CDCl3)  8.01 – 7.95 
(m, 2H), 7.52 – 7.45 (m, 1H), 7.43 – 7.36 (m, 4H), 7.35 – 7.28 (m, 2H), 7.26 – 7.20 (m, 
1H), 7.18 – 7.08 (m, 4H), 4.57 (d, J = 10.7 Hz, 1H), 3.53 – 3.37 (m, 1H), 3.27 (dd, J = 
15.8, 7.7 Hz, 1H), 2.77 – 2.54 (m, 3H); 13C NMR (126 MHz, CDCl3)  199.76, 142.91, 
142.54, 138.59, 137.06, 132.94, 128.97, 128.65, 128.59, 128.55, 127.27, 126.27, 126.24, 
124.54, 124.37, 58.86, 43.16, 38.65, 37.04; IR (film) 3026, 2938, 2836, 1675, 1596, 698 
cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C23H20O 313.1587; found 313.1592. 
 
(±)-2-(2,3-Dihydro-1H-inden-2-yl)cyclohexan-1-one (2-17c). The title compound was 
prepared from 2-allylphenyl triflate (53.3 mg, 0.2 mmol) and cyclohexanone (50 µL, 0.48 
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mmol) using General Procedure A, except with LiHMDS (73.6 mg, 0.44 mmol) as the 
base. The crude material was purified via column chromatography on silica gel using 
65:35 hexanes:dichloromethane as the eluent. The product was further purified via 
column chromatography on silica gel using 99:1 hexanes:ethyl acetate. This procedure 
afforded 30.5 mg (71%) of the title compound as a white solid, mp: 67-69°C. 1H NMR 
(500 MHz, CDCl3)  7.21 – 7.15 (m, 2H), 7.15 – 7.10 (m, 2H), 3.24 (dd, J = 15.9, 7.9 Hz, 
1H), 3.03 (dd, J = 15.3, 7.9 Hz, 1H), 2.76 (p, J = 8.5 Hz, 1H), 2.64 (dd, J = 15.4, 9.2 Hz, 
1H), 2.55 (dd, J = 15.9, 8.9 Hz, 1H), 2.49 – 2.39 (m, 2H), 2.39 – 2.30 (m, 1H), 2.19 – 2.11 
(m, 1H), 2.09 – 2.00 (m, 1H), 1.95 – 1.87 (m, 1H), 1.80 – 1.64 (m, 2H), 1.60 – 1.48 (m, 
1H); 13C NMR (100 MHz, CDCl3)  213.08, 143.51, 142.67, 126.14, 126.00, 124.29, 
124.13, 56.25, 42.23, 39.38, 38.22, 36.64, 32.17, 28.24, 24.64; IR (film) 2931, 2857, 
1704, 744 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C15H18O 215.1430; found 
215.1432. 
 
2-(2,3-Dihydro-1H-inden-2-yl)-2-methyl-1-phenylpropan-1-one (2-17d). The title 
compound was prepared from 2-allylphenyl triflate (53.3 mg, 0.2 mmol) and phenyl 
isopropyl ketone (36 µL, 0.24 mmol) using General Procedure A, except with LiHMDS 
(73.6 mg, 0.44 mmol) as the base. The crude material was purified via column 
chromatography on silica gel using 90:10 hexanes:dichloromethane -> 80:20 
hexanes:dichloromethane as the eluent. This procedure afforded 35.5 mg (67%) of the 
title compound as a colorless oil. 1H NMR (500 MHz, CDCl3)  7.72 – 7.66 (m, 2H), 7.51 
– 7.45 (m, 1H), 7.44 – 7.38 (m, 2H), 7.21 – 7.16 (m, 2H), 7.15 – 7.11 (m, 2H), 3.24 – 3.13 
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(m, 1H), 2.99 – 2.78 (m, 4H), 1.37 (s, 6H); 13C NMR (100 MHz, CDCl3)  209.32, 142.62, 
139.58, 130.65, 128.12, 127.43, 126.25, 124.33, 49.99, 46.61, 34.30, 22.93; IR (film) 
2914, 1669, 1593, 956, 740 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C19H20O 
265.1587; found 265.1592. 
 
(±)-2-(2,3-Dihydro-1H-inden-2-yl)-6-methoxy-3,4-dihydronaphthalen-1(2H)-one (2-
17e). The title compound was prepared from 2-allylphenyl triflate (53.3 mg, 0.2 mmol) 
and 6-methoxy-1-tetralone (42.3 mg, 0.24 mmol) using General Procedure A, except with 
LiHMDS (73.6 mg, 0.44 mmol) as the base. The crude material was purified via column 
chromatography on silica gel using 65:35 hexanes:dichloromethane -> 50:50 
hexanes:dichloromethane as the eluent. This procedure afforded 42.1 mg (72%) of the 
title compound as a colorless oil. 1H NMR (500 MHz, CDCl3)  8.04 (d, J = 8.7 Hz, 1H), 
7.23 – 7.17 (m, 2H), 7.15 – 7.11 (m, 2H), 6.84 (dd, J = 8.8, 2.5 Hz, 1H), 6.71 – 6.67 (m, 
1H), 3.85 (s, 3H), 3.18 (dd, J = 15.7, 7.9 Hz, 1H), 3.15 – 2.91 (m, 4H), 2.87 (dd, J = 15.7, 
8.4 Hz, 1H), 2.74 (dd, J = 15.0, 8.2 Hz, 1H), 2.62 (ddd, J = 9.8, 7.4, 4.1 Hz, 1H), 2.24 – 
2.17 (m, 1H), 2.02 – 1.92 (m, 1H); 13C NMR (126 MHz, CDCl3)  198.64, 163.38, 146.16, 
143.53, 142.78, 129.87, 126.34, 126.19, 126.09, 124.28, 124.16, 113.15, 112.39, 55.41, 
51.94, 38.75, 37.81, 36.74, 28.45, 26.21; IR (film) 2963, 2832, 1660, 1601, 1251, 742 cm-




one (2-17f). The title compound was prepared from 6-allylcyclohex-1-en-1-yl triflate (54.1 
mg, 0.2 mmol) and phenyl isopropyl ketone (36 µL, 0.24 mmol) using General Procedure 
A, except with LiHMDS (73.6 mg, 0.44 mmol) as the base. The crude material was purified 
via column chromatography on silica gel using 50:50 hexanes:dichloromethane as the 
eluent under high pressure. This procedure afforded 28.4 mg (53%) of the title compound 
as a colorless oil. The compound was obtained as a >20:1 mixture of diastereomers as 
judged by 1H NMR analysis. Data are for the major isomer. 1H NMR (500 MHz, CDCl3)  
7.63 – 7.59 (m, 2H), 7.46 – 7.42 (m, 1H), 7.41 – 7.35 (m, 2H), 5.35 (s, 1H), 2.63 – 2.53 
(m, 1H), 2.33 – 2.25 (m, 1H), 2.21 – 2.13 (m, 1H), 2.08 – 1.90 (m, 4H), 1.86 – 1.73 (m, 
2H), 1.42 (m, 1H), 1.27 (s, 3H), 1.23 (s, 3H), 1.07 – 0.90 (m, 2H); 13C NMR (126 MHz, 
CDCl3)  209.74, 143.29, 139.83, 130.43, 128.01, 127.34, 117.60, 49.61, 44.55, 41.15, 
35.16, 31.72, 28.81, 25.22, 23.03, 22.38; IR (film) 2925, 2837, 1673, 958 cm-1; HRMS 
(ESI+ TOF) m/z: [M + H+]+ calcd for C19H24O 269.1900; found 269.1905. 
 
(±)-2-(2,3-Dihydro-1H-inden-2-yl)-3,4-dihydronaphthalen-1(2H)-one (2-17g). The title 
compound was prepared from 2-allylphenyl triflate (53.3 mg, 0.2 mmol) and 1-tetralone 
(32 µL, 0.24 mmol) using General Procedure A, except with LiHMDS (73.6 mg, 0.44 
mmol) as the base. The crude material was purified via column chromatography on silica 
gel using 80:20 hexanes:dichloromethane as the eluent. This procedure afforded 37.8 mg 
(72%) of the title compound as a white solid, mp 61–63 °C. 1H NMR (500 MHz, CDCl3)  
8.08 (dd, J = 7.9, 1.4 Hz, 1H), 7.49 (td, J = 7.5, 1.5 Hz, 1H), 7.37 – 7.32 (m, 1H), 7.29 – 
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7.25 (m, 1H), 7.25 – 7.20 (m, 2H), 7.18 – 7.13 (m, 2H), 3.22 (dd, J = 15.7, 8.0 Hz, 1H), 
3.18 – 2.97 (m, 4H), 2.89 (dd, J = 15.8, 8.5 Hz, 1H), 2.78 (dd, J = 15.2, 8.4 Hz, 1H), 2.69 
(ddd, J = 10.1, 7.6, 4.2 Hz, 1H), 2.30 – 2.22 (m, 1H), 2.08 – 1.97 (m, 1H); 13C NMR (126 
MHz, CDCl3)  199.93, 143.76, 143.47, 142.74, 133.21, 132.72, 128.71, 127.46, 126.64, 
126.26, 126.16, 124.32, 124.21, 52.32, 38.72, 37.83, 36.73, 28.12, 26.25; IR (film) 3009, 
2877, 1671, 1597, 734 cm-1; HRMS (ESI+ TOF) m/z: [M + Na+]+ calcd for C19H18O 
285.1250; found 285.1255. 
 
(±)-(2S,3aR)-2-(2,3,3a,4,5,6-Hexahydro-1H-inden-2-yl)-1-phenylethan-1-one (2-17h). 
The title compound was prepared from 6-allylcyclohex-1-en-1-yl triflate (54.1 mg, 0.2 
mmol) and acetophenone (28 µL, 0.24 mmol) using General Procedure A, except with 
LiHMDS (73.6 mg, 0.44 mmol) as the base. The crude material was purified via column 
chromatography on silica gel using 99.5:0.5 hexanes:ethyl acetate as the eluent. This 
procedure afforded 25.0 mg (52%) of the title compound as a colorless oil. The compound 
was obtained as a >20:1 mixture of diastereomers as judged by 1H NMR analysis. Data 
are for the major isomer. 1H NMR (700 MHz, CDCl3) 7.95 (d, J = 7.7 Hz, 2H), 7.58 – 
7.53 (m, 1H), 7.49 – 7.43 (m, 2H), 5.37 (s, 1H), 3.06 – 2.94 (m, 2H), 2.73 – 2.64 (m, 1H), 
2.56 – 2.47 (m, 1H), 2.23 (br s, 1H), 2.16 – 2.09 (m, 1H), 2.06 – 1.94 (m, 3H), 1.93 – 1.86 
(m, 1H), 1.82 – 1.74 (m, 1H), 1.49 – 1.40 (m, 1H), 1.05 – 0.96 (m, 1H), 0.84 (q, J = 11.4 
Hz, 1H); 13C NMR (176 MHz, CDCl3)  200.22, 143.91, 137.35, 133.03, 128.69, 128.22, 
117.73, 45.15, 41.34, 40.73, 37.19, 33.57, 29.15, 25.39, 22.62; IR (film) 1682, 1448 cm-
1; HRMS (ES) [M]+ calcd for C17H20O 240.1514; found 240.1517. 
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(±)-(2S,3aR)-2-(2,3,3a,4,5,6-Hexahydro-1H-inden-2-yl)cyclohexan-1-one (2-17i). The 
title compound was prepared from 6-allylcyclohex-1-en-1-yl triflate (54.1 mg, 0.2 mmol) 
and cyclohexanone (50 µL, 0.48 mmol) using General Procedure A, except with LiHMDS 
(73.6 mg, 0.44 mmol) as the base. The crude material was purified via column 
chromatography on silica gel using 80:20 hexanes:dichloromethane as the eluent. This 
procedure afforded 29.5 mg (68%) of the title compound as a colorless oil. The compound 
was obtained as a 1:1 mixture of diastereomers epimeric at the stereocenter alpha to the 
carbonyl group, as judged by 1H NMR analysis. Data are for the mixture.  1H NMR (500 
MHz, CDCl3)  5.38 – 5.30 (m, 1H), 2.75 – 2.66 (m, 0.5H), 2.56 – 2.47 (m, 0.5H), 2.41 – 
2.33 (m, 1H), 2.33 – 2.12 (m, 4H), 2.13 – 2.06 (m, 1H), 2.06 – 1.91 (m, 5H), 1.90 – 1.69 
(m, 4H), 1.69 – 1.59 (m, 1H), 1.57 – 1.37 (m, 2H), 1.02 – 0.92 (m, 1H), 0.76 – 0.64 (m, 
1H); 13C NMR (100 MHz, CDCl3)  213.62, 213.49, 144.03, 143.49, 117.41, 117.06, 
57.36, 56.70, 42.09, 41.90, 41.47, 40.87, 39.04, 38.06, 36.80, 36.63, 36.24, 34.37, 32.21, 
32.13, 28.93, 28.80, 28.32, 28.28, 25.25, 25.20, 24.56, 24.11, 22.42; IR (film) 2920, 2853, 




17j). The title compound was prepared from 6-allylcyclohex-1-en-1-yl triflate (54.1 mg, 
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0.2 mmol) and deoxybenzoin (47.1 mg, 0.24 mmol) using General Procedure A, except 
with LiHMDS (73.6 mg, 0.44 mmol) as the base. The crude material was purified via 
column chromatography on silica gel using 99:1 hexanes:ethyl acetate as the eluent. The 
material was further purified via column chromatography on silica gel using 90:10 
hexanes:dichloromethane -> 80:20 hexanes:dichloromethane as the eluent. This 
procedure afforded 45.4 mg (72%) of the title compound as a viscous, colorless oil. The 
compound was obtained as a 1:1 mixture of diastereomers epimeric at the stereocenter 
alpha to the carbonyl group, as judged by 1H NMR analysis. Data are for the mixture.  1H 
NMR (500 MHz, CDCl3)  8.02 – 7.94 (m, 2H), 7.53 – 7.47 (m, 1H), 7.45 – 7.33 (m, 4H), 
7.33 – 7.26 (m, 2H), 7.25 – 7.19 (m, 1H), 5.34 (s, 1H), 4.39 – 4.29 (m, 1H), 2.98 – 2.84 
(m, 1H), 2.84 – 2.73 (m, 0.5H), 2.30 (br s, 0.5H), 2.24 – 2.13 (m 1H), 2.05 – 1.73 (m, 5H), 
1.66 – 1.55 (m, 1H), 1.50 – 1.38 (m, 1H), 1.04 – 0.92 (m, 1H), 0.89 – 0.73 (m, 1H); 13C 
NMR (100 MHz, CDCl3)  200.18, 199.77, 143.95, 143.37, 138.83, 138.80, 137.24, 
137.05, 132.81, 132.78, 128.76, 128.73, 128.60, 128.51, 128.49, 128.46, 128.35, 127.01, 
117.58, 117.48, 60.37, 59.63, 41.36, 41.08, 41.00, 40.58, 39.80, 38.93, 36.45, 34.99, 
28.97, 25.22, 22.38; IR (film) 2914, 2847, 1678, 1596, 659 cm-1; HRMS (ESI+ TOF) m/z: 
[M + H+]+ calcd for C23H24O 317.1900; found 317.1906. 
 
(±)-(2S,3aR)-2-(2,3,3a,4,5,6-Hexahydro-1H-inden-2-yl)-3,4-dihydronaphthalen-
1(2H)-one (2-17k). The title compound was prepared from 6-allylcyclohex-1-en-1-yl 
triflate (54.1 mg, 0.2 mmol) and 1-tetralone (32 µL, 0.24 mmol) using General Procedure 
A, except with LiHMDS (73.6 mg, 0.44 mmol) as the base. The crude material was purified 
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via column chromatography on silica gel using 80:20 hexanes:dichloromethane as the 
eluent. This procedure afforded 42.1 mg (79%) of the title compound as a colorless oil. 
The compound was obtained as a 1:1 mixture of diastereomers epimeric at the 
stereocenter alpha to the carbonyl group, as judged by 1H NMR analysis. Data are for the 
mixture. 1H NMR (500 MHz, CDCl3)  8.0 – 7.98 (m, 1H), 7.47 – 7.42 (m, 1H), 7.32 – 7.27 
(m, 1H), 7.25 -7.20 (m, 1H), 5.37 (s, 1H), 3.11 – 3.02 (m, 1H), 3.00 – 2.88 (m, 1H), 2.68 
– 2.54 (m, 1H), 2.50 – 2.35(m, 2H), 2.28 – 2.17 (m, 2H), 2.17 – 2.08 (m, 1H) 2.08 – 1.92 
(m, 5H), 1.84 – 1.73 (m, 1H), 1.50 – 1.37 (m, 1H), 1.08 – 0.82 (m, 2H); 13C NMR (126 
MHz, CDCl3)  200.29, 143.83, 143.71, 143.69, 143.47, 133.03, 132.99, 132.71, 132.67, 
128.64, 128.61, 127.43, 127.39, 126.51, 117.61, 117.32, 52.62, 52.09, 41.43, 41.08, 
38.76, 38.01, 36.25, 36.10, 35.60, 34.27, 28.90, 28.80, 27.95, 27.41, 26.31, 26.01, 25.27, 
25.23, 22.44; IR (film) 2934, 2869, 1675, 1598 cm-1; HRMS (ESI+ TOF) m/z: [M + Na+]+ 
calcd for C19H22O 289.1563; found 223.1569. 
 
(±)-(2S,3aR)-2-(2,3,3a,4,5,6-Hexahydro-1H-inden-2-yl)-2-methyl-3,4-
dihydronaphthalen-1(2H)-one (2-17l). The title compound was prepared from 6-
allylcyclohex-1-en-1-yl triflate (54.1 mg, 0.2 mmol) and 2-methyl-1-tetralone (37 µL, 0.24 
mmol) using General Procedure A, except with LiHMDS (73.6 mg, 0.44 mmol) as the 
base. The crude material was purified via column chromatography on silica gel using 
80:20 hexanes:dichloromethane as the eluent. This procedure afforded 31.6 mg (56%) of 
the title compound as a colorless oil. The compound was obtained as a 1:1 mixture of 
diastereomers epimeric at the stereocenter alpha to the carbonyl group, as judged by 1H 
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NMR analysis. Data are for the mixture. 1H NMR (401 MHz, CDCl3)  8.06 – 7.99 (m, 1H), 
7.48 – 7.41 (m, 1H), 7.33 – 7.26 (m, 1H), 7.23 – 7.18 (m, 1H), 5.35 (s, 1H), 3.12 – 2.98 
(m, 1H), 2.97 – 2.87 (m, 1H), 2.56 – 2.36 (m, 1.5H), 2.25 – 2.12 (m, 2H), 2.10 -  2.04 (m, 
1H), 2.03 – 1.84 (m, 5H), 1.82 – 1.72 (m, 1H), 1.71 – 1.63 (m, 0.5H), 1.49 – 1.33 (m, 1H), 
1.13 (s, 1.5H), 1.12 (s, 1.5H), 1.08 – 0.94 (m, 2H); 13C NMR (126 MHz, CDCl3)  202.51, 
202.36, 188.00, 143.51, 143.46, 143.22, 143.14, 132.86, 132.83, 132.03, 128.55, 128.00, 
127.97, 126.57, 117.49, 117.43, 46.25, 46.02, 41.23, 41.15, 40.74, 40.62, 35.00, 34.65, 
32.15, 32.09, 31.64, 30.97, 28.89, 28.82, 25.28, 25.26, 25.22, 22.43, 22.39, 18.75; IR 
(film) 2926, 2856, 1680, 1600, 1222, 747 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd 
for C20H24O 281.1900; found 281.1902. 
2.13 Assignment of Relative Stereochemistry 
The relative stereochemistry of products 2-7d, 2-7c (via 2-S12), 2-7e, 2-7p, 2-7k, 2-7o, 
2-6e, 2-16, and 2-17h was assigned on the basis of 1H NMR nOe studies. The data for 
these studies is provided below, along with the key nOe signals. The relative 
stereochemistry of all other products was assigned based on analogy to 2-7d, 2-7c (via 
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Chapter 3  
Regiodivergent Palladium-Catalyzed Alkene Difunctionalization Reactions for the 
Construction of Methylene Cyclobutanes and Methylene Cyclopentanes  
 
3.1 Introduction to the Synthesis of Cyclobutanes 
The most common method to construct cyclobutanes is, without doubt, the [2+2] 
cycloaddition of olefins.1 The [2+2] cyclization is facilitated in several different ways; 
notably, photochemically with an activated alkene,1,2,3 thermodynamically with a 
catalyst,1c,4 and photochemically with a catalyst.5 As shown in Scheme 3-1, a general 
mechanism representing a [2+2] photocycloaddition can be demonstrated in the 
cyclization of an enone with an unactivated olefin.  First, the activated olefin is excited 
into a short-lived singlet state which degrades by intersystem crossing (ISC) to the triplet 
state. The triplet state reacts with the ground state of the unactivated alkene to form a 
triplet 1,4 biradical. The triplet biradical undergoes spin inversion to the singlet biradical 
thus allowing for the formation of the desired cyclobutane. The photocycloaddition has 
the potential to generate two different regiomers (Table 3-1) which are called the head-
to-head and head-to-tail products.  Typically, head-to-head products are observed when 
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the R group on the alkene is electron-withdrawing and head-to-tail products when the R 
group is electron-donating.6,7 The application of [2+2] photocycloadditions have been 
used to good effect in the synthesis of natural products containing cyclobutane motifs. 
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Selected examples include, Nicolaou and coworkers used a [2+2] photocycloaddition 
between ent-zingiberene and hyperolactone C to synthesize (-)-biyouyanagin A in 54% 
yield (eq 3-1).8  Mangion and coworkers employed an intramolecular [2+2] 
photocycloaddition followed by a global deprotection to construct (-)-littoralisone (eq 3-
2).9 Hatakeyama and coworkers also utilized an intramolecular [2+2] photocycloaddition 
to form a crucial cyclobutane intermediate that, upon further transformations, would form 
(-)-paeoniflorin (eq 3-3).10 
The activation energy that would normally be prohibitive for a thermal [2+2] cyclization 
can be lowered to accessible levels via a catalyst. In 2007, the Toste group reported the 
first gold-catalyzed cycloisomerization of allenes to alkylidene-cyclobutanes (Scheme 3-
2). The proposed mechanism is a nucleophilic cascade cyclization that starts as the 
alkene attacks the allene producing a vinyl-gold species. This species in turn can attack 
the carbocation forming the 5,4- bicycle.  An axially chiral ligand can be employed to allow 
up to 97% ee of the cis-formed product.4a,11 Excitingly, in 2015, Hoyt and coworkers 
reported an iron-catalyzed intermolecular [2+2] cycloaddition of unactivated alkenes. This 
work was groundbreaking as for the first time, Hoyt and coworkers reported catalyst 
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conditions to thermally dimerize small, unactivited alkenes for the construction of simple 
cyclobutanes. The products of the iron-catalysis are ligand dependent and can result in 
up to 98% yield of the desired cyclobutane products. As detailed in Scheme 3-3, the 
meso cyclobutane product can be favored when R and aryl substituents are bulky, giving 
more reductive elimination.  The authors observe undesired beta-hydride elimination 
products when R and aryl groups are relatively smaller.4b 
Thermal catalytic [2+2] cycloadditions have had success installing 
stereostereocenters in cyclobutane products; however, outside of conformationally 
appropriate, intramolecular cyclizations, photocycloadditions have not had the same 
success in exhibiting stereochemical control as their thermal counterparts. Du and 
coworkers recently reported a duel catalytic system in an approach to enantioselective 
[2+2] photocyclizations. As shown in eq 3-4, utilizing a Ruthenium-catalyst and a chiral 
 127 
ligand cocatalyst (L3-1), Du and coworkers were able to impart 92% enantiomeric excess 
into their cyclobutane products.5b  
3.2 Introduction to Pd-Catalyzed Synthesis of Cyclobutanes 
Over the past 15-20 years, Palladium-catalyzed alkene difunctionalization reactions 
have emerged as powerful tools for the construction of heterocycles and carbocycles.12 
As described in Chapters 1 and 2, our group has recently reported a series of Palladium—
catalyzed alkene difunctionalization reactions for the synthesis of functionalized 
methylene cyclopentanes.13,14 In general, these transformations form carbocycles in good 
yield and diastereoselectivity through the coupling of 1,5-dienes bearing triflate groups at 
C2 with exogenous amine, alcohol/phenol, indole, or stabilized carbanion nucleophiles. 
For example, treatment of 3-1 with diethyl malonate in the presence of Pd(OAc)2, 
BrettPhos, and LiOtBu afforded 3-2 in 84% yield with >20:1 dr (eq 3-5). These 
transformations are also effective for the formation of monocyclic products, such as the 
conversion of 3-3 with methyl isobutyrate to afford 3-4 (52%, >20:1 dr, eq 3-6). In our 
early work, with one exception in which 2-allylphenyltriflate underwent reaction with 3-
methylindole to afford a benzocyclobutane derivative in 23% yield,13b all of these 
transformations provided exclusively 5-membered ring products through endo-cyclization 
reactions.  
Given the generally high selectivity for 5-endo-cyclization, we were quite surprised to 
find that the coupling of gem-diester substrate 3-5a with di-tert-butyl malonate under 
standard conditions afforded an inseparable 1:4 mixture of regioisomers 3-6a and 3-7a in 
53% yield with only modest (1:4 selectivity) for the cyclopentane product (eq 3-7). In 
addition, we were quite excited to find this surprising reactivity given the utility of 
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cyclobutanes and the challenges associated with their synthesis.1-11 In this chapter we 
describe our studies on this system, which have led to the development of conditions for 
the regioselective and regiodivergent formation of either 4-membered or 5-membered ring 
products from a single starting material, along with mechanistic experiments that shine 
light on the mechanism for cyclobutene formation, which appears to involve a rare sp3-
sp3 C-C bond-forming reductive elimination of a malonate from Pd(II).  
The work described in this chapter is comprised of both the author’s (ECB), Jim 
Shepich III’s (JS3), and Paige Maire Carpenter’s (PMC) contributions. JS3 conducted 
reactions with a pyrrolidine nucleophile (eq 3-12) and assisted with substrate synthesis 
(3-5b).  PMC conducted reactions with ethyl acetoacetate (eq 3-10 and eq 3-11) and 
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assisted with substrate synthesis (3-5a). We have decided to include JS3’s and PMC’s 
results in this dissertation to give the reader the full story about this transformation. 
3.3 Optimization of Conditions for Selective Formation of Methylene 
Cyclopentane or Cyclobutane products 
In our preliminary studies, we elected to take a two-pronged approach to optimization 
that involved an initial mechanistic experiment to generate a working hypothesis, followed 
by rational ligand screening to optimize conditions. Our previous studies suggested the 
formation of the cyclopentane product likely occurs as illustrated in Scheme 3-4. The 
reaction is presumably initiated by oxidative addition of the alkenyl triflate 3-8 to a Pd(0) 
complex generated by ligation and reduction of the Pd(II) precatalyst. Intermediate 3-9a 
is then positioned to have the olefin bind to the Pd(II) center (3-9b), activating it for attack 
by the malonate nucleophile in an anti-carbopalladation of the alkene (path a). The 
resulting palladacycle (3-9c) then undergoes reductive elimination to liberate the 5-exo 
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product (3-10) and regenerate the Pd(0) catalyst. For path b, after the initial oxidative 
addition, 3-9b could undergo a 1,2 migratory insertion that is facilitated by a Thorpe-Ingold 
effect from the alpha geminal substituents of the vinyl triflate substrate to form 
intermediate 3-9d. Intermediate 3-9d could either undergo beta-hydride elimination to 
form product 3-11 or be trapped by a nucleophile to give product 3-12. 
Given that 4-exo-migratory insertion processes are known to occur in Pd-catalyzed 
Heck reactions that afford cyclobutene products,15 it seemed plausible that the methylene 
cyclobutane products could arise from migratory insertion followed by trapping by the 
nucleophile. As such, we carried out a simple control experiment in which the nucleophile 
was omitted with substrate 3-5a. This reaction afforded from the reaction afforded the 
intramolecular Heck product, diene 3-11a, in approximately 51% NMR yield.16 This result 
is consistent the hypothesis outlined above, and with Mulzer’s prior studies on 
intramolecular Heck reactions of related substrates.15  
Based on this hypothesis, it seemed that use of bidentate ligands should favor the 
formation of the 5-exo product, as migratory insertion reactions are known to proceed 
most rapidly when monodentate ligands are employed.17 After some screening, we found 
that use of bidentate ligands with small bite angles led to good regioselectivity for the 5-
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exo product, 3-7aa, and 1,2-Bis(diphenylphosphino)benzene (dppBz) was selected as 
the optimal ligand (eq 3-9). Additionally, use of five equivalents of nucleophile increased 
both the regioselectivity and the chemical yield in these transformations.  
In contrast, labile, monodentate ligands should accelerate the migratory insertion 
step,17 and therefore lead to increased selectivity for the four-membered ring product. In 
general, a number of different monodentate ligands proved reasonable selectivities for 
the methylene cyclobutane product 3-6aa. However, tris(2,4-di-tert-butylphenyl)phosphite 
provided the best isolated yields and regioselectivities. Further optimization, by increasing 
the amount of nucleophile to 5 equiv, and decreasing the temperature to 60°C, increased 
the overall isolated yield of the reactions, and also led to cleaner reactions, which greatly 
simplified the isolation of the desired products (eq 3-8). Further efforts to optimize 
conditions by changing the solvent, base, or palladium source had deleterious effects on 
yield and selectivity for the 4-exo product.  
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3.4 Substrates Employed in Pd-Catalyzed Alkene Difunctionalization Study  
With conditions in hand for selective formation of either regioisomeric product, we 
turned our attention to exploring the scope of the reaction using a series of different 
alkenyl triflate derivatives. Substrates for these studies are shown in Scheme 3-5, and 
were prepared in 2-5 steps in most cases through formation and alkylation of the 
corresponding methyl ketone enolate, followed by enol triflate formation.  
3.5 Scope of Methylene Cyclobutanes 
As shown in Scheme 3-6, substrate 3-5b gave excellent selectivity for the 4-exo 
product 3-6b. However, utilizing smaller substituents (3-6d, 3-6g, 3-6h) the selectivity for 
the cyclobutane regioisomer is diminished, which suggests the Thorpe-Ingold effect plays 
a significant role in the cyclobutane-forming reactions. In addition, the fact that gem-
diester substrate 3-5a is transformed in much higher regioselectivity than gem-dimethyl 
substrate 3-5d indicates that electronic effects also influence the regioselectivty. Acetal-
bearing substrate 3-5c was smoothly transformed to 3-6c in excellent regioselectivity and 
good chemical yield. In contrast to other examples, in this case the cyclobutane  3-6c was 
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easily separable from its cyclopentane regioisomer 3-7c.18 Substrates 5g-j were 
efficiently transformed to spirocyclic products (3-6g, 3-6j) or bicyclic products (3-6h, 3-6i) 
in good yield, but with moderate regioselectivity.  
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3.6 Scope of Methylene Cyclopentanes 
The conditions re-optimized for formation of methylene cyclopentane products were 
also examined in reactions of 3-5a-j, and we were pleased to see high regioselectivity for 
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the 5-exo product in all cases except for 3-7b (Scheme 3-7, 77:23 rr). This further 
illustrates the dramatic impact of the Thorpe-Ingold effect on product regiochemistry. In 
contrast to the cyclobutene-forming reactions, in which regiochemistry decreased with 
smaller alpha substituents, this was not observed in five-membered ring-forming 
reactions. Unfortunately, the excellent diastereoselectivity (typically >20:1 in most cases) 
we observed with Brettphos under our original conditions14 was diminished when dppBz 
was employed (3-7f; 3-7h–3-7j). However, the diastereomers are separable by careful 
column chromatography. Functional group tolerance in these reactions was unaffected 
by ligand choice, and esters, alkenes, and acetals were tolerated under either set of 
conditions.18 Products 3-7h–3-7j gave the expected major diastereomer based on our 
previous observations and predictive model; however, product 3-7f gave the opposite of 
the expected diastereoselectivity. As shown in Scheme 3-8, We hypothesis substrate 3-
5f is uniquely situated to be able to provide additional stabilization of the palladium 
complex by donating electrons from the carbonyl to the metal center. The increased 
electron density reduces the cationic nature of palladium and reduces the rate of 
nucleophilic attack on the coordinated alkene. Although substrate 3-5j is similar to 3-5f in 
the electronics of geminal R functional groups, product 3-7j yields the expected 
diastereomer, opposite of the observed in 3-7f. We believe product 3-7j follows our 
stereochemical model because the steric effects of the tetralone ring outweigh the 
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electron donation effects of the carbonyl. However, it should be noted both 
diastereoselectivies are modest with 3-7f formed with 2:1 dr and 3-7j generated with 3:1 
dr.  
3.7 Scope of Additional Nucleophiles 
We also briefly explored the reactivity of other nucleophiles in these transformations 
(Scheme 3). The reaction of ethyl acetoacetate was less effective than diethyl malonate, 
providing a 53% yield of 3-6ab with a 9:1 regioselectivity (eq 3-10). However, efforts to 
form the methylene cyclopentane regioisomer utilizing ethyl acetoacetate as the 
nucleophile were unsuccessful. Use of acetylacetone as the nucleophile was also 
unsuccessful under both four- and five-membered ring forming conditions. However, the 
beta hydride elimination product, 3-11a, was isolated in 22% yield with the bulky 
phosphite ligand (eq 3-11). However, we were pleased to find that 3-5b did undergo 
coupling with pyrrolidine in low yield to afford a 5% isolated yield of a 54:46 mixture of 
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product regioisomers. Thus, although additional optimization will clearly be needed to 
further expand the scope of this chemistry, it appears that the cyclobutene-forming 
reactions are not strictly limited to malonate nucleophiles. Further optimization of reaction 
conditions with nitrogen nucleophiles will be detailed in Chapter 4.   
3.8 Proposed Reaction Mechanism and Stereochemistry 
Given the unusual, regiodivergent reactivity in this system, we sought to examine the 
mechanism of formation of the methylene cyclobutane regioisomer. Our preliminary 
studies described above suggested that cyclobutane formation occurred via migratory 
insertion of the alkene into the Pd-C bond after oxidative addition of the triflate group. 
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However, four different pathways could potentially lead to the observed product (Scheme 
3-9). Two pathways (a and b) involve initial 1,2-migratory insertion from 3-9a to 3-9d.17 
Intermediate 3-9d could then undergo a formal SN2-reductive elimination with the 
malonate anion to afford the product (path a). Alternatively, 3-9d could undergo 3-exo 
migratory insertion into the exocyclic alkene to form bicyclo[2.1.0]pentane intermediate  
3-9f. The bicycle can then be transformed to product 3-12a through SN2’-like reductive 
elimination with the nucleophile.19 
Two other pathways (c and d) would involve reductive elimination from the metal, 
rather than outer-sphere SN2 substitution. Intermediate 3-9d could undergo 
transmetallation with the nucleophile to afford 3-9g (path c), which could then undergo 
C–C bond-forming reductive elimination to provide 3-12b. Finally, intermediate 3-9g could 
also be generated by transmetallation of 3-9a with the malonate anion to provide 3-9e, 
followed by subsequent migratory insertion (path d). Given the fact that paths a and b 
should involve reductive elimination with inversion of configuration at the carbon bound 
to palladium to afford 3-12a, whereas paths c and d should proceed via stereoretentive 
reductive elimination to give stereoisomeric product 3-12b, it seemed possible to 
differentiate these pathways through stereochemical labeling.  
In order to examine the stereochemical outcome of this reaction, we elected to prepare 
a deuterated version of substrate 3-5b, as that substrate showed the highest inherent 
selectivity for generation of the methylene cyclobutane regioisomer. As such, Z-
deuterioalkene substrate 3-13 was prepared and subjected to our standard conditions. 
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Product 3-14 was generated in 62% yield as a single stereoisomer (>20:1 dr). The 
stereochemistry was then determined through multi-step conversion of 3-14 to 3-15, the 
stereochemistry of which was assigned by 1H NMR nOe experiments (Scheme 3-10). To 
the best of our knowledge, this is the first example of sp3-sp3 C-C bond-forming reductive 
elimination from Pd(II) involving a malonate nucleophile.20 Although this experiment has 
shed considerable light on the mechanism of these reactions, it remains unclear whether 
the malonate binds to the palladium(II) complex before (path d) or after (path c) the 
migratory insertion step.  
Finally, to provide support for our hypothesis that the 5-membered ring forming 
reactions still proceed through our previously reported mechanism (Scheme 3-4), despite 
the use of the chelating ligand, we examined the reaction of Z-deuterio alkene 3-16. As 
shown in Scheme 3-11, when 3-16 was treated with diethyl malonate under standard 
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conditions, 3-17 was formed in 75% yield with >20:1 dr (Scheme 3-11). The observed 
product stereoisomer is consistent with our prior observations13,14 that indicate the 
cyclopentane products are generated through nucleophilic attack of the malonate onto 
the coordinated alkene in intermediate 3-9ba.  
3.9 Explanation of Ligand Effects 
Regardless of whether the reaction proceeds via path c or path d, our observed ligand 
effects are also consistent with our mechanistic hypothesis. Migratory insertion reactions 
are known to proceed most rapidly with coordinatively unsaturated, cationic palladium 
complexes. The fact that the chelating bis-phosphine ligand dbbBz provides high 
selectivity for 5-membered ring formation is likely due to the fact that migratory insertion 
will be slower in an L2Pd complex that contains a chelating phosphine, rather than a labile, 
monodentate ligand.  
The efficiency of the bulky phosphite ligand at promoting selective 4-exo 
carbopalladation may be due to two different factors working simultaneously. First, the 
phosphite is relatively electron poor and labile, which likely accelerates the crucial 
migratory insertion step. In addition, as shown in Scheme 3-12, the phosphite ligand, 
which has bulky tert-butyl groups at that extend quite far from the metal center may also 
sterically shield the face of the coordinated olefin from attack by an exogenous 
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nucleophile in a manner similar to that of some ligands used for asymmetric additions to 
allylpalladium complexes.   
3.10 Conclusion 
In conclusion, we have developed two complementary catalyst systems to target for 
either the methylene cyclobutane or methylene cyclopentane regioisomer. Larger 
geminal substituents and electron withdrawing groups alpha to the vinyl triflate favor the 
methylene cyclobutane formation. The methylene cyclopentane regioisomer is formed via 
an exogenous nucleophilic attack of the coordinated olefin followed by reductive 
elimination off the metal center. The methylene cyclobutane regioisomer is formed via a 
syn-1,2-migratory insertion followed by reductive elimination off the metal center. To our 
knowledge this is the first example of a sp3-sp3 carbon-carbon coupling with a malonate. 
The work in this chapter is currently being prepared for publication.  
3.11 Experimental 
General Considerations: All reactions were carried out under a nitrogen atmosphere in 
vacuum and flame-dried glassware. All reagents, palladium precatalysts, and ligands 
were purchased from commercial sources and were used without purification unless 
otherwise noted. The substrates 3-5a,13c 3-5d,13d 3-5e,13d 3-5g,13c and N-(2-
pyridyl)triflimide21 were prepared by previously published methods. Alkenyl triflate starting 
materials were stored in a freezer under nitrogen. Bulk quantities of cesium carbonate, 
lithium tert-butoxide, and lithium hexamethyldisilazide were stored in nitrogen-filled glove 
box and small amounts were removed within a few days of use. Toluene, tetrahydrofuran, 
dichloromethane, and diethyl ether were purified using a GlassContour solvent 
purification system. Anhydrous 1,4 dioxane was purchased from Sigma-Aldrich and was 
used without purification. Structural and stereochemical assignments were made on the 
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basis of 2-D COSY and nOe experiments. Ratios of diastereomers were determined by 
1H NMR analysis. Yields refer to isolated yields of compounds estimated to be ≥95% pure 
as determined by 1H NMR analysis unless otherwise noted. The yields reported in the 
supporting information describe the result of a single experiment, whereas yields reported 
in Schemes 3-6 and 3-7 and equations 3–10 and 3-11 are average yields of two or more 
experiments. Thus, the yields reported in the supporting information may differ from those 
shown Schemes 3-6 and 3-7 and equations 3–10 and 3-1.  
Preparation and Characterization of Substrates 
 
3,3-diphenylhex-5-en-2-one (3-S1) A vacuum flame-dried flask equipped with a stir bar 
was cooled under a stream of nitrogen and charged with sodium hydride (95%, 7.53 
mmol, 181 mg, 1.1 equiv). 1,1 diphenyl acetone (6.85 mmol, 1.44 g, 1 equiv) was 
dissolved in DMF (7 mL, 1 M) and added to the flask. The reaction was stirred at rt for 10 
min until the bubbles stopped. Allyl bromide (8.22 mmol, 710 μL, 1.2 equiv) was added to 
the flask and the reaction heated to 80 °C with stirring for 15 h. The reaction was cooled 
to rt, and the mixture was quenched with aqueous ammonium chloride (15 mL). The 
mixture was stirred briefly then transferred to a separatory funnel. The layers were 
separated, and the aqueous layer was extracted with diethyl ether (3 x 20 mL). The 
combined organic layers were washed with water (3 x 20 mL), brine, dried over MgSO4, 
filtered and concentrated in vacuo to yield a yellow oil. The crude material was purified 
via column chromatography on silica gel using 98:2 -> 95:5 hexanes:ethyl acetate as the 
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eluent. This procedure afforded 1.317 g (77%) of the title compound as a yellow-white 
semisolid, mp 61-63 °C. 
1H NMR (400 MHz, CDCl3) δ 7.37–7.29 (m, 4 H) 7.28–7.20 (m, 6 H) 5.60–5.44 (m, 1 H) 
4.92–4.79 (m, 2 H) 3.07 (d, J = 7.1 Hz, 2 H) 2.04 (s, 3 H). 
 
3,3-diphenylhexa-1,5-dien-2-yl trifluoromethanesulfonate (3-5b) A vacuum flame-
dried flask equipped with a stir bar was cooled under a stream of nitrogen and charged 
with potassium hexamethyldisilazane (5.9 mmol, 1.2 g, 1.2 equiv) dissolved in THF (12 
mL, 0.5 M). The reaction flask was cooled to -78 °C. 3,3-diphenylhex-5-en-2-one (3-S1) 
(4.9 mmol, 1.23 g, 1 equiv) was dissolved in THF (10 mL, 0.5 M) and added dropwise to 
the flask. The reaction was stirred for 20 minutes at -78 °C. N-(2-
pyridyl)bis(trifluoromethanesulfonimide) (5.4 mmol, 1.93 g, 1.1 equiv) was dissolved in 
THF (11 mL, 0.5 M) and added to the reaction while at -78 °C. The reaction was stirred 
for 30 minutes at -78 °C. The reaction was warmed to 0 °C and allowed to stir overnight 
(15 h). The reaction was quenched with saturated ammonium chloride (15 mL) and stirred 
briefly. The mixture was transferred to a separatory funnel. The aqueous layer was 
extracted with diethyl ether (3 x 20 mL). The combined organic layers were washed with 
brine, dried over MgSO4, filtered and concentrated in vacuo to yield a yellow-orange oil. 
The crude material was purified via column chromatography on silica gel using 98.5:1:0.5 
hexanes: ethyl acetate: triethyl amine as the eluent. This procedure afforded 1.48 g (79%) 
of the title compound as a yellow oil. 
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1H NMR (500 MHz, CDCl3) δ 7.39–7.24 (m, 10 H) 5.65–5.53 (m, 1 H) 5.43 (d, J = 4.6 Hz, 
1 H) 5.19 (d, J = 4.6 Hz, 1 H) 5.13–4.97 (m, 2 H) 3.18 (d, J = 6.7 Hz, 2 H); 13C NMR (126 
MHz, CDCl3) δ 159.79, 141.34, 133.72, 129.03, 128.11, 127.25, 118.49, 118.08 (t, JCF = 
321 Hz), 104.40, 56.95, 42.93; IR (film) 3060, 3021, 1650, 1599, 1495, 1429, 1418 cm-1; 
HRMS (EI 70 eV) m/z: [M] calcd for C19H17F3O3S 382.0850; found 382.0 and 341.0 [M–
allyl radical] and 41.0 [allyl radical]. 
 
2-allyl-1,3-dithiane (3-S2) A vacuum flame-dried flask equipped with a stir bar was 
cooled under a stream of nitrogen and charged with 1,3 dithiane (30 mmol, 3.61 g, 1 
equiv) dissolved in THF (30 mL, 1 M). The flask was cooled to 0 °C and nBuLi (33 mmol, 
2.5 M in hex, 13.2 mL, 1.1 equiv) was added dropwise. The reaction was stirred for 4 
hours at 0 °C then cooled to -78 °C. Allyl bromide (33 mmol, 2.9 mL, 1.1 equiv) was added 
dropwise added to the flask. The reaction was stirred for 20 min at -78 °C. The reaction 
was warmed to rt and allowed to stir over night (15 h). The mixture was quenched with 
aqueous ammonium chloride (50 mL). The mixture was stirred briefly then transferred to 
a separatory funnel. The layers were separated, and the aqueous layer was extracted 
with diethyl ether (3 x 30 mL). The combined organic layers were washed with brine, dried 
over MgSO4, filtered and concentrated in vacuo to yield a yellow oil. The crude material 
was purified distillation (130 °C with reduced pressure). This procedure afforded 4.13 g 
(86%) of the title compound as a yellow oil. 
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1H NMR (500 MHz, CDCl3) δ 5.86 (ddt, J = 17.1, 10.0, 7.0 Hz, 1 H) 5.21–5.07 (m, 2 H) 
4.10 (t, J = 6.9 Hz, 1 H) 2.94–2.78 (m, 4 H) 2.55–2.48 (m, 2 H) 2.12 (dtt, J = 14.5, 4.8, 2.7 
Hz, 1 H) 1.93–1.79 (m, 1 H). 
 
1-(2-allyl-1,3-dithian-2-yl)ethan-1-ol (3-S3) A vacuum flame-dried flask equipped with a 
stir bar was cooled under a stream of nitrogen and charged with 2-allyl-1,3-dithiane (3-
S2) (25.7 mmol, 4.13 g, 1 equiv) dissolved in THF (26 mL, 1 M). The flask was cooled to 
0 °C and nBuLi (28.3 mmol, 2.5 M in hex, 11.3 mL, 1.1 equiv) was added dropwise. The 
reaction was stirred for 2 hours at 0 °C then cooled to -78 °C. Freshly distilled 
acetaldehyde (28.3 mmol, 1.6 mL, 1.1 equiv) was added dropwise added to the flask. The 
reaction was stirred for 20 min at -78 °C. The reaction was warmed to rt and allowed to 
stir over night (15 h). The mixture was quenched with aqueous ammonium chloride (50 
mL). The mixture was stirred briefly then transferred to a separatory funnel. The layers 
were separated, and the aqueous layer was extracted with ethyl acetate (3 x 25 mL). The 
combined organic layers were washed with brine, dried over MgSO4, filtered and 
concentrated in vacuo to yield a yellow oil. The crude material was purified via column 
chromatography on silica gel using 95:5 hexanes:ethyl acetate as the eluent. This 
procedure afforded 3.23 g (62%) of the title compound as a yellow oil and recovered 0.70 
g (17%) of unreacted starting material. 
1H NMR (500 MHz, CDCl3) δ 6.08–5.96 (m, 1 H) 5.20–5.10 (m, 2 H) 4.26 (qd, J = 6.3, 2.1 
Hz, 1 H) 3.03–2.93 (m, 2 H) 2.72 (s, 1 H) 2.70–2.60 (m, 3 H) 2.44 (ddt, J = 15.1, 7.0, 1.5 
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Hz, 1 H) 2.12–2.00 (m, 1 H) 1.85 (dtt, J = 14.5, 11.2, 3.4 Hz, 1 H) 1.38 (d, J = 6.3 Hz, 3 
H). 
 
3,3-dimethoxyhex-5-en-2-one (3-S4) A vacuum flame-dried flask equipped with a stir 
bar was cooled under a stream of nitrogen and charged with N-chlorosuccinimide (13.3 
mmol, 1.77 g, 4 equiv) and silver nitrate (13.3 mmol, 2.25 g, 4 equiv) dissolved in THF 
(15 mL, 0.9 M) and methanol (15 mL, 0.9 M). 2,6 lutidine (13.3 mmol, 1.75 mL, 4 equiv) 
was added to the flask. The flask was cooled to 0 °C and 1-(2-allyl-1,3-dithian-2-
yl)ethan-1-ol (3-S3) (3.3 mmol, 0.677, 1 equiv) dissolved in 1:1 THF:methanol (6 mL, 0.5 
M) was added dropwise. The reaction was stirred for 10 minutes at 0 °C then warmed to 
rt and stirred for an additional 90 minutes. While the first reaction was stirring, another 
vacuum flame-dried flask equipped with a stir bar was cooled under a stream of nitrogen 
and charged with oxalyl chloride (3.64 mmol, 350 μL, 1.1 equiv) dissolved in DCM (3 mL, 
1 M). The reaction flask was cooled to -78 °C. Dimethyl sulfoxide (7.3 mmol, 550 μL, 2.2 
equiv) was added dropwise to the flask. The reaction was stirred for 1 h at -78 °C. The 
first flask, after stirring for 90 minutes at rt, had the methanol removed under reduced 
pressure. Saturated aqueous sodium sulfite (15 mL), sodium carbonate (15 mL), brine 
(15 mL) and DCM (15 mL) were added to the reaction flask and the mixture was filtered 
through celite. The mixture was transferred to a separatory funnel. The aqueous layer 
was extracted with DCM (3 x 10 mL). The combined organic layers were washed with 
brine, dried over MgSO4, filtered and concentrated in vacuo to yield a yellow oil. The crude 
oil was dissolved in a minimal amount of dry DCM (2 mL) and added to the second flask 
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(after the 1 hour stir at -78 °C). The reaction was stirred for 2 hours at -78 °C. Triethyl 
amine (16.6 mmol, 2.3 mL) was added to the second flask and allowed to stir for an 
additional 30 minutes at -78 °C. The reaction was warmed to 0 °C and allowed to stir 
overnight (15 h). The reaction was quenched with saturated ammonium chloride (20 mL) 
and stirred for 5 minutes. The mixture was transferred to a separatory funnel. The 
aqueous layer was extracted with DCM (3 x 10 mL). The combined organic layers were 
washed with saturated aqueous sodium carbonate, brine, dried over MgSO4, filtered and 
concentrated in vacuo to yield a yellow oil. The crude material was purified via column 
chromatography on silica gel using 95:5 hexanes:diethyl ether as the eluent. Due to the 
volatility of the title compound, some solvent remained after column. This procedure 
afforded 0.243 g (46%) of the title compound as a clear oil. 
1H NMR (401 MHz, CDCl3) δ 5.68–5.53 (m, 1 H) 5.14–5.04 (m, 2 H) 3.26 (s, 6 H) 2.57 
(d, J = 7.2 Hz, 2 H) 2.19 (s, 3 H). 
 
3,3-dimethoxyhexa-1,5-dien-2-yl trifluoromethanesulfonate (3-5c) A vacuum flame-
dried flask equipped with a stir bar was cooled under a stream of nitrogen and charged 
with potassium hexamethyldisilazane (3.79 mmol, 756 mg, 1.2 equiv) dissolved in THF 
(4 mL, 0.9 M). The reaction flask was cooled to -78 °C. 3,3-dimethoxyhex-5-en-2-one 
(3-S4) (3.16 mmol, 500 mg, 1 equiv) was dissolved in THF (3 mL 1 M) and added 
dropwise to the flask. The reaction was stirred for 20 minutes at -78 °C. N-(2-
pyridyl)bis(trifluoromethanesulfonimide) (3.48 mmol, 1.25 g, 1.1 equiv) was dissolved in 
THF (4 mL, 0.8 M) and added to the reaction while at -78 °C. The reaction was stirred for 
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30 minutes at -78 °C. The reaction was warmed to rt and allowed to react for 4 hours. 
The reaction was quenched with saturated ammonium chloride (10 mL) and stirred for 5 
minutes. The mixture was transferred to a separatory funnel. The aqueous layer was 
extracted with diethyl ether (3 x 10 mL). The combined organic layers were washed with 
brine, dried over MgSO4, filtered and concentrated in vacuo to yield a yellow-orange oil. 
The crude material was purified via column chromatography on silica gel using 98: 2 
hexanes: ethyl acetate as the eluent. This procedure afforded 690 mg (75%) of the title 
compound as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 5.65–5.54 (m, 1 H) 5.49 (dd, J = 3.6, 1.4 Hz, 1 H) 5.42 
(dd, J = 3.6, 1.4 Hz, 1 H) 5.19–5.08 (m, 2 H) 3.24 (s, 6 H) 2.57 (dd, J = 7.1, 1.5 Hz, 2 
H); 13C NMR (126 MHz, CDCl3) δ 150.49, 130.70, 119.02, 118.27 (t, JCF = 320 Hz), 
107.36, 100.36, 49.07, 36.96; IR (film) 3082, 2949, 2840, 2157, 1662, 1645, 1418 cm-1; 
HRMS (GC-APCI) m/z: [M] calcd for C9H13F3O5S 290.0436; found 259.0256 [M–OCH3]; 
HRMS (EI 70 eV) m/z: [M]+ calcd for C9H13F3O5S 290.0436; found 259.0256 [M–OCH3] 
also 249.0 [M–allyl radical] and 41.0 [allyl radical]. 
 
Ethyl 2-acetyl-2-methylpent-4-enoate (3-S5) A vacuum flame-dried flask equipped with 
a stir bar was cooled under a stream of nitrogen and charged with potassium carbonate 
(22.5 mmol, 3.1 g, 1.5 equiv) and dry acetone (30 mL). Ethyl 2-methylacetoacetate (15 
mmol, 2.12 mL, 1 equiv) was added to the flask. The reaction was stirred at rt for 10 
minutes. Allyl bromide (22.5 mmol, 2 mL, 1.5 equiv) was added to the flask. The flask was 
equipped with a reflux condenser and refluxed at 70 °C overnight (15 h). The reaction 
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was cooled to rt, and the mixture was quenched with water (20 mL). The mixture was 
stirred briefly then transferred to a separatory funnel. The aqueous layer was extracted 
with diethyl ether (3 x 20 mL). The combined organic layers were washed with water (3 x 
20 mL), brine, dried over MgSO4, filtered and concentrated in vacuo to yield a yellow oil. 
The crude material was judged to be obtained in sufficient purity to continue without 
further purification. This procedure afforded 2.73 g (99%) of the title compound as a 
colorless oil. 
1H NMR (401 MHz, CDCl3) δ 5.71–5.55 (m, 1 H) 5.14–5.02 (m, 2 H) 4.17 (q, J = 7.1 Hz, 
2 H) 2.61 (ddt, J = 14.1, 7.2, 1.3 Hz, 1 H) 2.48 (ddt, J = 14.1, 7.6, 1.3 Hz, 1 H) 2.13 (s, 3 
H) 1.30 (s, 3 H) 1.24 (t, J = 7.1 Hz, 3 H). 
 
Ethyl 2-methyl-2-(1-(((trifluoromethyl)sulfonyl)oxy)vinyl)pent-4-enoate (3-5f) A 
vacuum flame-dried flask equipped with a stir bar was cooled under a stream of nitrogen 
and charged with potassium hexamethyldisilazane (12 mmol, 2.4 g, 1.2 equiv) dissolved 
in THF (12 mL, 1 M). The reaction flask was cooled to -78 °C. Ethyl 2-acetyl-2-
methylpent-4-enoate (3-S5) (10 mmol, 1.84 g, 1 equiv) was dissolved in THF (10 mL, 1 
M) and added dropwise to the flask. The reaction was stirred for 20 minutes at -78 °C. N-
(2-pyridyl)bis(trifluoromethanesulfonimide) (11 mmol, 3.94 g, 1.1 equiv) was dissolved in 
THF (11 mL, 1 M) and added to the reaction while at -78 °C. The reaction was stirred for 
30 minutes at -78 °C. The reaction was warmed to rt and allowed to stir overnight (15 h). 
The reaction was quenched with saturated ammonium chloride (20 mL) and stirred briefly. 
The mixture was transferred to a separatory funnel. The aqueous layer was extracted 
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with diethyl ether (3 x 20 mL). The combined organic layers were washed with brine, dried 
over MgSO4, filtered and concentrated in vacuo to yield a yellow-orange oil. The crude 
material was purified via column chromatography on silica gel using 98:2 hexanes: ethyl 
acetate as the eluent. This procedure afforded 2.40 g (76%) of the title compound as a 
yellow oil. 
1H NMR (700 MHz, CDCl3) δ 5.72—5.62 (m, 1 H) 5.30 (d, J = 4.7 Hz, 1 H) 5.18—5.13 
(m, 2 H) 5.10 (d, J = 4.7 Hz, 1 H) 4.23—4.14 (m, 2 H) 2.59 (ddt, J = 14.0, 7.6, 1.1 Hz, 1 
H) 2.53 (ddt, J = 13.9, 7.0, 1.2 Hz, 1 H) 1.38 (s, 3 H) 1.27 (t, J = 7.1 Hz, 3 H); 13C NMR 
(176 MHz, CDCl3) δ 171.81, 156.73, 131.72, 119.79, 118.25 (q, JCF = 320 Hz), 103.28, 
61.85, 50.95, 39.73, 20.59, 13.86; IR (film) 2985, 1739, 1660, 1419 cm-1; HRMS (ESI+ 
TOF) m/z: [M + H+]+ calcd for C11H15O5F3S 317.0665; found 317.0667. 
 
6,6-diallylcyclohex-1-en-1-yl trifluoromethanesulfonate (3-5h) A vacuum flame-dried 
flask equipped with a stir bar was cooled under a stream of nitrogen and charged with 
potassium hexamethyldisilazane (12 mmol, 2.4 g, 1.2 equiv) dissolved in THF (12 mL, 1 
M). The reaction flask was cooled to -78 °C. 2,2-diallylcyclohexan-1-one (10 mmol, 1.78 
g, 1 equiv) was dissolved in THF (10 mL, 1 M) and added dropwise to the flask. The 
reaction was stirred for 20 minutes at -78 °C. N-(2-
pyridyl)bis(trifluoromethanesulfonimide) (11 mmol, 3.94 g, 1.1 equiv) was dissolved in 
THF (11 mL, 1 M) and added to the reaction while at -78 °C. The reaction was stirred for 
30 minutes at -78 °C. The reaction was warmed to rt and allowed to stir overnight (15 h). 
The reaction was quenched with saturated ammonium chloride (20 mL) and stirred briefly. 
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The mixture was transferred to a separatory funnel. The aqueous layer was extracted 
with diethyl ether (3 x 20 mL). The combined organic layers were washed with brine, dried 
over MgSO4, filtered and concentrated in vacuo to yield a yellow-orange oil. The crude 
material was purified via column chromatography on silica gel using 99:1 hexanes: ethyl 
acetate as the eluent. This procedure afforded 2.51 g (81%) of the title compound as a 
yellow oil. 
1H NMR (700 MHz, CDCl3) δ 5.81 (t, J = 4.2 Hz, 1 H) 5.80–5.70 (m, 2 H) 5.14–5.03 (m, 4 
H) 2.39–2.29 (m, 2 H) 2.20–2.11 (m, 4 H) 1.70–1.64 (m, 2 H) 1.64–1.59 (m, 2 H); 13C 
NMR (176 MHz, CDCl3) δ 153.45, 133.39, 118.59, 118.31 (q, JCF = 320 Hz), 117.94, 
41.55, 41.25, 31.19, 24.56, 18.00; IR (film) 3079, 2937, 2844, 1673, 1640, 1441, 1409 
cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C13H17O3F3S 311.0923; found 311.0908. 
 
Ethyl 1-allyl-2-oxocyclohexane-1-carboxylate (3-S6) A vacuum flame-dried flask 
equipped with a stir bar was cooled under a stream of nitrogen and charged with sodium 
hydride (95%, 11 mmol, 264 mg, 1.1 equiv). Ethyl 2-oxocyclohexane-1-carboxylate (10 
mmol, 1.6 mL, 1 equiv) was dissolved in DMF (10 mL, 1 M) and added to the flask. The 
reaction was stirred at rt for 10 min until the bubbles stopped. Allyl bromide (12 mmol, 1.1 
mL, 1.2 equiv) was added to the flask and the reaction heated to 80 °C with stirring for 15 
h. The reaction was cooled to rt, and the mixture was quenched with aqueous ammonium 
chloride (20 mL). The mixture was stirred briefly then transferred to a separatory funnel. 
The layers were separated, and the aqueous layer was extracted with ethyl acetate (3 x 
20 mL). The combined organic layers were washed with water (3 x 20 mL), brine, dried 
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over MgSO4, filtered and concentrated in vacuo to yield a yellow oil. The crude material 
was judged to be obtained in sufficient purity to continue without further purification. This 
procedure afforded 2.09 g (99%) of the title compound as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 5.81–5.66 (m, 1 H) 5.08–4.97 (m, 2 H) 4.18 (q, 2 H) 2.60 
(dd, J = 13.9, 7.0 Hz, 1 H) 2.52–2.39 (m, 3 H) 2.33 (dd, J = 13.9, 7.8 Hz, 1 H) 2.02–1.94 
(m, 1 H) 1.80–1.55 (m, 3 H) 1.45 (ddd, J = 13.7, 11.9, 4.5 Hz, 1 H) 1.24 (t, J = 7.1 Hz, 3 
H). 
 
Ethyl 1-allyl-2-(((trifluoromethyl)sulfonyl)oxy)cyclohex-2-ene-1-carboxylate (3-5i) A 
vacuum flame-dried flask equipped with a stir bar was cooled under a stream of nitrogen 
and charged with diisopropyl amine (3.2 mmol, 0.45 mL, 1.2 equiv) dissolved in THF (3 
mL, 1 M). The flask was cooled to 0 °C and nBuLi (3.14 mmol, 2.5 M in hex, 1.25 mL, 1.1 
equiv) was added dropwise. The reaction was stirred for 20 minutes at 0 °C then cooled 
to -78 °C.  Ethyl 1-allyl-2-oxocyclohexane-1-carboxylate (3-S6) (2.85 mmol, 0.60 g, 1 
equiv) dissolved in THF (3 mL, 1 M) was added dropwise added to the flask. The reaction 
was stirred for 20 min at -78 °C. N-(2-pyridyl)bis(trifluoromethanesulfonimide) (3.14 mmol, 
1.124 g, 1.1 equiv) was dissolved in THF (3 mL, 1 M) and added dropwise to the flask 
and the reaction was stirred for 30 minutes at -78 °C. The reaction was warmed to rt and 
allowed to stir over night (15 h). The mixture was quenched with aqueous ammonium 
chloride (10 mL). The mixture was stirred briefly then transferred to a separatory funnel. 
The layers were separated, and the aqueous layer was extracted with diethyl ether (3 x 
10 mL). The combined organic layers were washed with brine, dried over MgSO4, filtered 
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and concentrated in vacuo to yield a yellow oil. The crude material was purified via column 
chromatography on silica gel using 95:5 hexanes: ethyl acetate as the eluent. This 
procedure afforded 0.88 g (90%) of the title compound as a colorless oil. 
1H NMR (700 MHz, CDCl3) δ 5.89 (dd, J = 5.2, 3.0 Hz, 1 H) 5.76–5.67 (m, 1 H) 5.18–5.11 
(m, 2 H) 4.24–4.15 (m, 2 H) 2.58 (ddt, J = 14.0, 7.8, 1.1 Hz, 1 H) 2.54 (ddt, J = 14.0, 6.8, 
1.3 Hz, 1 H) 2.30–2.22 (m, 1 H) 2.22–2.13 (m, 2 H) 1.73–1.64 (m, 2 H) 1.64–1.57 (m, 1 
H) 1.29 (t, J = 7.1 Hz, 3 H); 13C NMR (176 MHz, CDCl3) δ 172.63, 147.98, 132.24, 120.19, 
119.58, 118.26 (q, JCF = 319 Hz), 61.70, 50.05, 39.34, 31.99, 24.36, 18.54, 13.95; IR 
(film) 3080, 2940, 2868, 1733, 1676, 1641, 1431 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ 
calcd for C13H17O5F3S 343.0822; found 343.0829. 
 
2-acetyl-2-allyl-3,4-dihydronaphthalen-1(2H)-one (3-S7) A vacuum flame-dried flask 
equipped with a stir bar was cooled under a stream of nitrogen and charged with 
potassium carbonate (15 mmol, 2.1 g, 1.5 equiv). 2-Acetyl-1-tetralone (10 mmol, 1.88 g, 
1 equiv) was dissolved in DMF (15 mL, 0.7M) and added to the flask. The reaction was 
stirred at rt for 10 minutes. Allyl bromide (15 mmol, 1.3 mL, 1.5 equiv) was added to the 
flask. The reaction was stirred at 80 °C overnight (15 h). The reaction was cooled to rt, 
and the mixture was quenched with aqueous ammonium chloride (20 mL). The mixture 
was stirred briefly then transferred to a separatory funnel. The aqueous layer was 
extracted with ethyl acetate (3 x 15 mL). The combined organic layers were washed with 
water (3 x 20 mL), brine, dried over MgSO4, filtered and concentrated in vacuo to yield a 
yellow oil. The crude material was purified via column chromatography on silica gel using 
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98:2 hexanes: ethyl acetate as the eluent. This procedure afforded 1.87 g (82%) of the 
title compound as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 8.06 (dd, J = 7.9, 1.5 Hz, 1 H) 7.48 (td, J = 7.5, 1.5 Hz, 1 H) 
7.31 (t, J = 7.6 Hz, 1 H) 7.21 (d, J = 7.7 Hz, 1 H) 5.79–5.63 (m, 1 H) 5.19–5.05 (m, 2 H) 
3.08 (ddd, J = 16.2, 10.7, 4.8 Hz, 1 H) 2.89 (dt, J = 17.5, 4.8 Hz, 1 H) 2.73–2.63 (m, 2 H) 
2.57 (dt, J = 13.8, 4.7 Hz, 1 H) 2.13 (s, 3 H) 2.03 (ddd, J = 13.8, 10.6, 5.0 Hz, 1 H). 
 
1-(2-allyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)vinyl trifluoromethanesulfonate 
(3-5j) A vacuum flame-dried flask equipped with a stir bar was cooled under a stream of 
nitrogen and charged with diisopropyl amine (6.15 mmol, 0.87 mL, 1.2 equiv) dissolved 
in THF (6 mL, 1 M). The flask was cooled to 0 °C and nBuLi (5.64 mmol, 2.5 M in hex, 
2.25 mL, 1.1 equiv) was added dropwise. The reaction was stirred for 20 minutes at 0 °C 
then cooled to -78 °C. 2-acetyl-2-allyl-3,4-dihydronaphthalen-1(2H)-one (3-S7)  (5.12 
mmol, 1.17 g, 1 equiv) dissolved in THF (5 mL, 1 M) was added dropwise added to the 
flask. The reaction was stirred for 20 min at -78 °C. N-(2-
pyridyl)bis(trifluoromethanesulfonimide) (5.64 mmol, 2.02 g, 1.1 equiv) was dissolved in 
THF (5 mL, 1 M) and added dropwise to the flask and the reaction was stirred for 30 
minutes at -78 °C. The reaction was warmed to rt and allowed to stir over night (15 h). 
The mixture was quenched with aqueous ammonium chloride (15 mL). The mixture was 
stirred briefly then transferred to a separatory funnel. The layers were separated, and the 
aqueous layer was extracted with diethyl ether (3 x 15 mL). The combined organic layers 
were washed with brine, dried over MgSO4, filtered and concentrated in vacuo to yield a 
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yellow oil. The crude material was purified via column chromatography on silica gel using 
98.5:1: 0.5 hexanes:ethyl acetate:triethyl amine as the eluent. This procedure afforded 
1.59 g (86%) of the title compound as a light yellow oil. 
1H NMR (700 MHz, CDCl3) δ 8.07 (dd, J = 7.9, 1.4 Hz, 1 H) 7.50 (td, J = 7.5, 1.4 Hz, 1 H) 
7.33 (t, J = 7.6 Hz, 1 H) 7.24 (d, J = 7.7 Hz, 1 H) 5.77 (ddt, J = 17.2, 10.2, 7.2 Hz, 1 H) 
5.28 (d, J = 4.9 Hz, 1 H) 5.20–5.10 (m, 2 H) 4.89 (d, J = 4.9 Hz, 1 H) 3.09 (ddd, J = 17.1, 
10.7, 4.5 Hz, 1 H) 2.95 (dt, J = 17.3, 4.7 Hz, 1 H) 2.80 (dd, J = 14.1, 6.9 Hz, 1 H) 2.53 
(dd, J = 14.2, 7.6 Hz, 1 H) 2.28 (dt, J = 14.1, 4.7 Hz, 1 H) 2.20 (ddd, J = 14.5, 10.7, 4.5 
Hz, 1 H); 13C NMR (176 MHz, CDCl3) δ 195.33, 154.90, 143.17, 133.95, 132.53, 131.41, 
128.81, 128.36, 127.00, 119.18, 118.28 (q, JCF = 320 Hz), 105.41, 54.63, 38.84, 29.82, 
25.39; IR (film) 3075, 2935, 2844, 1965, 1686, 1651, 1601, 1416 cm-1; HRMS (ESI+ TOF) 
m/z: [M + H+]+ calcd for C16H15O4F3S 361.0716; found 361.0724. 
 
3,3-diphenylhex-5-yn-2-one (3-S8) A vacuum flame-dried flask equipped with a stir bar 
was cooled under a stream of nitrogen and charged with sodium hydride (95%, 14 mmol, 
0.336 g, 1.1 equiv). 1,1 diphenyl acetone (12.7 mmol, 2.673 g, 1.0 equiv) was dissolved 
in DMF (15 mL, 0.85 M) and added to the flask. The reaction was stirred at rt for 10 min 
until the bubbles stopped. Propargyl bromide (80% wt in toluene, 15.2 mmol, 2.26 g, 1.2 
equiv) was added to the flask and the reaction heated to 80 °C with stirring overnight (15 
h). The reaction was cooled to rt, and the mixture was quenched with aqueous ammonium 
chloride (15 mL). The mixture was stirred briefly then transferred to a separatory funnel. 
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The layers were separated, and the aqueous layer was extracted with diethyl ether (3 x 
20 mL). The combined organic layers were washed with water (3 x 20 mL), brine, dried 
over MgSO4, filtered and concentrated in vacuo to yield a yellow oil. The crude material 
was purified via column chromatography on silica gel using 98:2 -> 95:5 hexanes:ethyl 
acetate as the eluent. This procedure afforded 2.5491 g (81%) of the title compound as 
a yellow-white semisolid. 
1H NMR (500 MHz, CDCl3) δ 7.44–7.27 (m, 10 H) 3.20 (d, J = 2.7 Hz, 2 H) 2.12 (s, 3 H) 
1.87 (t, J = 2.6 Hz, 1 H). 
 
3,3-diphenylhex-5-yn-2-ol (3-S9) A vacuum flame-dried flask equipped with a stir bar 
was cooled under a stream of nitrogen and charged with 3,3-diphenylhex-5-yn-2-one 
(3-S8) (17 mmol, 4.215 g, 1 equiv) and dissolved in methanol (85 mL, 0.2 M). The solution 
was stirred rapidly. Sodium borohydride (17.34 mmol, 656 mg, 1.02 equiv) was added in 
portions over 30 seconds at rt. The reaction was stirred at rt for 7 min. The reaction 
mixture was slowly quenched with aqueous ammonium chloride (50 mL). The mixture 
was stirred briefly then methanol was removed under vacuum. The solution was 
transferred to a separatory funnel. The aqueous layer was extracted with DCM (3 x 20 
mL). The combined organic layers were washed with brine, dried over MgSO4, filtered 
and concentrated in vacuo to yield a yellow oil which later crystallized to a white-yellow 
solid. The crude material was judged to be obtained in sufficient purity to continue without 
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further purification. This procedure afforded 4.2514 g (>99%) of the title compound as a 
yellow-white semisolid. 
1H NMR (401 MHz, CDCl3) δ 7.35–7.21 (m, 10 H) 4.83 (q, 1 H) 3.15–2.96 (m, 2 H) 1.88 
(t, J = 2.7 Hz, 1 H) 1.10 (d, J = 6.3 Hz, 3 H). 
 
((3,3-diphenylhex-5-yn-2-yl)oxy)triethylsilane (3-S10) A vacuum flame-dried flask 
equipped with a stir bar was cooled under a stream of nitrogen and charged with imidazole 
(51 mmol, 3.50 g, 3 equiv) and 4-Dimethylaminopyridine (51 mmol, 6.23 g, 3 equiv). 3,3-
diphenylhex-5-yn-2-ol (3-S9) (17 mmol, 4.25 g, 1.0 equiv) was dissolved in DMF (40 
mL, 0.42 M) and added to the flask. Chlorotriethylsilane (51 mmol, 8.6 mL, 3 equiv) was 
added slowly to the flask and the reaction, then the flask was heated to 80 °C with stirring 
overnight (15 h). The reaction was cooled to rt, and the mixture was quenched with 
aqueous ammonium chloride (50 mL). The mixture was stirred briefly then transferred to 
a separatory funnel. The layers were separated, and the aqueous layer was extracted 
with diethyl ether (3 x 20 mL). The combined organic layers were washed with water (3 x 
30 mL), brine, dried over MgSO4, filtered and concentrated in vacuo to yield a yellow oil. 
The crude material was purified via column chromatography on silica gel using 98:2 
hexanes:ethyl acetate as the eluent. This procedure afforded 5.306 g (86%) of the title 
compound as a yellow oil. 
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1H NMR (400 MHz, CDCl3) δ 7.34–7.15 (m, 10 H) 4.80 (q, J = 6.1 Hz, 1 H) 3.20 (dd, J = 
16.4, 2.6 Hz, 1 H) 2.90 (dd, J = 16.4, 2.6 Hz, 1 H) 1.04 (d, J = 6.1 Hz, 3 H) 0.89 (t, J = 7.9 
Hz, 9 H) 0.56 (q, J = 7.9 Hz, 6 H). 
 
((3,3-diphenylhex-5-yn-2-yl-6-d)oxy)triethylsilane (3-S11) A vacuum flame-dried flask 
equipped with a stir bar was cooled under a stream of nitrogen and charged with ((3,3-
diphenylhex-5-yn-2-yl)oxy)triethylsilane (3-S10) (14.55 mmol, 5.306 g, 1 equiv) 
dissolved in THF and then cooled to 0 °C. nBuLi (16 mmol, 2.5 M in hex, 6.4 mL, 1.1 
equiv) was added dropwise to the reaction. The reaction was stirred for 20 minutes at 0 
°C. The reaction was quenched with D2O (1.11 mmol, 20 mL, 76 equiv) and stirred for 10 
minutes. The mixture was then transferred to a separatory funnel. The layers were 
separated, and the aqueous layer was extracted with diethyl ether (3 x 20 mL). The 
combined organic layers were dried over MgSO4, filtered and concentrated in vacuo to 
yield a yellow oil. The crude material was judged to be obtained in sufficient purity to 
continue without further purification. This procedure afforded 5.31 g (>99%) of the title 
compound as a yellow oil with ~98% deuterium incorporation. 
1H NMR (500 MHz, CDCl3) δ 7.35–7.19 (m, 10 H) 4.82 (q, J = 6.1 Hz, 1 H) 3.21 (d, J = 
16.4 Hz, 1 H) 2.92 (d, J = 16.3 Hz, 1 H) 1.06 (d, J = 6.1 Hz, 3 H) 0.91 (t, J = 8.0 Hz, 9 H) 
0.58 (q, J = 7.9 Hz, 6 H). 
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(Z)-((3,3-diphenylhex-5-en-2-yl-6-d)oxy)triethylsilane (3-S12) A vacuum flame-dried 
flask equipped with a stir bar was cooled under a stream of nitrogen and charged with 
bis(cyclopentadienyl)zirconium(iv) dichloride (20.37 mmol, 5.95 g, 1.4 equiv). ((3,3-
diphenylhex-5-yn-2-yl-6-d)oxy)triethylsilane (3-S11) (14.55 mmol, 5.31 g, 1 equiv) 
was dissolved in THF (20 mL, 0.7 M) and added to the flask. The reaction was stirred for 
10 minutes. Lithium tri tert-butoxy aluminum hydride (20.37 mmol, 5.18 g, 1.4 equiv) was 
dissolved in THF (20 mL, 1 M) and was added to the reaction. The reaction was stirred 
for 12 minutes at rt. The reaction was quenched with saturated ammonium chloride (20 
mL) and stirred for 10 minutes. THF was removed under reduced pressure and the 
mixture was then transferred to a separatory funnel. The aqueous layer was extracted 
with DCM (3 x 20 mL). The combined organic layers were washed with brine, dried over 
MgSO4, filtered and concentrated in vacuo to yield a yellow oil. The crude material was 
judged to be obtained in sufficient purity to continue without further purification. This 
procedure afforded 4.963 g (93%) of the title compound as a yellow oil (over reduced by 
~1-2% as judged by 1H NMR). 
1H NMR (500 MHz, CDCl3) δ 7.35–7.14 (m, 10 H) 5.50–5.41 (m, 1 H) 4.87 (d, J = 10.3 
Hz, 1 H) 4.69 (q, J = 6.1 Hz, 1 H) 3.01 (ddd, J = 14.1, 6.6, 1.3 Hz, 1 H) 2.83 (ddd, J = 
14.1, 7.4, 1.1 Hz, 1 H) 1.02 (d, J = 6.2 Hz, 3 H) 0.90 (t, J = 7.9 Hz, 9 H) 0.57 (q, J = 7.7 
Hz, 6 H). 
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(Z)-3,3-diphenylhex-5-en-6-d-2-ol (3-S13) A vacuum flame-dried flask equipped with a 
stir bar was cooled under a stream of nitrogen and charged with (Z)-((3,3-diphenylhex-
5-en-2-yl-6-d)oxy)triethylsilane (3-S12) (13.5 mmol, 4.96 g, 1 equiv) dissolved in THF 
(14 mL, 1 M). Tetra-n-butylammonium fluoride (40.6 mmol, 41 mL, 1 M in THF, 3 equiv) 
was added to the reaction. The reaction was stirred for 1 h. The reaction was quenched 
with saturated ammonium chloride (30 mL) and stirred for 5 minutes. The mixture was 
then transferred to a separatory funnel. The aqueous layer was extracted with ethyl 
acetate (3 x 20 mL). The combined organic layers were washed with brine, dried over 
MgSO4, filtered and concentrated in vacuo to yield a yellow oil. The crude material was 
purified via column chromatography on silica gel using 95:5 hexanes:ethyl acetate as the 
eluent. The isolated product was resubjected to the reaction conditions. After work up and 
subsequent isolation by another column chromatography, the product was obtained in 
>95% purity. This procedure afforded 2.7132 g (79%) of the title compound as a yellow 
oil. 
1H NMR (500 MHz, CDCl3) δ 7.39–7.23 (m, 10 H) 5.44 (tdd, J = 9.5, 6.7, 2.6 Hz, 1 H) 
4.97 (d, J = 10.1 Hz, 1 H) 4.67 (dq, J = 7.6, 6.3 Hz, 1 H) 3.03 (dd, J = 14.0, 6.7 Hz, 1 H) 
2.91 (dd, J = 14.0, 7.4 Hz, 1 H) 1.40 (d, J = 8.2 Hz, 1 H) 1.09 (d, J = 6.2 Hz, 3 H). 
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(Z)-3,3-diphenylhex-5-en-2-one-6-d (3-S14) A vacuum flame-dried flask equipped with 
a stir bar was cooled under a stream of nitrogen and charged with oxalyl chloride (14.85 
mmol, 1.3 mL, 1.1 equiv) dissolved in DCM (30 mL, 0.5 M). The reaction flask was cooled 
to -78 °C. Dimethyl sulfoxide (30 mmol, 2.2 mL, 2.2 equiv) was added dropwise to the 
flask. The reaction was stirred for 1 h at -78 °C. (Z)-3,3-diphenylhex-5-en-6-d-2-ol (3-
S13) (13.5 mmol, 2.71 g, 1 equiv) dissolved in DCM (27 mL, 0.5 M) was added to the 
reaction while at -78 °C. The reaction was stirred for 2 hours at -78 °C. Triethyl amine 
(67.5 mmol, 9.5 mL) was added to the reaction and allowed to stir for an additional 30 
minutes at -78 °C. The reaction was warmed to 0 °C and allowed to stir overnight (15 h). 
The reaction was quenched with saturated ammonium chloride (30 mL) and stirred for 5 
minutes. The mixture was transferred to a separatory funnel. The aqueous layer was 
extracted with DCM (3 x 20 mL). The combined organic layers were washed with brine, 
dried over MgSO4, filtered and concentrated in vacuo to yield a yellow oil. The crude 
material was purified via column chromatography on silica gel using 95:5 hexanes:ethyl 
acetate as the eluent. This procedure afforded 2.282 g (85%) of the title compound as a 
yellow oil. 
1H NMR (500 MHz, CDCl3) δ 7.39–7.31 (m, 4 H) 7.31–7.22 (m, 6 H) 5.53 (tdd, J = 9.7, 




(Z)-3,3-diphenylhexa-1,5-dien-2-yl-6-d trifluoromethanesulfonate (3-13) A vacuum 
flame-dried flask equipped with a stir bar was cooled under a stream of nitrogen and 
charged with potassium hexamethyldisilazane (10.9 mmol, 2.174 g, 1.2 equiv) dissolved 
in THF (11 mL, 1 M). The reaction flask was cooled to -78 °C. (Z)-3,3-diphenylhex-5-en-
2-one-6-d (3-S14) (9.1 mmol, 2.28, 1 equiv) was dissolved in THF (10 mL 0.9 M) and 
added dropwise to the flask. The reaction was stirred for 20 minutes at -78 °C. N-(2-
pyridyl)bis(trifluoromethanesulfonimide) (10 mmol, 3.58 g, 1.1 equiv) was dissolved in 
THF (10 mL, 1 M) and added to the reaction while at -78 °C. The reaction was stirred for 
30 minutes at -78 °C. The reaction was warmed to 0 °C and allowed to stir overnight (15 
h). The reaction was quenched with saturated ammonium chloride (20 mL) and stirred 
briefly. The mixture was transferred to a separatory funnel. The aqueous layer was 
extracted with diethyl ether (3 x 20 mL). The combined organic layers were washed with 
brine, dried over MgSO4, filtered and concentrated in vacuo to yield a yellow-orange oil. 
The crude material was purified via column chromatography on silica gel using 98.5:1:0.5 
hexanes:ethyl acetate:triethyl amine as the eluent. This procedure afforded 2.8336 g 
(81%) of the title compound as a yellow oil. 
1H NMR (700 MHz, CDCl3) δ 7.37–7.31 (m, 4 H) 7.31–7.26 (m, 6 H) 5.58 (tdd, J = 9.2, 
4.8, 2.4 Hz, 1 H) 5.43 (d, J = 4.6 Hz, 1 H) 5.19 (d, J = 4.6 Hz, 1 H) 5.00 (dd, J = 10.4, 1.5 
Hz, 1 H) 3.18 (dd, J = 6.7, 1.4 Hz, 2 H); 13C NMR (176 MHz, CDCl3) δ 159.82, 141.36, 
133.64, 129.04, 128.12, 127.26, 118.23 (t, JCD = 24 Hz), 118.09 (q, JCF = 320 Hz), 104.41, 
56.96, 42.88; IR (film) 3057, 3027, 2922, 1955, 1650, 1599, 1495, 1418 cm-1; HRMS (ESI+ 
TOF) m/z: [M + H+]+ calcd for C19H16O3F3SD 384.0986; found 384.0972. 
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Methyl 2,2-dimethylpent-4-ynoate (3-S15) A vacuum flame-dried flask equipped with a 
stir bar was cooled under a stream of nitrogen and charged with diisopropyl amine (30 
mmol, 4.3 mL, 1.2 equiv) dissolved in THF (30 mL, 1 M). The flask was cooled to 0 °C 
and nBuLi (27.5 mmol, 2.5 M in hex, 11 mL, 1.1 equiv) was added dropwise. The reaction 
was stirred for 20 minutes at 0 °C then cooled to -78 °C. Methyl isobutyrate (25 mmol, 2.9 
mL, 1.0 equiv) dissolved in THF (25 mL, 1 M) was added dropwise added to the flask. 
The reaction was stirred for 20 min at -78 °C. Propargyl bromide (80% wt in toluene, 30 
mmol, 4.46 g, 1.2 equiv) was added dropwise to the flask and the reaction was stirred for 
30 minutes at -78 °C. The reaction was warmed to rt and allowed to stir overnight (15 h). 
The mixture was quenched with aqueous ammonium chloride (50 mL). The mixture was 
stirred briefly then transferred to a separatory funnel. The layers were separated, and the 
aqueous layer was extracted with diethyl ether (3 x 30 mL). The combined organic layers 
were washed with brine, dried over MgSO4, filtered and concentrated in vacuo to yield a 
yellow oil. The crude material was purified distillation (150 °C). This procedure afforded 
2.81 g (81%) of the title compound as a clear oil. 
1H NMR (700 MHz, CDCl3) δ 3.70 (s, 3 H) 2.44 (dd, J = 2.8, 1.2 Hz, 2 H) 2.00 (td, J = 2.7, 
1.2 Hz, 1 H) 1.28 (s, 6 H). 
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2,2-dimethylpent-4-ynoic acid (3-S16) A vacuum flame-dried flask equipped with a stir 
bar was cooled under a stream of nitrogen and charged with potassium hydroxide (109 
mmol, 6.11 g, 5 equiv) and sodium hydroxide (24 mmol, 0.96 g, 1.1 equiv). Water (40mL) 
was added to the flask. Methyl 2,2-dimethylpent-4-ynoate (3-S15) (21.8 mmol, 3.0565 
g, 1 equiv) was dissolved in methanol (80 mL, 0.25 M) and added to the flask. The flask 
was equipped with a reflux condenser and the reaction was refluxed at 80 °C for 2 hours. 
The reaction was cooled to rt. Methanol was removed under vacuum and then the mixture 
was transferred to a separatory funnel. The solution was washed with DCM (3 x 20 mL). 
1 M HCl was added to the solution until the aqueous layer turned acidic (pH < 3). The 
acidic aqueous layer was extracted with DCM (3 x 20 mL). The combined, extracted 
organic layers were washed with brine, dried over MgSO4, filtered and concentrated in 
vacuo to yield a yellow oil. The crude material was judged to be obtained in sufficient 
purity to continue without further purification. This procedure afforded 2.295 g (83%) of 
the title compound as a colorless oil.  
1H NMR (500 MHz, CDCl3) δ 11.94 (bs, 1 H) 2.47 (d, J = 2.7 Hz, 2 H) 2.03 (t, J = 2.7 Hz, 
1 H) 1.32 (s, 3 H). 
 
3,3-dimethylhex-5-yn-2-one (3-S17) A vacuum flame-dried flask equipped with a stir bar 
was cooled under a stream of nitrogen and charged with 2,2-dimethylpent-4-ynoic acid 
(3-S16) (18.2 mmol, 2.2949 g, 1 equiv) dissolved in diethyl ether (60 mL, 0.3 M). The flask 
was cooled to -78 °C and methyl lithium (58.2 mmol, 1.6 M in Et2O, 36 mL, 3.2 equiv) was 
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added dropwise to the flask. The reaction was stirred for 10 minutes at -78 °C then 
allowed to warm to room temperature. The flask was equipped with a reflux condenser 
and the reaction was refluxed at 45 °C while stirring rapidly for 3 hours. The reaction was 
cooled to rt and quenched with saturated ammonium chloride (50 mL). The mixture was 
transferred to a separatory funnel. The aqueous layer was extracted with diethyl ether (3 
x 20 mL). The combined, extracted organic layers were washed with brine, dried over 
MgSO4, filtered and carefully concentrated in vacuo to yield a yellow oil. The crude 
material was purified via column chromatography on silica gel using 95:5 hexanes:diethyl 
ether as the eluent. Due to the volatility of the title compound, significant solvent remained 
after column and no accurate yield was obtained. 
1H NMR (700 MHz, CDCl3) δ 2.40—2.37 (m, 2 H) 2.19 (s, 3 H) 2.01 (td, J = 2.7, 1.1 Hz, 
1 H) 1.24 (s, 6 H). 
 
3,3-dimethylhex-5-yn-2-ol (3-S18) A vacuum flame-dried flask equipped with a stir bar 
was cooled under a stream of nitrogen and charged with 3,3-dimethylhex-5-yn-2-one 
(3-S17) (18.2 mmol, 2.260 g, 1 equiv) dissolved in methanol (50 mL, 0.33 M). The reaction 
was stirred rapidly and sodium borohydride (20 mmol, 757 mg, 1.1 equiv) was added in 
portions over 30 seconds at rt. The reaction was stirred at rt for 7 min. The reaction 
mixture was slowly quenched with aqueous ammonium chloride (30 mL). The mixture 
was stirred briefly then methanol was removed under vacuum. The solution was 
transferred to a separatory funnel. The aqueous layer was extracted with DCM (3 x 20 
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mL). The combined organic layers were washed with brine, dried over MgSO4, filtered 
and concentrated in vacuo to yield a colorless oil. The crude material was purified via 
column chromatography on silica gel using 85:15 hexanes:ethyl acetate as the eluent. 
This procedure afforded 1.00 g (44% over two steps) of the title compound as a colorless 
oil.  
1H NMR (700 MHz, CDCl3) δ 3.72 (p, J = 6.2 Hz, 1 H) 2.26 (dd, J = 16.7, 2.7 Hz, 1 H) 
2.13 (ddd, J = 16.7, 2.7, 0.9 Hz, 1 H) 2.01 (td, J = 2.7, 1.0 Hz, 1 H) 1.56 (d, J = 5.2 Hz, 1 
H) 1.15 (dd, J = 6.5, 1.0 Hz, 3 H) 0.97 (s, 3 H) 0.96 (s, 3 H). 
 
((3,3-dimethylhex-5-yn-2-yl)oxy)triethylsilane (3-S19) A vacuum flame-dried flask 
equipped with a stir bar was cooled under a stream of nitrogen and charged with imidazole 
(23.8 mmol, 1.62 g, 3 equiv) and 4-Dimethylaminopyridine (23.8 mmol, 2.91 g, 3 equiv). 
3,3-dimethylhex-5-yn-2-ol (3-S18) (7.92 mmol, 1.00 g, 1.0 equiv) was dissolved in DMF 
(40 mL, 0.2 M) and added to the flask. Chlorotriethylsilane (23.8 mmol, 4 mL, 3 equiv) 
was added slowly to the flask and the reaction was heated to 80 °C with stirring overnight 
(15 h) The reaction was cooled to rt, and the mixture was quenched with aqueous 
ammonium chloride (30 mL). The mixture was stirred briefly then transferred to a 
separatory funnel. The layers were separated, and the aqueous layer was extracted with 
diethyl ether (3 x 15 mL). The combined organic layers were washed with water (3 x 30 
mL), brine, dried over MgSO4, filtered and concentrated in vacuo to yield a yellow oil. The 
crude material was purified via column chromatography on silica gel using 98:2 
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hexanes:ethyl acetate as the eluent. This procedure afforded 1.28 g (67%) of the title 
compound as a yellow oil. 
1H NMR (401 MHz, CDCl3) δ 3.68 (q, J = 6.3 Hz, 1 H) 2.20 (dd, J = 16.5, 2.7 Hz, 1 H) 
2.11 (dd, J = 16.5, 2.7 Hz, 1 H) 1.95 (t, J = 2.7 Hz, 1 H) 1.07 (d, J = 6.3 Hz, 3 H) 0.96 
(t, J = 7.9 Hz, 9 H) 0.925 (s, 3 H) 0.915 (s, 3 H) 0.59 (q, J = 7.7 Hz, 6 H). 
 
((3,3-dimethylhex-5-yn-2-yl-6-d)oxy)triethylsilane (3-S20) A vacuum flame-dried flask 
equipped with a stir bar was cooled under a stream of nitrogen and charged with ((3,3-
dimethylhex-5-yn-2-yl)oxy)triethylsilane (3-S19) (5.33 mmol, 1.28 g, 1 equiv) 
dissolved in THF. The flask was cooled to 0 °C. nBuLi (3.2 mL, 2.5 M) was added 
dropwise to the reaction. The reaction was stirred for 20 minutes at 0 °C. The reaction 
was quenched with D2O (0.4 mmol, 7.5 mL, 75 equiv) and stirred for 10 minutes. The 
mixture was then transferred to a separatory funnel. The layers were separated, and the 
aqueous layer was extracted with diethyl ether (3 x 5 mL). The combined organic layers 
were dried over MgSO4, filtered and concentrated in vacuo to yield a yellow oil. The crude 
material was judged to be obtained in sufficient purity to continue without further 
purification. This procedure afforded 1.28 g (>99%) of the title compound as a yellow oil 
(~98% deuterium incorporation). 
1H NMR (401 MHz, CDCl3) δ 3.68 (q, J = 6.3 Hz, 1 H) 2.20 (d, J = 16.5 Hz, 1 H) 2.10 
(d, J = 16.5 Hz, 1 H) 1.07 (d, J = 6.3 Hz, 3 H) 0.96 (t, J = 7.9 Hz, 9 H) 0.923 (s, 3 H) 0.918 
(s, 3 H) 0.59 (q, J = 7.7 Hz, 6 H). 
 168 
 
(Z)-((3,3-dimethylhex-5-en-2-yl-6-d)oxy)triethylsilane (3-S21) A vacuum flame-dried 
flask equipped with a stir bar was cooled under a stream of nitrogen and charged with 
bis(cyclopentadienyl)zirconium(iv) dichloride (7.5 mmol, 2.18 g, 1.4 equiv). ((3,3-
dimethylhex-5-yn-2-yl-6-d)oxy)triethylsilane (3-S20) (5.33 mmol, 1.28 g, 1 equiv) was 
dissolved in THF (7.5 mL, 0.7 M) and added to the flask. The reaction was stirred for 10 
minutes. Lithium tri tert-butoxy aluminum hydride (7.5 mmol, 1.9 g, 1.4 equiv) dissolved 
in THF (7.5 mL, 1 M) and was added to the reaction. The reaction was stirred for 12 
minutes at rt. The reaction was quenched with saturated ammonium chloride (10 mL) and 
stirred for 10 minutes. THF was removed under reduced pressure and then the mixture 
was transferred to a separatory funnel. The aqueous layer was extracted with DCM (3 x 
20 mL). The combined organic layers were washed with brine, dried over MgSO4, filtered 
and concentrated in vacuo to yield a yellow oil. The crude material was judged to be 
obtained in sufficient purity to continue without further purification. This procedure 
afforded 1.20g (93%) of the title compound as a yellow oil (over reduced by ~1% as 
judged by 1HNMR). 
1H NMR (400 MHz, CDCl3) δ 5.82 (dtt, J = 10.0, 7.4, 2.5 Hz, 1 H) 4.99 (d, J = 10.1 Hz, 1 
H) 3.56–3.44 (m, 1 H) 2.03 (dd, J = 13.4, 7.2 Hz, 1 H) 1.96 (dd, J = 13.5, 7.7 Hz, 1 H) 
1.06 (d, J = 6.3 Hz, 3 H) 0.96 (t, J = 7.9 Hz, 9 H) 0.82 (s, 3 H) 0.79 (s, 3 H) 0.58 (q, J = 
7.6 Hz, 6 H). 
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(Z)-3,3-dimethylhex-5-en-6-d-2-ol (3-S22) A vacuum flame-dried flask equipped with a 
stir bar was cooled under a stream of nitrogen and charged with (Z)-((3,3-dimethylhex-
5-en-2-yl-6-d)oxy)triethylsilane (3-S21) (4.93 mmol, 1.20 g, 1 equiv) dissolved in THF 
(5 mL, 1 M). Tetra-n-butylammonium fluoride (15 mmol, 1 M in THF, 15 mL, 3 equiv) was 
added to the flask. The reaction was stirred for 1 h. The reaction was quenched with 
saturated ammonium chloride (10 mL) and stirred for 5 minutes. The mixture was then 
transferred to a separatory funnel. The aqueous layer was extracted with ethyl acetate (3 
x 10 mL). The combined organic layers were washed with brine, dried over MgSO4, 
filtered and concentrated in vacuo to yield a yellow oil. The crude material was purified 
via column chromatography on silica gel using 95:5 hexanes:ethyl acetate as the eluent. 
The isolated product was resubjected to the reaction conditions. After work up and 
subsequent isolation by another column chromatography, the product was obtained in 
>95% purity. This procedure afforded 0.417 g (66%) of the title compound as a yellow oil. 
1H NMR (700 MHz, CDCl3) δ 5.90–5.83 (m, 1 H) 5.03 (d, J = 10.1 Hz, 1 H) 3.54 (p, J = 
6.0 Hz, 1 H) 2.10 (dd, J = 13.6, 7.6 Hz, 1 H) 1.99 (dd, J = 13.6, 7.4 Hz, 1 H) 1.39 (d, J = 
5.1 Hz, 1 H) 1.13 (d, J = 6.4 Hz, 3 H) 0.88 (s, 3 H) 0.86 (s, 3 H). 
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(Z)-3,3-dimethylhex-5-en-2-one-6-d (3-S23) A vacuum flame-dried flask equipped with 
a stir bar was cooled under a stream of nitrogen and charged with oxalyl chloride (3.6 
mmol, 310 μL, 1.1 equiv) dissolved in DCM (1 mL, 0.33 M). The reaction flask was cooled 
to -78 °C. Dimethyl sulfoxide (7.1 mmol, 500 μL, 2.2 equiv) was added dropwise to the 
flask. The reaction was stirred for 1 h at -78 °C.  (Z)-3,3-dimethylhex-5-en-6-d-2-ol (3-
S22) (3.22 mmol, 0.414 g, 1 equiv) dissolved in DCM (6 mL, 0.5 M) was added to the 
reaction while at -78 °C. The reaction was stirred for 2 hours at -78 °C. Triethyl amine 
(16.1 mmol, 2.24 mL) was added to the reaction and allowed to stir for an additional 30 
minutes at -78 °C. The reaction was warmed to 0 °C and allowed to stir overnight (15 h). 
The reaction was quenched with saturated ammonium chloride (10 mL) and stirred for 5 
minutes. The mixture was transferred to a separatory funnel. The aqueous layer was 
extracted with DCM (3 x 10 mL). The combined organic layers were washed with brine, 
dried over MgSO4, filtered and concentrated in vacuo to yield a yellow oil. The crude 
material was purified via column chromatography on silica gel using 95:5 hexanes:diethyl 
ether as the eluent. Due to the volatility of the title compound, significant solvent remained 
after column and no accurate yield was obtained. 
1H NMR (500 MHz, CDCl3) δ 5.67 (dtq, J = 9.8, 4.9, 2.4 Hz, 1 H) 5.03 (d, J = 10.1 Hz, 1 
H) 2.26 (d, J = 7.4 Hz, 2 H) 2.12 (s, 3 H) 1.12 (s, 6 H). 
 
(Z)-3,3-dimethylhexa-1,5-dien-2-yl-6-d trifluoromethanesulfonate (3-16) A vacuum 
flame-dried flask equipped with a stir bar was cooled under a stream of nitrogen and 
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charged with potassium hexamethyldisilazane (3.86 mmol, 770 mg, 1.2 equiv) dissolved 
in THF (4 mL, 1 M). The reaction flask was cooled to -78 °C. (Z)-3,3-dimethylhex-5-en-
2-one-6-d (3-S23) (3.2 mmol, 0.40 g, 1 equiv) was dissolved in THF (4 mL, 0.7 M) and 
added dropwise to the flask. The reaction was stirred for 20 minutes at -78 °C. N-(2-
pyridyl)bis(trifluoromethanesulfonimide) (3.54 mmol, 1.27 g, 1.1 equiv) was dissolved in 
THF (3.5 mL, 1 M) and added to the reaction while at -78 °C. The reaction was stirred for 
30 minutes at -78 °C. The reaction was warmed to 0 °C and allowed to stir for 3 hours. 
The reaction was quenched with saturated ammonium chloride (10 mL) and stirred briefly. 
The mixture was transferred to a separatory funnel. The aqueous layer was extracted 
with diethyl ether (3 x 10 mL). The combined organic layers were washed with brine, dried 
over MgSO4, filtered and concentrated in vacuo to yield a yellow-orange oil. The crude 
material was purified via column chromatography on silica gel using 99: 1 hexanes: DCM 
as the eluent. This procedure afforded 20 mg (2%) of the title compound as a colorless 
oil. 
1H NMR (401 MHz, CDCl3) δ 5.70 (dtt, J = 9.9, 7.4, 2.5 Hz, 1 H) 5.13 (d, J = 4.3 Hz, 1 H) 
5.09 (d, J = 10.1 Hz, 1 H) 4.92 (d, J = 4.4 Hz, 1 H) 2.19 (d, J = 7.3 Hz, 2 H) 1.15 (s, 6 H). 
 
Preparation and Characterization of Products 
General Procedure for Pd-catalyzed Alkene Dialkylation Reactions on terminal 
alkenes, General Procedure A (butane) 
A vacuum and flame-dried 10 mL Schlenk tube equipped with a stir bar was cooled under 
a stream of nitrogen and charged with Pd(OAc)2 (0.008 mmol, 0.04 equiv), Tris(2,4-di-
tert-butylphenyl)phosphite (0.012 mmol, 0.06 equiv), and lithium tert-butoxide (1.00 
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mmol, 5 equiv). The Schlenk tube was evacuated and refilled with N2 twice. The alkenyl 
triflate (0.2 mmol, 1.0 equiv) was weighed in a dram vial and diluted with 1,4 dioxane (1 
mL, 0.2M). This mixture was added to the Schlenk tube and diethyl malonate (1 mmol, 5 
equiv) was added. 1,4 dioxane (1 mL, 0.2M) was used to rinse the dram vial and the 
solution was transferred to the Schlenk tube. The Schlenk tube was then heated to 60 °C 
with stirring overnight until the starting material had been consumed. The mixture was 
then cooled to rt and quenched with saturated aqueous ammonium chloride (2 mL). The 
aqueous layer was extracted with ethyl acetate (3 x 1 mL), dried over MgSO4, filtered and 
concentrated in vacuo. The crude product was purified via flash chromatography on silica 
gel to afford the desired product. 
 
General Procedure for Pd-catalyzed Alkene Dialkylation Reactions on terminal 
alkenes, General Procedure B (pentane) 
A vacuum and flame-dried 10 mL Schlenk tube equipped with a stir bar was cooled under 
a stream of nitrogen and charged with Pd(OAc)2 (0.008 mmol, 0.04 equiv), 1,2-
Bis(diphenylphosphino)benzene (0.012 mmol, 0.06 equiv), and lithium tert-butoxide (1.00 
mmol, 5 equiv). The Schlenk tube was evacuated and refilled with N2 twice. The alkenyl 
triflate (0.2 mmol, 1.0 equiv) was weighed in a dram vial and diluted with 1,4 dioxane (1 
mL, 0.2M). This mixture was added to the Schlenk tube and diethyl malonate (1 mmol, 5 
equiv) was added. 1,4 dioxane (1 mL, 0.2M) was used to rinse the dram vial and the 
solution was transferred to the Schlenk tube. The Schlenk tube was then heated to 95 °C 
with stirring for 1 hour until the starting material had been consumed. The mixture was 
then cooled to rt and quenched with saturated aqueous ammonium chloride (2 mL). The 
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aqueous layer was extracted with ethyl acetate (3 x 1 mL), dried over MgSO4, filtered and 
concentrated in vacuo. The crude product was purified via flash chromatography on silica 
gel to afford the desired product. 
 
Diethyl 3-(3-ethoxy-2-(ethoxycarbonyl)-3-oxopropyl)-2-methylenecyclobutane-1,1-
dicarboxylate (3-6aa) The title compound was prepared from 3-5a (0.2 mmol, 75.1 mg) 
using General Procedure A. The crude material was purified via column chromatography 
on silica gel using 95:5 hexanes:ethyl acetate as the eluent. This procedure afforded 65.6 
mg (85%) of the title compound as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 5.38–3.35 (m, 1 H) 5.18–5.10 (m, 1 H) 4.26–4.13 (m, 8 H) 
3.36 (t, J = 7.6 Hz, 1 H) 3.06–2.97 (m, 1 H) 2.67 (dd, J = 11.9, 9.3 Hz, 1 H) 2.30–2.20 (m, 
2 H) 2.04 (ddd, J = 14.0, 9.2, 7.7 Hz, 1 H) 1.30–1.21 (m, 12 H); 13C NMR (126 MHz, 
CDCl3) δ 169.35, 169.15, 168.98, 168.87, 147.32, 110.70, 61.75, 61.60, 61.53, 61.51, 
59.12, 49.72, 38.22, 32.82, 31.79, 14.04, 13.99; IR (film) 2980, 2939, 1726, 1673, 1449 
cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C19H28O8 385.1857; found 385.1866. 
 
Diethyl 4-(1,3-diethoxy-1,3-dioxopropan-2-yl)-2-methylenecyclopentane-1,1-
dicarboxylate (3-7aa) The title compound was prepared from 3-5a (0.2 mmol, 75.0 mg) 
using General Procedure B. The crude material was purified via column chromatography 
on silica gel using 95:5 hexanes:ethyl acetate as the eluent. This procedure afforded 59.6 
mg (77%) of the title compound as a colorless oil. 
 174 
1H NMR (500 MHz, CDCl3) δ 5.37–5.31 (m, 1 H) 5.29–5.23 (m, 1 H) 4.27–4.13 (m, 8 H) 
3.24 (d, J = 9.0 Hz, 1 H) 2.78–2.61 (m, 3 H) 2.24 (ddt, J = 18.2, 12.5, 2.8 Hz, 1 H) 2.21–
2.03 (m, 1 H) 1.30–1.19 (m, 12 H); 13C NMR (126 MHz, CDCl3) δ 170.16, 170.09, 168.29, 
168.23, 145.95, 112.93, 63.10, 61.71, 61.68, 61.42, 56.30, 39.79, 38.37, 36.80, 14.07, 
13.98, 13.94; IR (film) 2979, 2934, 1727, 1654, 1448 cm-1; HRMS (ESI+ TOF) m/z: [M + 
H+]+ calcd for C19H28O8 385.1857; found 385.1864. 
 
Diethyl 2-((2-methylene-3,3-diphenylcyclobutyl)methyl)malonate (3-6b) The title 
compound was prepared from 3-5b (0.2 mmol, 77.1 mg) using General Procedure A. The 
crude material was purified via column chromatography on silica gel using 95:5 
hexanes:ethyl acetate as the eluent. Excess diethyl malonate was removed by distillation 
under vacuum at 95 °C. This procedure afforded 58.2 mg (74%) of the title compound as 
a yellow oil.  
 
Diethyl 2-((2-methylene-3,3-diphenylcyclobutyl)methyl)malonate (3-6b) The title 
compound was prepared from 3-5b (21.6 mmol, 8.2474 g) and diethyl malonate (108 
mmol, 16.5 mL), Pd(OAc)2 (0.864 mmol, 0.19 g), Tris(2,4-di-tert-butylphenyl)phosphite 
(0.864 mmol, 0.559 g), lithium tert-butoxide (108 mmol, 8.645 g) using General Procedure 
A. The crude material was purified via column chromatography on silica gel using 95:5 
hexanes:ethyl acetate as the eluent. Excess diethyl malonate was removed by distillation 
under vacuum at 95 °C. This procedure afforded 6.358 g (75%) of the title compound as 
a yellow oil. 
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1H NMR (500 MHz, CDCl3) δ 7.42–7.12 (m, 10 H) 5.22–5.16 (m, 1 H) 5.07–5.02 (m, 1 H) 
4.20 (dqd, J = 10.9, 7.1, 2.0 Hz, 4 H) 3.39 (t, J = 7.5 Hz, 1 H) 2.95 (ttd, J = 11.0, 5.3, 4.9, 
2.5 Hz, 1 H) 2.77 (dd, J = 10.6, 8.8 Hz, 1 H) 2.53 (dd, J = 10.6, 8.6 Hz, 1 H) 2.37 (ddd, J = 
13.5, 8.0, 5.2 Hz, 1 H) 2.08 (ddd, J = 13.9, 9.6, 7.1 Hz, 1 H) 1.28 (t, J = 7.1 Hz, 3 H) 1.25 
(t, J = 7.1 Hz, 3 H); 13C NMR (126 MHz, CDCl3) δ 169.41, 169.16, 158.34, 146.28, 146.18, 
128.23, 128.09, 127.58, 127.24, 126.14, 125.91, 106.74, 61.45, 61.41, 58.40, 50.00, 
38.76, 38.06, 32.29, 14.06, 14.01; IR (film) 3056, 2980, 2932, 1739, 1728, 1667, 1601, 
1492 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C25H28O4 393.2060; found 
393.2062. 
 
Diethyl 2-(4-methylene-3,3-diphenylcyclopentyl)malonate (3-7b) The title compound 
was prepared from 3-5b (0.2 mmol, 76.4 mg) and diethyl malonate (0.4 mmol, 64μL),  
sodium tert-butoxide (0.4 mmol, 38.4 mg) and toluene (0.1M) using General Procedure 
B. The crude material was purified via column chromatography on silica gel using 95:5 
hexanes:ethyl acetate as the eluent. Excess diethyl malonate was removed by distillation 
under vacuum at 95 °C. This procedure afforded 55.6 mg (71%) of the title compound 
(4:1 ratio of regiomers) as a yellow oil. The reported peaks are for the mixture of 4:1 
regiomers. 
1H NMR (500 MHz, CDCl3) δ 7.38–7.27 (m, 4 H) 7.26–7.18 (m, 3 H) 7.18–7.13 (m, 1.5 H) 
7.09–7.03 (m, 1.5 H) 5.23–5.18 (m, 0.75 H) 5.18–5.14 (m, 0.22 H) 5.04–5.01 (m, 0.22 H) 
4.63–4.58 (m, 0.75 H) 4.25–4.10 (m, 4 H) 3.37 (t, J = 7.5 Hz, 0.23 H) 3.28 (d, J = 9.8 Hz, 
0.77 H) 2.98–2.86 (m, 0.35 H) 2.86–2.72 (m, 1.75 H) 2.64–2.54 (m, 0.82 H) 2.51 (dd, J = 
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10.6, 8.6 Hz, 0.23 H) 2.40–2.33 (m, 1 H) 2.32–2.25 (m, 0.75 H) 2.06 (ddd, J = 14.0, 9.6, 
7.1 Hz, 0.23 H) 1.32–1.20 (m, 6 H); 13C NMR (126 MHz, CDCl3) δ 168.61, 168.57, 155.88, 
146.83, 145.10, 128.38, 128.25, 128.23, 128.19, 128.08, 127.81, 127.57, 127.24, 126.28, 
126.14, 125.94, 125.90, 111.38, 106.73, 61.44, 61.40, 61.32, 61.28, 60.57, 57.12, 49.99, 
46.10, 38.75, 38.05, 37.22, 35.32, 32.28, 14.09, 14.05, 14.00; IR (film) 3057, 2980, 2932, 
1747, 1729, 1596, 1490, 1443 cm-1; HRMS (ESI+ TOF) m/z: [M + NH4+]+ calcd for 
C25H28O4 410.2326; found 410.2329. 
 
Diethyl 2-((3,3-dimethoxy-2-methylenecyclobutyl)methyl)malonate (3-6c) The title 
compound was prepared from 3-5c (0.4 mmol, 115.9 mg) using General Procedure A. 
The crude material was purified via column chromatography on silica gel using 95:5 
hexanes:ethyl acetate as the eluent. This procedure afforded 86.0 mg (72%) of the title 
compound as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 5.25–5.16 (m, 1 H) 5.09–5.03 (m, 1 H) 4.19 (q, J = 7.0 Hz, 
4 H) 3.35 (t, J = 7.6 Hz, 1 H) 3.21 (s, 6 H) 2.73–2.63 (m, 1 H) 2.35–2.23 (m, 2 H) 2.05–
1.95 (m, 1 H) 1.79 (dd, J = 11.4, 7.1 Hz, 1 H) 1.26 (t, J = 7.1 Hz, 6 H); 13C NMR (126 
MHz, CDCl3) δ 169.27, 169.10, 151.48, 107.67, 102.14, 61.42, 50.22, 49.61, 49.01, 
37.50, 34.05, 32.89, 14.04; IR (film) 2982, 2938, 2827, 1747, 1730, 1441 cm-1; HRMS 
(ESI+ TOF) m/z: [M + Na+]+ calcd for C15H24O6 323.1465; found 323.1469. 
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Diethyl 2-(3,3-dimethoxy-4-methylenecyclopentyl)malonate (3-7c) The title 
compound was prepared 3-5c (0.2 mmol, 58.3 mg) using General Procedure B. The 
crude material was purified via column chromatography on silica gel using 99:1 
hexanes:ethyl acetate -> 95:5 hexanes:ethyl acetate as the eluent. This procedure 
afforded 50.7 mg (84%) of the title compound as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 5.17–5.12 (m, 1 H) 5.11–5.05 (m, 1 H) 4.24–4.13 (m, 4 H) 
3.27 (d, J = 10.2 Hz, 1 H) 3.22 (s, 3 H) 3.15 (s, 3 H) 2.75 (h, J = 8.5 Hz, 1 H) 2.64 (dd, J = 
16.5, 8.6 Hz, 1 H) 2.23 (dd, J = 12.6, 7.6 Hz, 1 H) 2.15 (ddt, J = 16.7, 8.4, 2.6 Hz, 1 H) 
1.61 (dd, J = 12.6, 9.3 Hz, 1 H) 1.29–1.21 (m, 6 H); 13C NMR (126 MHz, CDCl3) δ 168.48, 
145.85, 109.72, 105.67, 61.29, 57.33, 49.99, 49.12, 40.01, 34.53, 33.21, 14.08, 14.07; IR 
(film) 2980, 2937, 2829, 1749, 1730, 1445 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd 
for C15H24O6 300.1573; found 269.1375 [M–HOCH3+H+]+ (elimination product). 
 
Diethyl 2-((3,3-dimethyl-2-methylenecyclobutyl)methyl)malonate (3-6d) The title 
compound was prepared from 3-5d (0.2 mmol, 52.1 mg) using General Procedure A. The 
crude material was purified via column chromatography on silica gel using 98:2 
hexanes:ethyl acetate as the eluent. This procedure afforded 46.7 mg (86%) of the title 
compound (3:2 ratio of regiomers) as a colorless oil. The reported peaks are for the 
mixture of 3:2 regiomers. 
1H NMR (500 MHz, CDCl3) δ 4.81–4.77 (m, 0.4 H) 4.77–4.72 (m, 1.60 H) 4.25–4.13 (m, 
4 H) 3.35 (t, J = 7.6 Hz, 0.6 H) 3.16 (d, J = 9.8 Hz, 0.4 H) 2.97–2.87 (m, 0.6 H) 2.74–2.60 
(m, 0.8 H) 2.26 (ddd, J = 13.7, 8.0, 5.7 Hz, 0.6 H) 2.19–2.10 (m, 0.4 H) 2.01–1.89 (m, 1.3 
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H) 1.81–1.74 (m, 0.4 H) 1.42 (dd, J = 10.7, 7.7 Hz, 0.6 H) 1.29–1.24 (m, 6 H) 1.15 (s, 2 
H) 1.12 (s, 3 H) 1.05 (s, 1 H); 13C NMR (126 MHz, CDCl3) δ 169.54, 169.34, 168.78, 
168.75, 162.83, 159.82, 103.75, 101.53, 61.33, 61.31, 61.25, 61.21, 57.41, 50.13, 46.53, 
41.82, 41.42, 38.73, 38.18, 37.05, 35.93, 33.38, 29.74, 29.68, 28.75, 28.09, 27.69, 14.10, 
14.06, 14.05; IR (film) 2956, 2861, 1742, 1733, 1671, 1462 cm-1; HRMS (ESI+ TOF) m/z: 
[M + H+]+ calcd for C15H24O4 269.1747; found 269.1742. 
 
Diethyl 2-(3,3-dimethyl-4-methylenecyclopentyl)malonate (3-7d) The title compound 
was prepared from 3-5d (0.2 mmol, 51.6 mg) using General Procedure B. The crude 
material was purified via column chromatography on silica gel using 98:2 hexanes:ethyl 
acetate as the eluent. This procedure afforded 40.0 mg (75%) of the title compound as a 
colorless oil. 
1H NMR (500 MHz, CDCl3) δ 4.83–4.79 (m, 1 H) 4.78–4.73 (m, 1 H) 4.25–4.16 (m, 4 H) 
3.17 (d, 1 H) 2.76–2.61 (m, 2 H) 2.21 (m, 1 H) 1.82 (m, 1 H) 1.36–1.30 (m, 1 H) 1.30–
1.25 (m, 6 H) 1.13 (s, 3 H) 1.06 (s, 3 H); 13C NMR (126 MHz, CDCl3) δ 168.77, 168.75, 
159.82, 103.75, 61.25, 61.21, 57.41, 46.53, 41.82, 38.18, 35.93, 29.74, 28.75, 14.10; IR 
(film) 2957, 2864, 1741, 1731, 1654, 1463 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd 
for C15H24O4 269.1747; found 269.1745. 
1750, 1731, 1670, 1444 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C17H26O4 
295.1904; found 295.1905. 
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Diethyl 2-((3,3-diallyl-2-methylenecyclobutyl)methyl)malonate (3-6e) The title 
compound was prepared from 3-5e (0.2 mmol, 62.3 mg) using General Procedure A. The 
crude material was purified via column chromatography on silica gel using 98:2 
hexanes:ethyl acetate as the eluent. This procedure afforded 53.4 mg (83%) of the title 
compound (3:1 ratio of regiomers) as a colorless oil. The reported peaks are for the 
mixture of 3:1 regiomers. 
1H NMR (500 MHz, CDCl3) δ 5.85–5.68 (m, 2 H) 5.09–4.99 (m, 4 H) 4.98–4.94 (m, 0.27 
H) 4.89–4.84 (m, 0.8 H) 4.79–4.76 (m, 0.76 H) 4.74–4.71 (m, 0.26 H) 4.25–4.13 (m, 4 H) 
3.34 (t, J = 7.6 Hz, 0.75 H) 3.14 (d, J = 9.6 Hz, 0.25 H) 2.84–2.75 (m, 0.75 H) 2.66–2.53 
(m, 0.55 H) 2.27–2.08 (m, 5 H) 1.99–1.92 (m, 0.75 H) 1.92–1.86 (m, 0.80 H) 1.82 (dd, J = 
12.7, 6.7 Hz, 0.31 H) 1.53 (dd, J = 11.3, 7.7 Hz, 0.84 H) 1.40–1.36 (m, 0.3 H) 1.30–1.21 
(m, 7 H); 13C NMR (126 MHz, CDCl3) δ 169.48, 169.29, 159.03, 155.83, 135.21, 135.01, 
134.88, 134.70, 117.49, 117.44, 117.22, 117.18, 105.86, 104.30, 61.35, 61.32, 61.25, 
61.20, 57.36, 50.05, 47.90, 47.37, 44.55, 43.99, 42.56, 42.27, 40.45, 39.23, 36.68, 35.95, 
33.52, 32.94, 31.49, 30.31, 14.09, 14.06, 14.04; IR (film) 3073, 2977, 2925, 1750, 1732, 
1639, 1443 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C19H28O4 321.2060; found 
321.2050. 
 
Diethyl 2-(3,3-diallyl-4-methylenecyclopentyl)malonate (3-7e) The title compound 
was prepared from 3-5e (0.2 mmol, 62.3 mg) using General Procedure B. The crude 
material was purified via column chromatography on silica gel using 98:2 hexanes:ethyl 
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acetate as the eluent. This procedure afforded 51.1 mg (79%) of the title compound as a 
colorless oil. 
1H NMR (500 MHz, CDCl3) δ 5.84–5.67 (m, 2 H) 5.08–4.99 (m, 4 H) 4.98–4.94 (m, 1 H) 
4.75–4.69 (m, 1 H) 4.23–4.12 (m, 4 H) 3.14 (d, J = 9.5 Hz, 1 H) 2.67–2.52 (m, 2 H) 2.22–
2.02 (m, 5 H) 1.82 (dd, J = 12.6, 6.4 Hz, 1 H) 1.39 (t, J = 11.9 Hz, 1 H) 1.29–1.21 (m, 6 
H); 13C NMR (126 MHz, CDCl3) δ 168.74, 168.60, 155.83, 135.20, 135.01, 117.49, 
117.44, 105.86, 61.25, 61.20, 57.35, 47.90, 44.55, 43.99, 40.45, 39.23, 35.95, 14.09; IR 
(film) 3070, 2976, 2903, 1750, 1731, 1636, 1436 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ 
calcd for C19H28O4 321.2060; found 321.2048. 
 
Diethyl 2-((3-(ethoxycarbonyl)-3-methyl-2-methylenecyclobutyl)methyl)malonate 
(3-6f) The title compound was prepared from 3-5f (0.2 mmol, 63.6 mg) using General 
Procedure A. The crude material was purified via column chromatography on silica gel 
using 95:5 hexanes:ethyl acetate as the eluent. Excess diethyl malonate was removed 
by distillation under vacuum at 95 °C. This procedure afforded 56.6 mg (86%) of the title 
compound (3:1 ratio of regiomers and 3:1 diastereomers) as a colorless oil. The reported 
peaks are for the mixture of 3:1 regiomers and 3:1 diastereomers. 
1H NMR (500 MHz, CDCl3) δ 5.08–5.05 (m, 0.53 H) 5.03–5.01 (m, 0.22 H) 5.01–4.99 (m, 
0.13 H) 4.98–4.95 (m, 0.42 H) 4.95–4.92 (m, 0.22 H) 4.92–4.89 (m, 0.53 H) 4.25–4.08 
(m, 6 H) 3.41–3.32 (m, 0.73 H) 3.27 (d, J = 9.7 Hz, 0.2 H) 3.20 (d, J = 9.8 Hz, 0.06 H) 
3.05–2.90 (m, 0.73 H) 2.90–2.82 (m, 0.7 H) 2.74 (dd, J = 11.3, 9.3 Hz, 0.29 H) 2.69–2.59 
(m, 0.43 H) 2.50 (dd, J = 12.9, 6.3 Hz, 0.07 H) 2.32–2.16 (m, 1.82 H) 2.06–1.98 (m, 0.76 
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H) 1.95 (dd, J = 11.5, 9.2 Hz, 0.57 H) 1.89–1.82 (m, 0.22 H) 1.50 (dd, J = 11.3, 7.8 Hz, 
0.25 H) 1.44 (s, 1.63 H) 1.41 (s, 0.69 H) 1.36 (s, 0.26 H) 1.33 (s, 0.72 H) 1.29–1.22 (m, 9 
H); 13C NMR (126 MHz, CDCl3) δ 175.64, 174.70, 174.34, 169.34, 169.32, 169.17, 
169.13, 168.62, 168.52, 155.66, 155.20, 154.43, 153.75, 108.14, 107.56, 106.21, 105.99, 
61.45, 61.43, 61.39, 61.37, 61.34, 61.28, 60.84, 60.78, 60.68, 56.96, 56.81, 52.12, 51.82, 
50.39, 49.92, 49.87, 49.56, 43.25, 42.35, 38.89, 38.48, 37.92, 37.02, 36.83, 36.60, 35.41, 
33.74, 33.55, 32.75, 25.51, 25.08, 24.22, 23.82, 14.16, 14.09, 14.05; IR (film) 2978, 2929, 
1747, 1727, 1668, 1444 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C17H26O6 
327.1802; found 327.1803. 
 
Diethyl 2-(3-(ethoxycarbonyl)-3-methyl-4-methylenecyclopentyl)malonate (3-7f) 
The title compound was prepared from 3-5f (0.2 mmol, 63.6 mg) using General Procedure 
B. The crude material was purified via column chromatography on silica gel using 98:2 
hexanes:ethyl acetate as the eluent. Excess diethyl malonate was removed by distillation 
under vacuum at 95 °C. This procedure afforded 47.8 mg (73%) of the title compound 
compound (2:1 ratio of diastereomers) as a colorless oil. The reported peaks are for the 
mixture of 2:1 diastereomers. 
 
Diethyl 2-(3-(ethoxycarbonyl)-3-methyl-4-methylenecyclopentyl)malonate (3-7f) 
The title compound was prepared from 3-5f (3 mmol, 948.9 mg) and diethyl malonate (15 
mmol, 2.3 mL), Pd(OAc)2 (0.12 mmol, 27 mg), Tris(2,4-di-tert-butylphenyl)phosphite (0.18 
mmol, 80.4 mg), lithium tert-butoxide (15 mmol, 1.2 g) using General Procedure A. The 
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crude material was purified via column chromatography on silica gel using 98:2 
hexanes:ethyl acetate as the eluent. Excess diethyl malonate was removed by distillation 
under vacuum at 95 °C. This procedure afforded 714.7 mg (73%) of the title compound 
(2:1 ratio of diastereomers) as a colorless oil. The reported peaks are for the mixture of 
2:1 diastereomers. 
1H NMR (500 MHz, CDCl3) δ 5.04–4.99 (m, 0.7 H) 4.99–4.93 (m, 1.3 H) 4.25–4.16 (m, 4 
H) 3.27 (d, J = 9.6 Hz, 0.62 H) 3.20 (d, J = 9.6 Hz, 0.33 H) 2.87 (dtd, J = 17.2, 10.4, 7.0 
Hz, 0.34 H) 2.74 (ddt, J = 16.2, 7.7, 1.7 Hz, 0.36 H) 2.69–2.60 (m, 1.33 H) 2.51 (dd, J = 
12.9, 6.5 Hz, 0.37 H) 2.31–2.16 (m, 1.72 H) 1.87 (ddd, J = 12.4, 5.9, 2.2 Hz, 0.67 H) 1.37 
(s, 1 H) 1.34 (s, 2 H) 1.30–1.20 (m, 9 H); 13C NMR (126 MHz, CDCl3) δ 175.64, 175.45, 
168.62, 168.52, 168.49, 154.43, 153.75, 108.14, 107.56, 61.37, 61.34, 61.28, 60.84, 
60.77, 56.96, 56.81, 52.12, 51.82, 43.25, 42.35, 38.89, 37.92, 37.02, 36.60, 25.51, 25.08, 
14.09, 14.05, 14.01; IR (film) 2980, 2923, 2852, 1750, 1727, 1655, 1450 cm-1; HRMS 
(ESI+ TOF) m/z: [M + H+]+ calcd for C17H26O6 327.1802; found 327.1795. 
 
Diethyl 2-((1R,3R)-3-(ethoxycarbonyl)-3-methyl-4-methylenecyclopentyl)malonate 
(3-S24) The mixture of diastereomers was purified via column chromatography on silica 
gel using 99.8:0.2 DCM:ethyl acetate as the eluent. This procedure afforded 450 mg 
(63%) of the title compound as a colorless oil.  
1H NMR (700 MHz, CDCl3) δ 4.97–4.94 (m, 2 H) 4.24–4.16 (m, 4 H) 4.16–4.08 (m, 2 H) 
3.27 (d, J = 9.7 Hz, 1 H) 2.69–2.60 (m, 2 H) 2.29–2.22 (m, 1 H) 2.22–2.15 (m, 1 H) 1.86 
(dd, J = 12.8, 6.3 Hz, 1 H) 1.33 (s, 3 H) 1.29–1.20 (m, 9 H); 13C NMR (176 MHz, CDCl3) 
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δ 175.65, 168.63, 168.53, 154.44, 107.57, 61.37, 61.35, 60.84, 56.80, 51.82, 42.34, 
38.89, 36.60, 25.50, 14.09, 14.08, 14.04; IR (film) 2981, 2925, 2852, 1750, 1726, 1655, 




(3-S25) The mixture of diastereomers was purified via column chromatography on silica 
gel using 99.8:0.2 DCM:ethyl acetate as the eluent. This procedure afforded 215 mg 
(30%) of the title compound as a colorless oil. 
1H NMR (700 MHz, CDCl3) δ 5.02–4.97 (m, 2 H) 4.23–4.15 (m, 4 H) 4.14–4.06 (m, 2 H) 
3.18 (d, J = 9.7 Hz, 1 H) 2.85 (dtd, J = 17.4, 10.3, 7.0 Hz, 1 H) 2.73 (dd, J = 16.2, 7.5 Hz, 
1 H) 2.49 (dd, J = 12.9, 6.5 Hz, 1 H) 2.20 (ddt, J = 16.1, 10.4, 2.8 Hz, 1 H) 1.36 (s, 3 H) 
1.34–1.30 (m, 1 H) 1.29–1.18 (m, 9 H); 13C NMR (126 MHz, CDCl3) δ 175.43, 168.51, 
168.48, 153.74, 108.12, 61.26, 60.75, 56.94, 52.10, 43.24, 37.90, 37.01, 25.06, 14.07, 
14.00; IR (film) 2979, 2920, 2853, 1750, 1727, 1654, 1452 cm-1; HRMS (ESI+ TOF) m/z: 
[M + H+]+ calcd for C17H26O6 327.1802; found 327.1801. 
 
Diethyl 2-((1-methylenespiro[3.4]octan-2-yl)methyl)malonate (3-6g) The title 
compound was prepared from 3-5g (0.2 mmol, 57.0 mg) using General Procedure A. The 
crude material was purified via column chromatography on silica gel using 98:2 
hexanes:ethyl acetate as the eluent. This procedure afforded 50.0 mg (85%) of the title 
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compound (3:2 ratio of regiomers) as a colorless oil. The reported peaks are for the 
mixture of 3:2 regiomers. 
1H NMR (500 MHz, CDCl3) δ 4.82–4.79 (m, 0.41 H) 4.79–4.76 (m, 0.43 H) 4.76–4.70 (m, 
1.15 H) 4.24–4.12 (m, 4 H) 3.36 (t, J = 7.6 Hz, 0.54 H) 3.18 (d, J = 10.0 Hz, 0.37 H) 2.89–
2.80 (m, 0.59 H) 2.68 (dd, J = 16.0, 7.6 Hz, 0.46 H) 2.64–2.52 (m, 0.50 H) 2.24 (ddd, J = 
13.8, 7.9, 5.9 Hz, 0.64 H) 2.15 (ddt, J = 15.4, 10.0, 2.4 Hz, 0.50 H) 2.05–1.99 (m, 0.68 H) 
1.99–1.93 (m, 0.56 H) 1.85 (dd, 0.51 H) 1.79–1.42 (m, 9 H) 1.32 (m, 6.5 H); 13C NMR 
(126 MHz, CDCl3) δ 169.56, 169.36, 168.78, 162.39, 159.18, 103.42, 101.29, 61.32, 
61.30, 61.24, 61.19, 57.22, 53.36, 52.29, 50.13, 45.25, 41.53, 39.91, 39.66, 38.78, 38.39, 
38.32, 37.73, 36.51, 33.21, 24.99, 24.67, 24.57, 24.39, 14.10, 14.06; IR (film) 2951, 2869, 
1750, 1731, 1670, 1444 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C17H26O4 
295.1904; found 295.1905. 
 
Diethyl 2-(4-methylenespiro[4.4]nonan-2-yl)malonate (3-7g) The title compound was 
prepared from 3-5g (0.2 mmol, 56.6 mg) using General Procedure B. The crude material 
was purified via column chromatography on silica gel using 95:5 hexanes:ethyl acetate 
as the eluent. This procedure afforded 47.8 mg (82%) of the title compound as a colorless 
oil. 
1H NMR (500 MHz, CDCl3) δ 4.82–4.79 (m, 1 H) 4.78–4.73 (m, 1 H) 4.24–4.12 (m, 4 H) 
3.18 (d, J = 10.0 Hz, 1 H) 2.68 (ddt, J = 15.9, 7.7, 1.7 Hz, 1 H) 2.64–2.53 (m, 1 H) 2.15 
(ddt, J = 14.5, 10.0, 2.2 Hz, 1 H) 1.85 (dd, J = 12.1, 6.0 Hz, 1 H) 1.79–1.65 (m, 3 H) 1.65–
1.51 (m, 4 H) 1.51–1.43 (m, 1 H) 1.33–1.29 (m, 1 H) 1.29–1.19 (m, 6 H); 13C NMR (126 
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MHz, CDCl3) δ 168.80, 159.20, 103.44, 61.25, 61.20, 57.22, 53.37, 45.26, 41.54, 39.66, 
38.40, 36.51, 25.00, 24.67, 14.10; IR (film) 2943, 2868, 1751, 1733, 1650, 1447 cm-1; 
HRMS (ESI+ TOF) m/z: [M + Na+]+ calcd for C17H26O4 317.1723; found 317.1720. 
 
Diethyl 2-((1-allylbicyclo[4.2.0]oct-5-en-7-yl)methyl)malonate (3-6h) The title 
compound was prepared from 3-5h (0.2 mmol, 62.1 mg) using General Procedure A. The 
crude material was purified via column chromatography on silica gel using 98:2 
hexanes:ethyl acetate as the eluent. This procedure afforded 57.7 mg (90%) of the title 
compound (1:1 ratio of regiomers) as a colorless oil. The reported peaks are for the 
mixture of 1:1 regiomers. 
1H NMR (500 MHz, CDCl3) δ 5.85–5.70 (m, 1 H) 5.36–5.30 (m, 1 H) 5.10–5.01 (m, 2 H) 
4.24–4.13 (m, 4 H) 3.30 (t, J = 7.5 Hz, 0.51 H) 3.16 (d, J = 9.8 Hz, 0.45 H) 3.13–3.06 (m, 
1 H) 2.84–2.69 (m, 0.93 H) 2.36–2.21 (m, 1.66 H) 2.19–2.10 (m, 1 H) 2.09–2.02 (m, 1.5 
H) 2.02–1.88 (m, 3 H) 1.74 (dt, J = 12.4, 3.5 Hz, 0.57 H) 1.66–1.52 (m, 2.18 H) 1.30–1.23 
(m, 6 H) 1.17 (t, J = 9.2 Hz, 0.64 H) 1.01 (dtd, J = 25.5, 12.8, 4.3 Hz, 1.12 H) 0.88 (dd, J = 
12.2, 10.2 Hz, 0.57 H); 13C NMR (126 MHz, CDCl3) δ 169.59, 169.42, 168.93, 168.77, 
147.50, 145.46, 135.68, 135.00, 118.35, 117.08, 116.75, 113.23, 61.34, 61.31, 61.22, 
61.17, 58.08, 50.38, 45.00, 43.82, 42.22, 41.94, 39.73, 38.96, 38.35, 34.59, 34.25, 32.69, 
31.97, 24.80, 24.39, 18.72, 17.98, 14.10, 14.07, 14.05; IR (film) 2976, 2929, 2849, 1745, 




Diethyl 2-((2S,3aS)-3a-allyl-2,3,3a,4,5,6-hexahydro-1H-inden-2-yl)malonate (3-7h) 
The title compound was prepared from 3-5h (0.2 mmol, 61.8 mg) using General 
Procedure B. The crude material was purified via column chromatography on silica gel 
using 98:2 hexanes:ethyl acetate as the eluent. This procedure afforded 60.0 mg (94%) 
of the title compound compound (93:7 ratio of diastereomers) as a colorless oil. The 
reported peaks are for the mixture of 93:7 diastereomers. 
1H NMR (500 MHz, CDCl3) δ 5.75 (ddt, J = 15.2, 11.9, 7.5 Hz, 1 H) 5.36–5.29 (m, 1 H) 
5.08–5.04 (m, 1 H) 5.04–4.98 (m, 1 H) 4.24–4.11 (m, 4 H) 3.27 (d, J = 10.4 Hz, 0.07 H) 
3.16 (d, J = 9.8 Hz, 0.92 H) 2.86–2.69 (m, 1.76 H) 2.34–2.19 (m, 0.26 H) 2.15–1.80 (m, 
7 H) 1.69–1.57 (m, 2 H) 1.30–1.21 (m, 6 H) 0.99 (td, J = 12.9, 4.4 Hz, 1 H) 0.92–0.80 (m, 
1 H); 13C NMR (126 MHz, CDCl3) δ 168.93, 168.77, 145.46, 135.00, 118.35, 117.08, 
61.22, 61.17, 58.08, 43.82, 42.21, 38.96, 34.59, 34.24, 31.96, 24.80, 17.98, 14.10; IR 
(film) 2976, 2928, 2853, 1750, 1731, 1637, 1446 cm-1; HRMS (ESI+ TOF) m/z: [M + Na+]+ 
calcd for C19H28O4 343.1880; found 343.1881. 
 
Diethyl 2-((1-(ethoxycarbonyl)bicyclo[4.2.0]oct-5-en-7-yl)methyl)malonate (3-6i) 
The title compound was prepared from 3-5i (0.2 mmol, 68.4 mg) using General Procedure 
A. The crude material was purified via column chromatography on silica gel using 95:5 
hexanes:ethyl acetate as the eluent. Excess diethyl malonate was removed by distillation 
under vacuum at 95 °C. This procedure afforded 56.5 mg (80%) of the title compound 
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(3:1 ratio of regiomers) as a colorless oil. The reported peaks are for the mixture of 3:1 
regiomers. 
1H NMR (500 MHz, CDCl3) δ 5.53–5.49 (m, 0.21 H) 5.47–5.41 (m, 0.73 H) 4.25–4.09 (m, 
6 H) 3.42–3.32 (m, 0.76 H) 3.30 (t, J = 7.5 Hz, 0.76 H) 3.17 (d, J = 9.9 Hz, 0.23 H) 2.91–
2.81 (m, 0.27 H) 2.76–2.65 (m, 0.26 H) 2.50 (dd, J = 10.2, 8.5 Hz, 0.8 H) 2.43–2.35 (m, 
0.49 H) 2.35–2.28 (m, 0.8 H) 2.28–2.21 (m, 0.83 H) 2.17–1.90 (m, 3.23 H) 1.76–1.66 (m, 
1.07 H) 1.59–1.47 (m, 1.74 H) 1.44–1.36 (m, 0.42 H) 1.29–1.22 (m, 9 H) 1.19–1.11 (, 0.55 
H); 13C NMR (126 MHz, CDCl3) δ 175.42, 169.42, 169.23, 168.59, 142.47, 140.04, 
120.97, 114.85, 61.42, 61.41, 61.28, 60.71, 60.64, 57.43, 53.03, 51.94, 50.21, 43.54, 
43.19, 39.57, 35.47, 35.11, 32.74, 32.71, 31.75, 24.84, 24.19, 19.87, 19.63, 14.22, 14.08, 
14.04; 2979, 2933, 2857, 1748, 1724, 1446 cm-1; HRMS (ESI+ TOF) m/z: [M + NH4+]+ 
calcd for C19H28O6 370.2224; found 370.2219. 
 
Diethyl 2-(3a-(ethoxycarbonyl)-2,3,3a,4,5,6-hexahydro-1H-inden-2-yl)malonate (3-
7i) The title compound was prepared from 3-5i (0.5 mmol, 172 mg) using General 
Procedure B. The crude material was purified via column chromatography on silica gel 
using 95:5 hexanes:ethyl acetate as the eluent. Excess diethyl malonate was then 
removed by distillation under vacuum at 95 °C.  This procedure afforded 141 mg (80%) 
of the title compound (4:1 ratio of diastereomers) as a yellow oil. The reported peaks are 
for the mixture of 4:1 diastereomers. 
1H NMR (700 MHz, CDCl3) δ 5.54–5.50 (m, 1 H) 4.23–4.09 (m, 6 H) 3.26 (d, J = 10.6 Hz, 
0.18 H) 3.17 (d, J = 10.0 Hz, 0.77 H) 2.90–2.83 (m, 0.8 H) 2.75–2.67 (m, 0.79 H) 2.63–
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2.55 (m, 0.19 H) 2.46 (dd, J = 13.9, 7.2 Hz, 0.19 H) 2.42–2.30 (m, 2.03 H) 2.11–2.03 (m, 
1.84 H) 2.02–1.90 (m, 1.52 H) 1.73–1.66 (m, 1.02 H) 1.53–1.46 (m, 0.19 H) 1.45–1.37 
(m, 0.87 H) 1.28–1.22 (m, 9.82 H) 1.16 (ddd, J = 14.0, 12.7, 3.1 Hz, 1.12 H); 13C NMR 
(176 MHz, CDCl3) δ 176.59, 175.79, 168.70, 168.67, 168.59, 168.58, 140.82, 140.04, 
120.97, 120.46, 61.28, 61.27, 60.70, 60.65, 57.56, 57.43, 53.03, 50.48, 43.19, 41.81, 
38.37, 36.13, 35.47, 35.11, 32.89, 32.70, 24.84, 24.36, 19.77, 19.63, 14.21, 14.16, 14.08; 
IR (film) 2979, 2934, 2862, 1749, 1721, 1445; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for 
C19H28O6 353.1959; found 353.1958. 
 
Diethyl 2-((2R,3aS)-3a-(ethoxycarbonyl)-2,3,3a,4,5,6-hexahydro-1H-inden-2-
yl)malonate (3-S26) The mixture of diastereomers was purified via column 
chromatography on silica gel using 98:2 hexanes:ethyl acetate as the eluent. This 
procedure afforded 110 mg (78%) of the title compound as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 5.56–5.51 (m, 1 H) 4.23–4.07 (m, 6 H) 3.17 (d, J = 9.9 Hz, 
1 H) 2.92–2.81 (m, 1 H) 2.78–2.64 (m, 1 H) 2.44–2.32 (m, 2 H) 2.13–1.92 (m, 3 H) 1.75–
1.64 (m, 1 H) 1.48–1.36 (m, 1 H) 1.30–1.20 (m, 10 H) 1.16 (td, J = 13.4, 3.0 Hz, 1 H); 13C 
NMR (126 MHz, CDCl3) δ 175.80, 168.58, 140.04, 120.97, 61.29, 61.27, 60.71, 57.43, 
53.03, 43.19, 35.47, 35.11, 32.71, 24.84, 19.63, 14.21, 14.08; IR (film) 2979, 2933, 2866, 





yl)malonate (3-S27) The mixture of diastereomers was purified via column 
chromatography on silica gel using 98:2 hexanes:ethyl acetate as the eluent. This 
procedure afforded 25 mg (18%) of the title compound as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 5.56–5.50 (m, 1 H) 4.24–4.07 (m, 6 H) 3.26 (d, J = 10.6 Hz, 
1 H) 2.59 (qt, J = 10.1, 7.4 Hz, 1 H) 2.46 (dd, J = 13.9, 7.2 Hz, 1 H) 2.40—2.29 (m, 2 H) 
2.11–1.89 (m, 4 H) 1.73–1.65 (m, 1 H) 1.54–1.45 (m, 1 H) 1.30–1.22 (m, 9 H) 1.18 (td, 1 
H); 13C NMR (126 MHz, CDCl3) δ 176.59, 168.70, 168.68, 140.82, 120.46, 61.28, 60.65, 
57.57, 50.48, 41.81, 38.37, 36.13, 32.90, 24.35, 19.77, 14.16, 14.08; IR (film) 2979, 2933, 
2868, 1740, 1725, 1445 cm-1; HRMS (ESI+ TOF) m/z: [M + Na+]+ calcd for C19H28O6 
375.1778; found 375.1777. 
 
Diethyl 2-((2-methylene-1'-oxo-3',4'-dihydro-1'H-spiro[cyclobutane-1,2'-
naphthalen]-3-yl)methyl)malonate (3-6j) The title compound was prepared from 3-5j 
(0.2 mmol, 72.4 mg) using General Procedure A. The crude material was purified via 
column chromatography on silica gel using 95:5 hexanes:ethyl acetate as the eluent. This 
procedure afforded 62.5 mg (84%) of the title compound (3:1 ratio of regiomers) as a 
colorless oil. The reported peaks are for the mixture of 3:1 regiomers. Regiomers can be 
partially separated via column chromatography on silica gel using 20:2:78 DCM:ethyl 
acetate:hexanes as the eluent (see spectra). 
1H NMR (500 MHz, CDCl3) δ 8.09–7.99 (m, 1 H) 7.51–7.42 (m, 1 H) 7.35–7.28 (m, 1 H) 
7.25–7.20 (m, 1 H) 4.99–4.94 (m, 0.33 H) 4.93–4.90 (m, 0.62 H) 4.62–4.60 (m, 0.6 H) 
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4.60–4.55 (m, 0.32 H) 4.26–4.13 (m, 4 H) 3.44–3.38 (m, 0.64 H) 3.32 (d, J = 9.9 Hz, 0.27 
H) 3.22 (ddd, J = 16.7, 11.2, 5.1 Hz, 0.66 H) 3.15–3.07 (m, 0.37 H) 3.07–2.99 (m, 0.66 
H) 2.96–2.86 (m, 1 H) 2.83–2.72 (m, 0.64 H) 2.60 (dd, J = 11.2, 7.9 Hz, 0.64 H) 2.41–
2.16 (m, 3 H) 2.10–2.00 (m, 1 H) 2.00–1.94 (m, 0.32 H) 1.85 (dd, J = 11.1, 9.3 Hz, 0.64 
H) 1.31–1.22 (m, 6 H); 13C NMR (126 MHz, CDCl3) δ 199.59, 196.45, 169.35, 169.23, 
168.74, 168.68, 153.84, 152.47, 143.84, 143.78, 133.34, 133.30, 132.42, 131.99, 128.78, 
128.77, 128.16, 128.07, 126.69, 108.33, 106.78, 61.43, 61.41, 61.38, 61.37, 56.87, 56.40, 
55.16, 49.78, 40.38, 38.90, 36.69, 36.22, 33.46, 33.11, 32.38, 29.83, 26.14, 25.58, 14.11, 
14.09, 14.07; IR (film) 2979, 2933, 2850, 1747, 1729, 1681, 1600, 1453 cm-1; HRMS (ESI+ 
TOF) m/z: [M + H+]+ calcd for C22H26O5 371.1853; found 371.1855. 
 
Diethyl 2-(2-methylene-1'-oxo-3',4'-dihydro-1'H-spiro[cyclopentane-1,2'-
naphthalen]-4-yl)malonate (3-7j) The title compound was prepared from 3-5j (0.2 mmol, 
71.5 mg) using General Procedure B except the reaction was stirred for 15 hours. The 
crude material was purified via column chromatography on silica gel using 98:2 
hexanes:ethyl acetate as the eluent. This procedure afforded 62.8 mg (85%) of the title 
compound (3:1 ratio of diastereomers) as a yellow oil. The reported peaks are for the 
mixture of 3:1 diastereomers. 
1H NMR (500 MHz, CDCl3) δ 8.08–8.02 (m, 1 H) 7.50–7.43 (m, 1 H) 7.34–7.28 (m, 1 H) 
7.25–7.20 (m, 1 H) 5.09–5.04 (m, 0.64 H) 4.99–4.95 (m, 0.34 H) 4.78–4.73 (m, 0.65 H) 
4.60–4.56 (m, 0.33 H) 4.25–4.11 (m, 4 H) 3.33 (d, J = 9.9 Hz, 0.33 H) 3.24 (d, J = 9.2 Hz, 
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0.63 H) 3.15–3.07 (m, 0.38 H) 3.05–3.00 (m, 1.27 H) 2.99–2.73 (m, 2.43 H) 2.52–2.44 
(m, 0.66 H) 2.40–2.29 (m, 1.69 H) 2.29–2.23 (m, 0.39 H) 2.23–2.15 (m, 0.38 H) 2.09–
1.94 (m, 1.42 H) 1.61–1.52 (m, 0.59 H) 1.31–1.20 (m, 6 H); 13C NMR (126 MHz, CDCl3) 
δ 199.65, 199.59, 168.74, 168.68, 168.47, 168.43, 153.21, 152.47, 143.84, 143.43, 
133.34, 133.21, 132.42, 131.46, 128.77, 128.61, 128.29, 128.16, 126.73, 126.69, 108.33, 
107.99, 61.41, 61.37, 61.32, 61.28, 56.87, 56.72, 56.51, 56.40, 40.98, 40.38, 38.98, 
38.90, 36.22, 36.03, 35.00, 33.46, 26.49, 25.58, 14.11, 14.09, 14.04; IR (film) 2980, 2924, 
2851, 1750, 1730, 1677, 1601, 1450 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for 
C22H26O5 371.1853; found 371.1851. 
 
Diethyl 2-((1S,4R)-2-methylene-1'-oxo-3',4'-dihydro-1'H-spiro[cyclopentane-1,2'-
naphthalen]-4-yl)malonate (3-S28) The mixture of diastereomers was purified via 
column chromatography on silica gel using 99.8:0.2 DCM:ethyl acetate as the eluent. This 
procedure afforded 45 mg (72%) of the title compound as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 8.04 (dd, J = 7.8, 1.4 Hz, 1 H) 7.46 (td, J = 7.4, 1.4 Hz, 1 H) 
7.30 (t, J = 7.6 Hz, 1 H) 7.22 (d, J = 7.6 Hz, 1 H) 5.09–5.04 (m, 1 H) 4.78–4.72 (m, 1 H) 
4.24–4.10 (m, 4 H) 3.24 (d, J = 9.0 Hz, 1 H) 3.08–2.97 (m, 2 H) 2.90–2.77 (m, 2 H) 2.48 
(dd, J = 12.1, 6.9 Hz, 1 H) 2.39–2.28 (m, 2 H) 2.02 (dt, J = 13.4, 5.1 Hz, 1 H) 1.55 (dd, J = 
12.8, 10.7 Hz, 1 H) 1.28–1.20 (m, 6 H); 13C NMR (126 MHz, CDCl3) δ 199.61, 168.44, 
168.40, 153.19, 143.41, 133.19, 131.44, 128.59, 128.27, 126.71, 107.97, 61.30, 61.26, 
56.71, 56.50, 40.98, 38.98, 36.02, 35.00, 26.48, 14.09, 14.04; IR (film) 2980, 2926, 2852, 
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1749, 1730, 1680, 1601, 1453 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C22H26O5 
371.1853; found 371.1850. 
 
Diethyl 2-((1R,4R)-2-methylene-1'-oxo-3',4'-dihydro-1'H-spiro[cyclopentane-1,2'-
naphthalen]-4-yl)malonate (3-S29) The mixture of diastereomers was purified via 
column chromatography on silica gel using 99.8:0.2 DCM:ethyl acetate as the eluent. This 
procedure afforded 14 mg (22%) of the title compound as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 8.05 (d, J = 7.8 Hz, 1 H) 7.47 (t, J = 7.4 Hz, 1 H) 7.31 (t, J = 
7.5 Hz, 1 H) 7.24 (d, J = 7.6 Hz, 1 H) 4.99–4.94 (m, 1 H) 4.62–4.56 (m, 1 H) 4.25–4.13 
(m, 4 H) 3.33 (d, J = 9.8 Hz, 1 H) 3.11 (ddd, J = 17.2, 9.2, 4.8 Hz, 1 H) 2.92 (dt, J = 17.3, 
5.4 Hz, 1 H) 2.84–2.72 (m, 2 H) 2.41–2.30 (m, 1 H) 2.30–2.23 (m, 1 H) 2.22–2.15 (m, 1 
H) 2.05 (ddd, J = 13.7, 9.1, 4.6 Hz, 1 H) 1.97 (dd, J = 12.8, 5.9 Hz, 1 H) 1.31–1.24 (m, 6 
H); 13C NMR (126 MHz, CDCl3) δ 199.56, 168.71, 168.65, 152.46, 143.82, 133.32, 
132.40, 128.75, 128.14, 126.67, 108.31, 61.39, 61.35, 56.86, 56.40, 40.37, 38.89, 36.22, 
33.45, 25.57, 14.10, 14.08; IR (film) 2972, 2924, 2849, 1748, 1730, 1680, 1600, 1454 cm-
1; HRMS (ESI+ TOF) m/z: [M + H+]+ calcd for C22H26O5 371.1853; found 371.1854. 
 
Diethyl 2,3-dimethylenecyclobutane-1,1-dicarboxylate (3-11a) The title compound 
was prepared from 3-5a (0.2 mmol, 74.9 mg) using General Procedure A excluding the 
diethyl malonate. The crude material was purified via column chromatography on silica 
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gel using 95:5 hexanes:ethyl acetate as the eluent. This procedure afforded 10 mg (22%) 
of the title compound as a colorless oil.  
1H NMR (500 MHz, CDCl3) δ 5.45–5.41 (m, 1 H) 5.31–5.28 (m, 1 H) 5.27–5.24 (m, 1 H) 
4.90–4.86 (m, 1 H) 4.28–4.16 (m, 4 H) 3.24–3.17 (m, 2 H) 1.27 (t, J = 7.2 Hz, 6 H); 13C 
NMR (126 MHz, CDCl3) δ 169.02, 145.37, 143.15, 107.91, 106.22, 61.74, 58.35, 36.93, 
14.01; IR (film) 3452, 2980, 2921, 2849, 1728, 1450 cm-1; HRMS (ESI+ TOF) m/z: [M + 
H+]+ calcd for C12H16O4 225.1779; found 449.2152 [M2+H+]+ and 471.1977 [M2+Na+]+. 
 
Diethyl 3-(2-(ethoxycarbonyl)-3-oxobutyl)-2-methylenecyclobutane-1,1-
dicarboxylate (3-6ab) The title compound was prepared from 3-5a (0.2 mmol, 75.3 mg) 
using General Procedure A. The crude material was purified via column chromatography 
on silica gel using 95:5 hexanes:ethyl acetate as the eluent. Excess diethyl malonate was 
removed by distillation under vacuum at 95 °C. This procedure afforded 37.5 mg (53%) 
of the title compound (88:12 ratio of regiomers) as a colorless oil. The reported peaks are 
for the mixture of 88:12 regiomers and enol tautomer. 
1H NMR (401 MHz, CDCl3) δ 12.89 (s, 0.13 H) 5.37–5.32 (m, 0.77 H) 5.32—5.30 (m, 0.05 
H) 5.30–5.27 (m, 0.14 H) 5.27–5.22 (m, 0.09 H) 5.15–5.08 (m, 0.76 H) 5.07–5.03 (m, 0.16 
H) 4.28–4.11 (m, 6 H) 3.50–3.39 (m, 0.80 H) 3.34–3.28 (m, 0.09 H) 3.17–3.05 (m, 0.16 
H) 3.03–2.88 (m, 0.77 H) 2.64 (ddd, J = 12.1, 9.4, 2.9 Hz, 1 H) 2.48 (dd, J = 14.5, 7.1 Hz, 
0.19 H) 2.43–2.35 (m, 0.21 H) 2.31 (dd, J = 12.1, 7.1 Hz, 0.21 H) 2.26–2.11 (m, 4 H) 
2.05–1.87 (m, 1.34 H) 1.30–1.21 (m, 9 H); 13C NMR (100 MHz, CDCl3) δ 202.49, 202.32, 
173.41, 173.14, 169.47, 169.31, 169.28, 169.25, 168.88, 168.83, 148.23, 147.39, 147.32, 
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110.79, 110.60, 110.44, 97.81, 64.39, 61.74, 61.60, 61.55, 61.53, 60.40, 59.10, 59.04, 
58.92, 57.45, 57.12, 40.21, 39.72, 39.61, 38.24, 38.18, 36.52, 36.42, 32.03, 31.97, 31.75, 
31.67, 31.62, 30.47, 29.65, 28.83, 28.80, 19.25, 14.22, 14.03, 14.01, 13.98, 13.96, 13.92. 
IR (film) 2967, 2958, 2931, 2871, 1716, 1463, 1445 cm-1; HRMS (ESI+ TOF) m/z: [M + 




dicarboxylate (3-S30) A vacuum flame-dried flask equipped with a stir bar was cooled 
under a stream of nitrogen and charged with dry magnesium chloride (1.06 mmol, 101 
mg, 2 equiv) dissolved in acetonitrile (2 mL, 0.5 M). The flask was cooled to 0 °C. Triethyl 
amine was added to the flask (1.06 mmol, 150 μL, 2 eq). 3-6ab (0.53 mmol, 189 mg, 1 
equiv) was added to the flask dissolved in acetonitrile (2 mL, 0.25 M). The reaction was 
stirred for 20 minutes. Acyl chloride (0.53 mmol, 38 μL, 1 equiv) was added to the flask. 
The reaction was stirred for an additional hour at 0 °C then allowed to warm to rt and stir 
for 15 h. The reaction was quenched with HCl (5 mL, 1 M). The mixture was then 
transferred to a separatory funnel. The aqueous layer was extracted with ethyl acetate (3 
x 5 mL). The combined organic layers were washed with brine, dried over MgSO4, filtered 
and concentrated in vacuo to yield a yellow oil. The crude material was purified via column 
chromatography on silica gel using 90:10 hexanes:ethyl acetate as the eluent. This 
procedure afforded 94.5 mg (45%) of the title compound (88:12 ratio of regiomers) as a 
colorless oil. The reported peaks are for the major regiomer only. 
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1H NMR (500 MHz, CDCl3) δ 5.37–5.34 (m, 0.88 H) 5.19–5.15 (m, 0.79 H) 4.32–4.12 (m, 
6 H) 3.04–2.94 (m, 1 H) 2.59 (dd, J = 12.0, 9.1 Hz, 1 H) 2.52 (dd, J = 14.5, 2.7 Hz, 1 H) 
2.33–2.15 (m, 8 H) 1.32–1.20 (m, 9 H); 13C NMR (500 MHz, CDCl3) δ 201.30, 201.18, 
169.21, 168.82, 168.26, 147.81, 109.94, 62.22, 61.71, 61.56, 59.46, 37.02, 36.60, 34.17, 
28.59, 28.40, 14.04, 13.96, 13.88. IR (film) 2981, 2933, 2905, 1726, 1725, 1445 cm-1; 
HRMS (ESI+ TOF) m/z: [M + Na+]+ calcd for C20H28O8 419.1676; found 419.1662 
[M+Na+]+. 
Preparation and Characterization of Deuterium Labeled Products 
 
Diethyl 2-((2-methylene-3,3-diphenylcyclobutyl)methyl-d)malonate (3-14) The title 
compound was prepared from (Z)-3,3-diphenylhexa-1,5-dien-2-yl-6-d 
trifluoromethanesulfonate (3-13) (7.39 mmol, 2.817 g) and diethyl malonate (37 mmol, 
5.6 mL), Pd(OAc)2 (0.30 mmol, 66 mg), Tris(2,4-di-tert-butylphenyl)phosphite (0.44 mmol, 
0.287 g), lithium tert-butoxide (37 mmol, 3.00 g) using General Procedure A. The crude 
material was purified via column chromatography on silica gel using 95:5 hexanes:ethyl 
acetate as the eluent. Excess diethyl malonate was removed by distillation under vacuum 
at 95 °C. This procedure afforded 1.7969 g (62%) of the title compound as a yellow oil. 
1H NMR (500 MHz, CDCl3) δ 7.40–7.14 (m, 10 H) 5.20–5.15 (m, 1 H) 5.07–5.00 (m, 1 H) 
4.24–4.13 (m, 4 H) 3.37 (d, J = 8.0 Hz, 1 H) 2.98–2.88 (m, 1 H) 2.76 (dd, J = 10.5, 8.9 
Hz, 1 H) 2.51 (dd, J = 10.6, 8.6 Hz, 1 H) 2.33 (dd, J = 8.0, 5.2 Hz, 1 H) 1.31–1.19 (m, 6 
H); 13C NMR (126 MHz, CDCl3) δ 169.43, 169.18, 158.35, 146.30, 146.19, 128.24, 
128.21, 128.10, 127.58, 127.25, 126.15, 125.92, 106.75, 61.45, 61.42, 58.40, 49.93, 
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38.71, 37.98, 31.94 (t, JCD = 19.7 Hz), 14.05, 14.01; IR (film) 3056, 2981, 2937, 2180–
1885, 1749, 1731, 1669, 1598, 1491, 1445; HRMS (ESI+ TOF) m/z: [M + Na+]+ calcd for 
C25H27DO4 416.1943; found 416.1937. 
 
Diethyl 2-((1S,5S)-3,3-dimethyl-4-methylenecyclopentyl-5-d)malonate (3-17) The 
title compound was prepared from (Z)-3,3-dimethylhexa-1,5-dien-2-yl-6-d 
trifluoromethanesulfonate (3-16)  (0.08 mmol, 20 mg), diethyl malonate (0.16 mmol, 24 
μL), Pd(OAc)2 (0.003 mmol, 0.7 mg), 1,2-Bis(diphenylphosphino)benzene (0.0047 mmol, 
2.1 mg), lithium tert-butoxide (0.16 mmol, 13 mg) using General Procedure B. The crude 
material was purified via column chromatography on silica gel using 98:2 hexanes:ethyl 
acetate as the eluent. This procedure afforded 16.2 mg (75%) of the title compound as a 
colorless oil. 
1H NMR (700 MHz, CDCl3) δ 4.81–4.78 (m, 1 H) 4.77–4.72 (m, 1 H) 4.20 (q, J = 7.1 Hz, 
4 H) 3.16 (d, J = 9.5 Hz, 1 H) 2.71–2.62 (m, 2 H) 1.78 (ddd, J = 12.3, 5.6, 2.5 Hz, 1 H) 
1.30–1.28 (m, 1 H) 1.28–1.24 (m, 6 H) 1.12 (s, 3 H) 1.05 (s, 3 H); 13C NMR (176 MHz, 
CDCl3) δ 168.81, 168.78, 159.79, 103.79, 61.26, 61.22, 57.37, 46.53, 41.83, 37.78 
(t, JCD = 19.4 Hz), 35.83, 29.74, 28.72, 14.10; IR (film) 2970, 2957, 2932, 2865, 1741, 
1732, 1653, 1463 cm-1; HRMS (ESI+ TOF) m/z: [M + Na+]+ calcd for C15H23DO4 292.1630; 
found 292.1622. 
 
Preparation and Characterization of Cyclized Product 
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Diethyl 2-((2-oxo-3,3-diphenylcyclobutyl)methyl)malonate (3-S31) A vacuum flame-
dried flask equipped with a stir bar was cooled under a stream of nitrogen and charged 
with diethyl 2-((2-methylene-3,3-diphenylcyclobutyl)methyl)malonate (3-6b)  (16.2 
mmol, 6.39 g, 1 equiv) dissolved in DCM (150 mL, 0.11 M). The reaction flask was cooled 
to -78 °C. Ozone was bubbled through the reaction until the solution turned a dark blue 
color. Nitrogen gas was then bubbled through the solution to remove excess ozone. An 
excess of dimethyl sulfide was added to the flask and the reaction was stirred at -78 °C 
for an additional hour. The reaction was warmed to rt and stirred overnight (15 h). The 
solvents were removed under vacuum without additional work up. The crude material was 
purified via column chromatography on silica gel using 49:49:1 hexanes:DCM:ethyl 
acetate as the eluent. This procedure afforded 1.28 g (20%) of the title compound as a 
yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.40–7.14 (m, 10 H) 4.26–4.09 (m, 4 H) 3.55 (dd, J = 8.2, 
6.8 Hz, 1 H) 3.50–3.39 (m, 1 H) 3.10 (t, J = 10.9 Hz, 1 H) 2.48 (dd, J = 11.2, 8.7 Hz, 1 H) 
2.35 (dt, J = 14.0, 6.9 Hz, 1 H) 2.14 (dt, J = 14.0, 8.3 Hz, 1 H) 1.31–1.19 (m, 6 H). 
 
Diethyl 2-((2-hydroxy-3,3-diphenylcyclobutyl)methyl)malonate (3-S32) A vacuum 
flame-dried flask equipped with a stir bar was cooled under a stream of nitrogen and 
charged with diethyl 2-((2-oxo-3,3-diphenylcyclobutyl)methyl)malonate (3-S31)  
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(3.24 mmol, 1.278 g, 1 equiv) dissolved in methanol (30 mL, 0.1 M). The reaction was 
stirred rapidly and sodium borohydride (3.5 mmol, 131mg, 1.05 equiv) was added in 
portions over 30 seconds at rt. The reaction was stirred at rt for 7 min. The reaction 
mixture was slowly quenched with aqueous ammonium chloride (30 mL). The mixture 
was stirred briefly then methanol was removed under vacuum. The solution was 
transferred to a separatory funnel. The aqueous layer was extracted with DCM (3 x 20 
mL). The combined organic layers were washed with brine, dried over MgSO4, filtered 
and concentrated in vacuo to yield a colorless oil. The crude material was judged to be 
obtained in sufficient purity to continue without further purification. This procedure 
afforded 1.23 g (96%) of the title compound as a colorless oil. The reported peaks are for 
an unassigned mixture of 3:2 diastereomers. 
1H NMR (401 MHz, CDCl3) δ 7.42–7.10 (m, 10 H) 4.99 (td, J = 5.5, 3.4 Hz, 0.37 H) 4.38 
(dd, J = 11.4, 7.4 Hz, 0.63 H) 4.25–4.09 (m, 4 H) 3.48–3.33 (m, 1 H) 3.03 (dd, J = 11.7, 
7.6 Hz, 0.62 H) 2.79 (dd, J = 11.2, 9.0 Hz, 0.42 H) 2.64 (ddd, J = 11.3, 8.0, 3.3 Hz, 0.43 
H) 2.44 (ddd, J = 13.3, 8.9, 6.7 Hz, 0.45 H) 2.25–2.04 (m, 2.58 H) 1.93 (dt, J = 13.8, 6.8 
Hz, 0.45 H) 1.64 (dd, J = 11.7, 9.7 Hz, 0.70 H) 1.58–1.54 (m, 0.74 H) 1.31–1.18 (m, 6 H). 
 
Diethyl 8,8-diphenyl-2-oxabicyclo[4.2.0]octane-4,4-dicarboxylate (3-S33) A vacuum 
flame-dried flask equipped with a stir bar was cooled under a stream of nitrogen and 
charged with diethyl 2-((2-hydroxy-3,3-diphenylcyclobutyl)methyl)malonate (3-S32) 
(3.1 mmol, 1.23 g, 1 equiv) dissolved in DMF (4 mL, 0.75 M). Diiodomethane (3.63 mmol, 
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300 μL, 1.1 equiv) was added to the flask. Sodium hydride (95%, 7.26 mmol, 175 mg, 2.2 
equiv) was added to the flask. The reaction was stirred at 80 °C overnight (15 h). The 
reaction mixture was quenched with aqueous ammonium chloride (5 mL). The solution 
was transferred to a separatory funnel. The aqueous layer was extracted with ethyl 
acetate (3 x 10 mL). The combined organic layers were washed with water (3 x 15 mL), 
brine, dried over MgSO4, filtered and concentrated in vacuo to yield a colorless oil. The 
crude material was purified via column chromatography on silica gel using 95: 5 
hexanes:ethyl acetate as the eluent. Further purification was required, and the title 
compound was further purified via column chromatography on silica gel using 35:64:1 
DCM:hexanes:ethyl acetate as the eluent. This procedure afforded 94 mg (7%) of the title 
compound as a colorless oil.  
1H NMR (700 MHz, CDCl3) δ 7.49 (d, J = 7.6 Hz, 2 H) 7.33 (t, J = 7.8 Hz, 2 H) 7.27–7.17 
(m, 5 H) 7.15–7.10 (m, 1 H) 6.20–6.15 (m, 1 H) 5.98 (dd, J = 6.3, 3.5 Hz, 1 H) 5.56–5.51 
(m, 1 H) 4.19 (q, J = 7.1 Hz, 2 H) 4.12–4.01 (m, 2 H) 2.93 (dd, J = 10.8, 9.4 Hz, 1 H) 2.90–
2.84 (m, 1 H) 2.72 (ddd, J = 11.1, 7.7, 3.5 Hz, 1 H) 2.61 (ddd, J = 14.8, 6.8, 1.2 Hz, 1 H) 
2.47 (dd, J = 14.8, 8.2 Hz, 1 H) 1.28 (t, J = 7.1 Hz, 3 H) 1.17 (t, J = 7.1 Hz, 3 H); 13C NMR 
(176 MHz, CDCl3) δ 166.91, 154.82, 146.45, 143.13, 138.44, 128.60, 128.00, 127.46, 
126.73, 126.22, 126.01, 125.58, 80.88, 63.98, 60.67, 54.35, 36.61, 33.27, 31.18, 14.19, 
14.18; IR (film) 2980, 2925, 2850, 1739, 1716, 1626, 1598, 1494, 1450 cm-1; HRMS (ESI+ 
TOF) m/z: [M + H+]+ calcd for C25H28O5 426.2275; found 426.2268. 
 
Preparation and Characterization of Cyclized Deuterium-Labeled Product 
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Diethyl 2-((2-oxo-3,3-diphenylcyclobutyl)methyl-d)malonate (3-S34) A vacuum 
flame-dried flask equipped with a stir bar was cooled under a stream of nitrogen and 
charged with diethyl 2-((2-methylene-3,3-diphenylcyclobutyl)methyl-d)malonate (3-
14) (4.57 mmol, 1.796 g, 1 equiv) dissolved in DCM (45 mL, 0.1 M). The reaction flask 
was cooled to -78 °C. Ozone was bubbled through the reaction until the solution turned a 
dark blue color. Nitrogen gas was then bubbled through the solution to remove excess 
ozone. An excess of dimethyl sulfide was added to the flask and the reaction was stirred 
at -78 °C for an additional hour. The reaction was warmed to rt and stirred overnight (15 
h). The solvents were removed under vacuum without additional work up. The crude 
material was purified via column chromatography on silica gel using 49:49:1 
hexanes:DCM:ethyl acetate as the eluent. This procedure afforded 0.367 g (20%) of the 
title compound as a yellow oil. 
1H NMR (500 MHz, CDCl3) δ 7.39–7.26 (m, 8 H) 7.25–7.15 (m, 2 H) 4.25–4.12 (m, 4 H) 
3.54 (d, J = 6.7 Hz, 1 H) 3.48–3.41 (m, 1 H) 3.15–3.05 (m, 1 H) 2.48 (dd, J = 11.3, 8.8 
Hz, 1 H) 2.33 (t, J = 7.0 Hz, 1 H) 1.30–1.22 (m, 6 H). 
 
Diethyl 2-((2-hydroxy-3,3-diphenylcyclobutyl)methyl-d)malonate (3-S35) A vacuum 
flame-dried flask equipped with a stir bar was cooled under a stream of nitrogen and 
charged with diethyl 2-((2-oxo-3,3-diphenylcyclobutyl)methyl-d)malonate (3-S34)  
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(0.93 mmol, 0.367 g, 1 equiv) dissolved in methanol (10 mL, 0.1 M). The reaction was 
stirred rapidly and sodium borohydride (0.974 mmol, 37mg, 1.05 equiv) was added in 
portions over 30 seconds at rt. The reaction was stirred at rt for 7 min. The reaction 
mixture was slowly quenched with aqueous ammonium chloride (10 mL). The mixture 
was stirred briefly then methanol was removed under vacuum. The solution was 
transferred to a separatory funnel. The aqueous layer was extracted with DCM (3 x 20 
mL). The combined organic layers were washed with brine, dried over MgSO4, filtered 
and concentrated in vacuo to yield a colorless oil. The crude material was judged to be 
obtained in sufficient purity to continue without further purification. This procedure 
afforded 0.356 g (97%) of the title compound as a colorless oil. The reported peaks are 
for an unassigned mixture of 3:2 diastereomers. 
NMR (500 MHz, CDCl3) δ 7.42–7.07 (m, 10 H) 4.99 (td, J = 5.5, 3.3 Hz, 0.35 H) 4.38 
(dd, J = 11.3, 8.2 Hz, 0.56 H) 4.26–4.12 (m, 4 H) 3.42 (d, J = 7.0 Hz, 0.50 H) 3.37 (d, J = 
7.6 Hz, 0.36 H) 3.03 (dd, J = 11.6, 8.4 Hz, 0.58 H) 2.79 (dd, J = 11.2, 8.9 Hz, 0.41 H) 2.64 
(ddd, J = 11.3, 8.1, 3.3 Hz, 0.40 H) 2.43 (qd, J = 8.5, 5.9 Hz, 0.38 H) 2.21–2.06 (m, 1.84 
H) 1.64 (dd, J = 11.7, 10.3 Hz, 0.62 H) 1.59–1.55 (m, 0.76 H) 1.29–1.18 (m, 6 H). 
 
Diethyl (1S,5S,6R)-8,8-diphenyl-2-oxabicyclo[4.2.0]octane-4,4-dicarboxylate-5-d (3-
15) A vacuum flame-dried flask equipped with a stir bar was cooled under a stream of 
nitrogen and charged with diethyl 2-((2-hydroxy-3,3-diphenylcyclobutyl)methyl-
d)malonate (3-S35)  (0.87 mmol, 0.35 g, 1 equiv) dissolved in DMF (1.5 mL, 0.5 M). 
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Diiodomethane (0.96 mmol, 78 μL, 1.1 equiv) was added to the flask. Sodium hydride 
(95%, 1.92 mmol, 46 mg, 2.2 equiv) was added to the flask. The reaction was stirred at 
80 °C overnight (15 h). The reaction mixture was quenched with aqueous ammonium 
chloride (5 mL). The solution was transferred to a separatory funnel. The aqueous layer 
was extracted with ethyl acetate (3 x 5 mL). The combined organic layers were washed 
with water (3 x 10 mL), brine, dried over MgSO4, filtered and concentrated in vacuo to 
yield a yellow oil. The crude material was purified via column chromatography on silica 
gel using 95:5 hexanes:ethyl acetate as the eluent. Further purification was required and 
the title compound was purified via column chromatography on silica gel using 35:64:1 
DCM:hexanes:ethyl acetate as the eluent. This procedure afforded 34 mg (10%) of the 
title compound as a colorless oil.  
1H NMR (700 MHz, CDCl3) δ 7.48 (d, J = 7.8 Hz, 2 H) 7.32 (t, J = 7.6 Hz, 2 H) 7.25–7.21 
(m, 2 H) 7.22–7.17 (m, 3 H) 7.12 (t, J = 7.0 Hz, 1 H) 6.17–6.14 (m, 1 H) 5.96 (dd, J = 6.5, 
3.5 Hz, 1 H) 5.53 (m, 1 H) 4.18 (q, J = 7.1 Hz, 2 H) 4.10–4.00 (m, 2 H) 2.95–2.88 (m, 1 
H) 2.88–2.81 (m, 1 H) 2.70 (ddd, J = 11.2, 7.7, 3.5 Hz, 1 H) 2.57 (d, J = 6.8 Hz, 1 H) 1.28 
(t, J = 7.0 Hz, 3 H) 1.16 (t, J = 7.1 Hz, 3 H); 13C NMR (176 MHz, CDCl3) δ 166.91, 154.81, 
146.44, 143.10, 138.38, 128.58, 127.98, 127.45, 126.72, 126.19, 125.99, 125.61, 80.88, 
63.97, 60.66, 54.33, 36.53, 33.18, 30.82 (t, JCD = 19.4 Hz), 14.18, 14.17; IR (film) 2980, 
2924, 2850, 1740, 1714, 1627, 1597, 1494, 1447 cm-1; HRMS (ESI+ TOF) m/z: [M + H+]+ 
calcd for C25H27DO5 427.2338; found 427.2328. 
 
Deprotection of Acetal Products 
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Diethyl 2-((2-methylene-3-oxocyclobutyl)methyl)malonate (3-S36) A vacuum flame-
dried flask equipped with a stir bar was cooled under a stream of nitrogen and charged 
with pyridinium p-toluenesulfonate (0.17 mmol, 42.7 mg, 1 equiv). Diethyl 2-((3,3-
dimethoxy-2-methylenecyclobutyl)methyl)malonate (3-6c) (0.17 mmol, 50 mg, 1 
equiv) was dissolved in THF (1 mL, 0.1 M) and water (1 mL, 0.1 M) and added to the 
flask. The reaction was heated to 50 °C and stirred overnight (15 h). The reaction was 
cooled to rt then transferred to a separatory funnel. The layers were separated, and the 
aqueous layer was extracted with diethyl ether (3 x 1 mL). The combined organic layers 
were washed with brine, dried over MgSO4, filtered and concentrated in vacuo to yield a 
yellow oil. The crude material was purified via column chromatography on silica gel using 
95:5 hexanes:ethyl acetate as the eluent. This procedure afforded 20 mg (47%) of the 
title compound as a light yellow oil. 
1H NMR (700 MHz, CDCl3) δ 5.76 (dd, J = 2.8, 1.1 Hz, 1 H) 5.16 (dd, J = 2.4, 1.1 Hz, 1 
H) 4.24–4.15 (m, 4 H) 3.40 (t, J = 7.6 Hz, 1 H) 3.12 (dd, J = 17.5, 9.0 Hz, 1 H) 2.98 
(dqt, J = 8.8, 6.2, 3.1 Hz, 1 H) 2.62 (dd, J = 17.5, 5.9 Hz, 1 H) 2.31 (ddd, J = 14.0, 7.5, 
6.6 Hz, 1 H) 2.15 (ddd, J = 14.0, 9.1, 7.7 Hz, 1 H) 1.29–1.20 (m, 6 H); 13C NMR (176 MHz, 
CDCl3) δ 197.83, 168.96, 168.80, 157.70, 113.02, 61.65, 50.56, 50.53, 33.37, 33.10, 
14.04; IR (film) 2981, 2921, 2849, 1735, 1726, 1654, 1450, 1444; HRMS (ESI+ TOF) m/z: 
[M + Na+]+ calcd for C13H18O5 277.1046; found 277.1041. 
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Diethyl 2-(3-methylene-4-oxocyclopentyl)malonate (3-S37) A vacuum flame-dried 
flask equipped with a stir bar was cooled under a stream of nitrogen and charged with 
pyridinium p-toluenesulfonate (0.06 mmol, 15.1 mg, 1 equiv). diethyl 2-(3,3-dimethoxy-
4-methylenecyclopentyl)malonate (3-7c) (0.06 mmol, 17.9 mg, 1 equiv) was dissolved 
in THF (0.6 mL, 0.1 M) and water (0.6 mL, 0.1 M) and added to the flask. The reaction 
was heated to 50 °C and stirred overnight (15 h). The reaction was cooled to rt then 
transferred to a separatory funnel. The layers were separated, and the aqueous layer was 
extracted with diethyl ether (3 x 1 mL). The combined organic layers were washed with 
brine, dried over MgSO4, filtered and concentrated in vacuo to yield a yellow oil. The 
crude material was purified via column chromatography on silica gel using 95:5 
hexanes:ethyl acetate as the eluent. This procedure afforded 12.1 mg (80%) of the title 
compound as a light yellow oil. 
1H NMR (500 MHz, CDCl3) δ 6.05–5.97 (m, 1 H) 5.39–5.29 (m, 1 H) 4.28–4.15 (m, 4 H) 
3.35 (d, J = 9.0 Hz, 1 H) 2.96 (dd, J = 16.3, 7.2 Hz, 1 H) 2.93–2.81 (m, 1 H) 2.62 (dd, J = 
18.2, 7.7 Hz, 1 H) 2.47 (ddt, J = 15.8, 9.1, 3.0 Hz, 1 H) 2.24 (dd, J = 18.2, 9.8 Hz, 1 H) 
1.34–1.23 (m, 6 H); 13C NMR (126 MHz, CDCl3) δ 204.34, 168.02, 167.96, 143.46, 
117.90, 61.64, 61.63, 56.39, 42.75, 34.26, 33.10, 14.07, 14.05; IR (film) 2986, 2916, 
2847, 1741, 1725, 1641 cm-1; HRMS (ESI+ TOF) m/z: [M + Na+]+ calcd for C13H18O5 
277.1046; found 277.1042. 
3.12 Assignment of Relative Stereochemistry 
The relative stereochemistry of products 3-7d, 3-17, 3-S24, 3-S25, 3-S28, 3-S29, 3-S33, 
3-15, was assigned on the basis of 1H NMR nOe studies along with J coupling constant 
values. The data for these studies is provided below, along with the key nOe signals. The 
relative stereochemistry of all other products was assigned based on analogy to 3-S24, 
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3-S25, 3-S28, 3-S29. The red arrows are for strong nOe correlations and the blue arrows 
are for lesser nOe correlations. 
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Chapter 4  
Preliminary Results of Palladium-Catalyzed Alkene Difunctionalization Reactions 
 
4.1 Introduction to Dihydrobenzofurans 
Dihydrobenzofurans and benzofurans are prominent structures in natural products 
exhibiting biological activity.1 Transition metal induced cyclizations of o-allyl phenols for 
the synthesis of dihydrobenzofurans has been known since 1976. Hosokawa and co-
workers demonstrated the oxidative cyclization of 4-1 to 4-2 via palladium(II) (eq 4-1).2 
Since then, there has been substantial interest in the cyclizations of phenols to yield 
dihydrobenzofuran products.3 In general, the most common approach has been a 
transition metal-catalyzed strategy. A shown in Scheme 4-1, several different 
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functionalization possibilities exist after the first oxy-palladation step. Similar to 
Hosokawa, following oxy-palladation, the palladium(II) intermediate may undergo beta-
hydride elimination. Tietze and co-workers reported the Pd-alkyl intermediate after oxy-
palladation being trapped by carbon monoxide or methyl acrylate;  however, they biased 
the system by eliminating the possibility of beta-hydride elimination as to allow for  
nucleophilic capture or alkene insertion.4  
Another common strategy used to target dihydrobenzofurans via a transition metal-
catalytic cyclization is to utilize allylic phenyl ethers. In general, these methods involve a 
key migratory insertion event where the transition metal inserts itself into the coordinating 
olefin. Geng and co-workers report a nickel-catalyzed cyclization where they capture the 
Pd-alkyl intermediate arising from migratory insertion with carbon monoxide. A 
subsequent reductive elimination gives the product seen in eq 4-2.5 Carral-Menoyo and 
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co-workers report a cobalt-catalyzed cyclization utilizing an amide directing group to 
facilitate C-H activation. From the Co-aryl intermediate, the migratory insertion into the 
1,1 substituted olefin takes place and subsequent protonation of the metal-alkyl 
intermediate yields the product shown in eq 4-3.6 Lastly, Zhang and co-workers report an 
enantioselective Pd-cyclization where the iodine from oxidative addition returns to 
undergo the reductive elimination and form a new alkyl-halogen bond (eq 4-4). This 
transformation uses the chiral ligand L4-1 to impart the desired enantioselectivity through 
the migratory insertion step.7 
The work described in this chapter is comprised of both the author’s (ECB), Alan 
Wortman’s (AW), Chen Lei’s (CL), and Jim Shepich III’s (JS3) contributions. AW 
conducted reaction optimization (Table 4-1, Entry 2-17). CL conducted reaction 
optimization (Table 4-2) and assembly of preliminary substrate scope (Scheme 4-4). JS3 
conducted reaction optimization (Table 4-3, Table 4-4) and ran recrystallization 
purifications (eq 4-10, eq 4-11) We have decided to include AW’s, CL’s, and JS3’s results 
in this dissertation because they were in close mentorship by the author, and we wished 
to give the reader the full story about these transformations. 
4.2 Preliminary Results for the Construction of Dihydrobenzofurans 
Due to the abundance of dihydrobenzofurans in natural products, we sought to adapt 
our chemistry to target functionalized dihydrobenzofurans. As shown in Scheme 4-2 we 
reasoned we could substitute in a heteroatom (oxygen) for the methylene spacer in our 
2-allylphenyl triflate substrate to make a vinyl ether aryl triflate (4-1). We hypothesized 
our vinyl ether could participate in our Pd-catalyzed alkene difunctionalization reactions 
with exogenous nucleophiles to form functionalized dihydrobenzofurans (4-2). Our 
strategy is fundamentally different than those described previously. Instead of targeting a 
 238 
key migratory insertion step, our fundamental step would be an attack of the coordinated 
alkene by an exogenous nucleophile (4-3).  This new methodology would readily access 
new functionalizations of dihydrobenzofurans than have been previously reported.  
The starting substrate vinyl ether aryl triflate (4-1) can be made in two simple steps. 
As shown in eq 4-5, treating benzo-1,4-dioxane with nBuLi gave 55% yield of the ring 
opened phenol.  Subsequent triflation with Tf2O in DCM (eq 4-6) yielded 71% of our 
desired starting material.  
We set out to optimize the desired reaction. During optimization it was discovered the 
reaction is air and/or moisture sensitive. Reaction screens conducted in our typical Teflon-
coated 4 mL screw cap vials yielded only unreacted starting material regardless of 
reaction conditions. Once this was known, screens were conducted in Schlenk tubes 
under a nitrogen atmosphere and the desired product was observed. Table 4-1 details a 
selection of our preliminary reaction screens. Entry 1 shows the first successful product 
formation. With Pd(OAc)2, ligand P(cy)3HBF4, and LiOtBu in Toluene, 4-1 was coupled 
with diethyl malonate to provide 4-4 in 27% isolated yield. Ligand screens (Entry 2-9) 
proved unfruitful until Brettphos exhibited promising reactivity (Entry 10). A brief screen 
of palladium pre-catalysts gave similar reactivity to Pd(OAc)2 without showing drastic 
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improvement (Entry11-13). Switching bases away from LiOtBu inhibited the desired 
reactivity (Entry 14-15). Interestingly, reducing the time and temperature of the reaction 
allowed for similar conversion as Entry 10, however, with the remaining starting material 
4-1 present in the crude reaction the potential exists to increase overall isolated yields 
(Entry 17). Additional reaction conditions have been investigated; however, the conditions 
were screened outside of Schlenk conditions and such conditions should be revisited.   
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4.3 Introduction to Palladium-Catalyzed Alkene Difunctionalization Reactions with 
Exogenous Nitrile Nucleophiles 
The use of nitriles as coupling partners in Pd-catalyzed reactions has been 
demonstrated by several groups.8 Notably, Hartwig’s group reports the α-arylation of 
nitriles.8a Hartwig proposes the mechanism of α-arylation of nitriles to go through an inner 
sphere mechanism where the nitrile carbanion is bound to the metal before reductive 
elimination (Scheme 4-3).8b Following after Hartwig’s reports, other groups have used 
carbanions arising from nitriles in palladium couplings.  Notably, in these reports, the 
nitrile carbanion functions in an analogous inter sphere fashion as described by 
Hartwig.8d-f In these reports, more substituted nitriles are more successful coupling 
partners.  
4.4 Preliminary Results for the Expansion of Nitrile Nucleophiles in Pd-Catalyzed 
Alkene Difunctionalization Reactions 
Our group has reported Pd-catalyzed alkene difunctionalization reactions with 
nitrogen,9 oxygen,10 indole,11 and carbon (enolate)12 exogenous nucleophiles. In our 
latest publication, we reported the coupling of aryl and alkenyl triflates with ethyl 
cyanoacetate (eq 4-6, eq 4-7). Under the standard reaction conditions described in the 
article the coupling with ethyl cyanoacetate was not observed. Changing the pre-catalyst 
and base to (BrettPhos)Pd(allyl)(Cl) and Cs2CO3 respectively was crucial to obtaining the 
 241 
desired reactivity. Interestingly, in our case, the nitrile carbanion presumably reacts 
through an outer sphere attack of the coordinated alkene. With these primary results in 
hand, we sought to increase the scope of nitriles that participate in our alkene 
difunctionalization reactions.  
It was quickly determined through rapid screening of reaction conditions that the use 
of (BrettPhos)Pd(allyl)(Cl) as the precatalyst was essential for any desired reactivity. 
Once (BrettPhos)Pd(allyl)(Cl) was confirmed as the most effective catalyst, a variety of 
nitrile nucleophiles were examined as coupling partners with 2-allyl phenol triflate 
(Scheme 4-4). In general, nitriles with higher substitution gave higher yields and worked 
well as coupling partners. While the crude reaction yield seemed promising, there was 
difficulty in the isolation of products and the isolated yield suffered. 4-6b and 4-6d were 
isolated in 31% and 54% yield, respectively. The products resulting from less substituted 
nitriles were isolated in 15% for 4-6c and 7% for 4-6e. Product 4-6e was isolated in a 
mixture of 2:1 diastereomers. Products 4-6f and 4-6g were only observed via NMR in 
extremely small quantities.  
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While screening reaction conditions, we observed unique and unexpected reactivity. 
As shown in (eq 4-8), when running a control experiment with no nucleophile, substrate 
4-5 presumably cyclized with itself to give the unexpected carbocycle product 4-9. The 
mechanism by which this product is formed is currently unclear. We briefly explored 
additional reactions with multiple equivalents of aryl triflates and no nucleophile present 
and observed a variety of cyclization products that were difficult to characterize and 
isolate. Additional screening and optimization is required to expand on this interesting 
result.  
We still strongly desired to use acetonitrile as a coupling partner due to its simplicity 
and potential for further functionalization. With our current catalyst conditions failing to 
couple acetonitrile, we shifted to a decarboxylation strategy. In 2011, Shang and co-
workers reported the decarboxylative coupling of cyanoacetate salts with aryl triflates (eq 
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4-9).13 We hypothesized we could take advantage of the same system for our cyclization. 
Unfortunately, as seen from select examples in Table 4-2, we did not observe any of the 
desired cyclization (4-6g) when utilizing the cyanoacetate potassium salt. We did observe 
and isolate the direct C-C coupling product with alkene isomerization (4-10) in relatively 
low yields. Additional strategies are needed to fully develop the alkene difunctionalization 
reactions with aryl and alkenyl triflates and nitrile nucleophiles.  
4.5 Preliminary Results for Regiodivergent Pd-Catalyzed Alkene 
Difunctionalization Reactions with Amine Nucleophiles 
As described in Chapter 3, we have developed a regiodivergent Pd-catalyzed alkene 
difunctionalization reaction with exogenous malonate nucleophiles for the construction of 
methylene cyclobutanes. Expanding the scope to nucleophiles other than malonates 
would greatly increase the overall utility of the reaction. Our group has previously reported 
successful reactions with exogenous nitrogen and oxygen nucleophiles and we hoped  to 
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leverage this experience to develop a natural extension of the regiodivergent chemistry 
with nitrogen and/or oxygen nucleophiles.9-10  
For our initial screens we elected to use substrate 4-11 due to its propensity to yield 
the cyclobutane product in the previous system and the observation that the cyclobutane 
product proved harder to select for in general. We began our nucleophilic scope 
expansion screens with pyrrolidine due to its abundance and success as a nucleophile in 
our palladium coupling chemistry. We sought to optimize reactions conditions to select 
for either the cyclobutane product (4-12a) or cyclopentane product (4-13a) by primarily 
changing the ligand. Table 4-3 details selected examples of our ligand screens. After 
screening over 40 different phosphorus ligands, a general trend was not easily detectable. 
However, as shown by Entry 1, when no ligand was employed the reaction gives 
approximately a 1:1 ratio of regioisomers clearly showing the ligand has an effect on the 
regioselectivity. Three ligands (Entry 4, Entry 9-10) gave selectivity for the methylene 
cyclobutane isomer and two ligands (Entry 11-12) gave selectivity for the methylene 
cyclopentane isomer. Entry 4 and Entry 12 gave gratifying results as the ligands gave 
similar regioselectivity trends with the previous malonate nucleophiles. Interestingly, 
RuPhos and BrettPhos (Entry 9 and Entry 11) gave opposite selectivities even though 
they are structurally and electronically similar. Attempts to isolate the mixture of regiomers 
was met with limited success and significant impurities remained after isolation by column 
chromatography.  
Due to limited success in purification, we sought alternative methods to isolate product 
4-12a and 4-12b. We envisioned a protonation strategy where the pyrrolidine would be 
protonated with an organic salt, the resulting solid isolated, and then the organic salt 
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recrystallized to yield the desired products. To this end, we subjected the products 
isolated from Entry 11 to tosic acid and isolated the resultant organic salt. After a 
subsequent recrystallization and base wash, we were overjoyed to isolate the pyrrolidine 
functionalized methylene cyclopentane product 4-13a cleanly (eq 4-10) in overall 10% 
yield in 97% regioselectivity. We repeated this method for the mixture of regiomers from 
Entry 10 and isolated the functionalized methylene cyclobutane product 4-12a as well (eq 
4-11) in overall 20% yield in 97% regioselectivity. The overall yield of these reactions 
needs improvement; however, the clean isolation of each regioisomer is encouraging. 
Additional organic acids and recrystallization methods should be screened to obtain 
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higher overall yields. The recrystallization seems to purify the major isomer for each 
reaction. It is unclear at this point what the minimum ratio needed separate the 
regioisomers by recrystallization.  
After we obtained relatively good selectivity of each regioisomer and developed an 
isolation technique for each regioisomer by recrystallization (12a and 13a), we started to 
examine the amine scope. We started reaction screens with analogous reaction 
conditions that achieved high selectivities for the pyrrolidine nucleophile. We started with 
two ligands that selected highly for the cyclobutane regioisomer 4-12 (RuPhos and 
P(tBu)3HBF4) and two ligands that selected highly for the cyclopentane regioisomer 4-13 
(BrettPhos and dppBz).  Unfortunately, it quickly became clear additional optimization 
was required, including potentially another ligand screen. As shown in Table 4-4 a variety 
of amines have been screened against our chosen ligands. No desired reaction occurred 
when aniline was used as the exogenous coupling partner amine (Entry 1-2). 
Diethylamine did not select for the cyclobutane, but the β-hydride elimination product 4-
14 was observed (Entry 3). Diethylamine did show promise in selecting for the 
cylcopentane isomer, however the NMR yield was low (Entry 4-5). Surprisingly, when 
employing dppBz as the ligand to select for the 5-membered ring, we observed the 
formation of the 4-membered ring and 4-14 (Entry 6). Butylamine gave modest selectivity 
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for each regioisomer (Entry 7-10) and Boc-protected butylamine resulted in 
decomposition of the starting material (Entry 11-12). Butylamine seemed to have potential 
for further optimization and switching the base to Cs2CO3 gave drastically different results. 
Changing the palladium source in addition to the base gave increased regioselectivities 
and NMR yields. Additional optimization is required to fully expand the nitrogen 
nucleophile scope of this reaction.  
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4.6 Conclusion 
In this chapter we have provided early data for three unique Pd-catalyzed alkene 
difunctionalization projects that show early promise. The construction of 
dihydrobenzofurans, the expansion of carbon nucleophile scope with nitrile carbanions, 
and expansion of amine nucleophile scope in our regiodivergent cyclization will increase 
access to complex products that would be challenging to make with other methods.  
4.7 Experimental 
General Considerations: All reactions were carried out under a nitrogen atmosphere in 
vacuum and flame-dried glassware. All reagents, palladium precatalysts, and ligands 
were purchased from commercial sources and were used without purification unless 
otherwise noted. The substrates 4-5,9a 4-7,9a 4-11,3.11 Experimental and N-(2-
pyridyl)triflimide14 were prepared by previously published methods. Alkenyl triflate starting 
materials were stored in a freezer under nitrogen. Bulk quantities of cesium carbonate, 
lithium tert-butoxide, and lithium hexamethyldisilazide were stored in nitrogen-filled glove 
box and small amounts were removed within a few days of use. Toluene, tetrahydrofuran, 
dichloromethane, and diethyl ether were purified using a GlassContour solvent 
purification system. Anhydrous 1,4 dioxane was purchased from Sigma-Aldrich and was 
used without purification. Structural and stereochemical assignments were made on the 
basis of 2-D COSY. Ratios of diastereomers were determined by 1H NMR analysis. Yields 
refer to isolated yields of compounds estimated to be ≥95% pure as determined by 1H 
NMR analysis unless otherwise noted.  
Preparation and Characterization of Substrates 
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2-(vinyloxy)phenyl trifluoromethanesulfonate (4-1) A vacuum flame-dried flask 
equipped with a stir bar was cooled under a stream of nitrogen and charged with 2-
(vinyloxy)phenol (5 mmol, 0.68 g, 1 equiv) dissolved in DCM (10 mL, 0.5 M). Pyridine (6 
mmol, 485 μL, 1.2 equiv) was added to the flask. The reaction was cooled to 0 °C. Triflic 
anhydride (5.5 mmol, 925 μL, 1.1 equiv) was added to the flask and the reaction warmed 
to rt and allowed to react overnight (15 h). The reaction was quenched with aqueous 
ammonium chloride (15 mL). The mixture was stirred briefly then transferred to a 
separatory funnel. The layers were separated, and the aqueous layer was extracted with 
diethyl ether (3 x 10 mL). The combined organic layers were washed with brine, dried 
over MgSO4, filtered and concentrated in vacuo to yield a yellow oil. The crude material 
was purified via column chromatography on silica gel using 98:2 -> 95:5 hexanes:ethyl 
acetate as the eluent. This procedure afforded 0.74 g (55%) of the title compound as a 
yellow oil. 
1H NMR (401 MHz, CDCl3) δ 7.39–7.25 (m, 2 H) 7.19–7.09 (m, 2 H) 6.69–6.55 (m, 1 H) 
4.95–4.83 (m, 1 H) 4.60 (dd, J = 6.0, 2.1 Hz, 1 H). 
Preparation and Characterization of Products 
 
diethyl 2-(2,3-dihydrobenzofuran-2-yl)malonate (4-4) A vacuum and flame-dried 10 
mL Schlenk tube equipped with a stir bar was cooled under a stream of nitrogen and 
charged with Pd(OAc)2 (0.008 mmol, 1.8 mg, 0.04 equiv), P(cy)3HBF4 (0.012 mmol, 4.4 
mg, 0.06 equiv), and lithium tert-butoxide (0.28 mmol, 22.4 mg, 1.4 equiv). The Schlenk 
tube was evacuated and refilled with N2 twice. 4-1 (0.2 mmol, 53.6 mg, 1.0 equiv) was 
weighed in a dram vial and diluted with toluene (1 mL, 0.2M). This mixture was added to 
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the Schlenk tube and diethyl malonate (0.24 mmol, 37 μL 1.2 equiv) was added. Toluene 
(1 mL, 0.2M) was used to rinse the dram vial and the solution was transferred to the 
Schlenk tube. The Schlenk tube was then heated to 95 °C with stirring overnight until the 
starting material had been consumed. The mixture was then cooled to rt and quenched 
with saturated aqueous ammonium chloride (2 mL). The aqueous layer was extracted 
with ethyl acetate (3 x 1 mL), dried over MgSO4, filtered and concentrated in vacuo. The 
crude product was purified via flash chromatography on silica gel using 50:50 
DCM:hexanes as the eluent. This procedure afforded 15 mg (27%) of the title compound 
as a yellow oil.  
1H NMR (500 MHz, CDCl3) δ 7.16 (d, J = 7.3 Hz, 1 H) 7.10 (t, J = 7.7 Hz, 1 H) 6.85 (t, J = 
7.4 Hz, 1 H) 6.77 (d, J = 8.0 Hz, 1 H) 5.33 (td, J = 9.0, 6.6 Hz, 1 H) 4.34–4.11 (m, 4 H) 
3.74 (d, J = 8.8 Hz, 1 H) 3.47 (dd, J = 16.1, 9.3 Hz, 1 H) 3.12 (dd, J = 16.0, 6.6 Hz, 1 H) 
1.32–1.21 (m, 6 H). 
General Procedure for Palladium-Catalyzed Alkene Difunctionalizations with Nitrile 
Nucleophiles, General Procedure A 
 A vacuum and flame-dried 10 mL Schlenk tube equipped with a stir bar was cooled under 
a stream of nitrogen and charged with Pd(BrettPhos)(allyl)Cl (0.008 mmol, 8.6 mg, 0.04 
equiv), BrettPhos (0.012 mmol, 6.4 mg, 0.06 equiv), and Lithium bis(trimethylsilyl)amide 
(0.44 mmol, 73.6 mg, 2.2 equiv). The Schlenk tube was evacuated and refilled with N2 
twice. 4-5 (0.2 mmol, 53.2 mg, 1.0 equiv) was weighed in a dram vial and diluted with 1,4 
dioxane (1 mL, 0.2M). This mixture was added to the Schlenk tube and the nitrile 
nucleophile (0.24 mmol, 1.2 equiv) was added. 1,4 dioxane (1 mL, 0.2M) was used to 
rinse the dram vial and the solution was transferred to the Schlenk tube. The Schlenk 
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tube was then heated to 95 °C with stirring overnight until the starting material had been 
consumed. The mixture was then cooled to rt and quenched with saturated aqueous 
ammonium chloride (2 mL). The aqueous layer was extracted with ethyl acetate (3 x 1 
mL), dried over MgSO4, filtered and concentrated in vacuo. The crude product was 
purified via flash chromatography on silica gel. 
 
 
2-(2,3-dihydro-1H-inden-2-yl)-2-methylpropanenitrile (4-6b) The title compound was 
prepared using General Procedure A with isobutyronitrile (0.24 mmol, 22 μL, 1.2 equiv). 
The crude material was purified via column chromatography on silica gel using 95:5 
hexanes:ethyl acetate as the eluent. This procedure afforded 11.5 mg (31%) of the title 
compound as a yellow oil. 
1H NMR (401 MHz, CDCl3) δ 7.24–7.18 (m, 2 H) 7.18–7.12 (m, 2 H) 3.08 (dd, J = 15.2, 
8.4 Hz, 2 H) 2.96 (dd, J = 15.5, 10.0 Hz, 2 H) 2.48 (tt, J = 10.0, 8.3 Hz, 1 H) 1.43 (s, 6 H). 
 
2-(2,3-dihydro-1H-inden-2-yl)-2-phenylacetonitrile (4-6c) The title compound was 
prepared using General Procedure A with phenylacetonitrile (0.24 mmol, 28 mg, 1.2 
equiv). The crude material was purified via column chromatography on silica gel using 
95:5 hexanes:ethyl acetate as the eluent. This procedure afforded 7 mg (15%) of the title 
compound as a colorless oil. 
1H NMR (401 MHz, CDCl3) δ 7.47–7.33 (m, 5 H) 7.24–7.12 (m, 4 H) 3.83 (d, J = 8.0 Hz, 
1 H) 3.16 (dd, J = 15.2, 7.2 Hz, 1 H) 3.08–2.86 (m, 3 H) 2.77 (dd, J = 15.3, 7.5 Hz, 1 H). 
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2-(2,3-dihydro-1H-inden-2-yl)-2-phenylacetonitrile (4-6d) The title compound was 
prepared using General Procedure A with cyclohexane carbonitrile (0.24 mmol, 26 mg, 
1.2 equiv). The crude material was purified via column chromatography on silica gel using 
95:5 hexanes:ethyl acetate as the eluent. This procedure afforded 24.3 mg (54%) of the 
title compound as a colorless oil. 
1H NMR (401 MHz, CDCl3) δ 7.23–7.18 (m, 2 H) 7.18–7.12 (m, 2 H) 3.11–2.90 (m, 4 H) 
2.45 (tt, J = 10.2, 8.4 Hz, 1 H) 2.14–2.03 (m, 1 H) 1.85–1.55 (m, 6 H) 1.41–1.30 (m, 2 H) 
1.29–1.18 (m, 1 H). 
 
(E)-2-(2,3-dihydro-1H-inden-2-yl)pent-3-enenitrile (4-6e) The title compound was 
prepared using General Procedure A with 3-pentenenitrile (0.24 mmol, 20 mg, 1.2 equiv). 
The crude material was purified via column chromatography on silica gel using 95:5 
hexanes:ethyl acetate as the eluent. This procedure afforded 3 mg (7%) of the title 
compound as mixture of 2:1 diastereomers and as a colorless oil. 1H NMR peaks reported 
for the mixture. 
1H NMR (401 MHz, CDCl3) δ 7.25–7.11 (m, 4 H) 5.94–5.74 (m, 1 H) 5.45–5.35 (m, 1 H) 
3.56–3.46 (m, 0.5 H) 3.34–2.67 (m, 5 H) 1.78–1.74 (m, 1.33 H) 1.69–1.65 (m, 1.87 H). 
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1-((2-methylene-3,3-diphenylcyclobutyl)methyl)pyrrolidine (4-12a) A vacuum and 
flame-dried 10 mL Schlenk tube equipped with a stir bar was cooled under a stream of 
nitrogen and charged with Pd(OAc)2 (0.008 mmol, 1.8 mg, 0.04 equiv), P(tBu)3HBF4 
(0.012 mmol, 3.5 mg, 0.06 equiv), and lithium tert-butoxide (0.28 mmol, 22.4 mg, 1.4 
equiv). The Schlenk tube was evacuated and refilled with N2 twice. 4-11 (0.2 mmol, 76.5 
mg, 1.0 equiv) was weighed in a dram vial and diluted with toluene (1 mL, 0.2M). This 
mixture was added to the Schlenk tube and pyrrolidine (0.24 mmol, 20 μL 1.2 equiv) was 
added. Toluene (1 mL, 0.2M) was used to rinse the dram vial and the solution was 
transferred to the Schlenk tube. The Schlenk tube was then heated to 95 °C with stirring 
overnight until the starting material had been consumed. The mixture was then cooled to 
rt and quenched with saturated aqueous ammonium chloride (2 mL). The aqueous layer 
was extracted with ethyl acetate (3 x 1 mL), dried over MgSO4, filtered and concentrated 
in vacuo. The crude product was purified via flash chromatography on silica gel using 
25:75 (3:1 ethyl acetate:ethanol):hexanes as the eluent. The isolated material was 
dissolved in ethyl acetate and tosic acid (0.24 mmol, 41 mg, 1.2 equiv) was added. The 
solution was stirred briefly then allowed to crystalize overnight. The crystals were 
collected and recrystallized in 15:1 ethyl acetate:ethanol. The crystals were dissolved in 
aqueous NaOH (2 mL, 1 M) and the organics were extracted with DCM. Solvent was 
removed under vacuum. This procedure afforded 12.1mg (20%) of the title compound as 
a yellow oil.  
1H NMR (500 MHz, CDCl3) δ 7.34–7.30 (m, 2 H) 7.25–7.21 (m, 2 H) 7.21–7.15 (m, 2 H) 
7.15–7.10 (m, 3 H) 7.10–7.05 (m, 1 H) 5.09 (d, J = 2.4 Hz, 1 H) 4.95 (d, J = 2.8 Hz, 1 H) 
3.17–3.04 (m, 1 H) 2.85–2.73 (m, 2 H) 2.60 (dd, J = 10.8, 8.6 Hz, 1 H) 2.50 (dd, J = 12.1, 
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9.5 Hz, 1 H) 2.47–2.35 (m, 4 H) 1.78–1.64 (m, 4 H); 13C NMR (126 MHz, CDCl3) δ 158.03, 
146.65, 146.60, 128.27, 128.11, 127.63, 127.31, 126.12, 125.87, 106.42, 59.85, 58.68, 
54.59, 39.70, 39.56, 23.51. 
 
1-(4-methylene-3,3-diphenylcyclopentyl)pyrrolidine (4-13a) A vacuum and flame-
dried 10 mL Schlenk tube equipped with a stir bar was cooled under a stream of nitrogen 
and charged with Pd(OAc)2 (0.008 mmol, 1.8 mg, 0.04 equiv), BrettPhos (0.012 mmol, 
6.4 mg, 0.06 equiv), and lithium tert-butoxide (0.28 mmol, 22.4 mg, 1.4 equiv). The 
Schlenk tube was evacuated and refilled with N2 twice. 4-11 (0.2 mmol, 76.5 mg, 1.0 
equiv) was weighed in a dram vial and diluted with toluene (1 mL, 0.2M). This mixture 
was added to the Schlenk tube and pyrrolidine (0.24 mmol, 20 μL 1.2 equiv) was added. 
Toluene (1 mL, 0.2M) was used to rinse the dram vial and the solution was transferred to 
the Schlenk tube. The Schlenk tube was then heated to 95 °C with stirring overnight until 
the starting material had been consumed. The mixture was then cooled to rt and 
quenched with saturated aqueous ammonium chloride (2 mL). The aqueous layer was 
extracted with ethyl acetate (3 x 1 mL), dried over MgSO4, filtered and concentrated in 
vacuo. The crude product was purified via flash chromatography on silica gel using 25:75 
(3:1 ethyl acetate:ethanol):hexanes as the eluent. The isolated material was dissolved in 
ethyl acetate and tosic acid (0.24 mmol, 41 mg, 1.2 equiv) was added. The solution was 
stirred briefly then allowed to crystalize overnight. The crystals were collected and 
recrystallized in 15:1 ethyl acetate:ethanol. The crystals were dissolved in aqueous NaOH 
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(2 mL, 1 M) and the organics were extracted with DCM. Solvent was removed under 
vacuum. This procedure afforded 6 mg (10%) of the title compound as a yellow oil.  
1H NMR (500 MHz, CDCl3) δ 7.34–7.21 (m, 4 H) 7.20–7.11 (m, 3 H) 7.10–7.04 (m, 1 H) 
7.03–6.98 (m, 2 H) 5.19–5.12 (m, 1 H) 4.56–4.45 (m, 1 H) 2.77–2.67 (m, 2 H) 2.54–2.35 
(m, 7 H) 1.79–1.66 (m, 4 H); 13C NMR (126 MHz, CDCl3) δ 155.64, 147.16, 145.92, 
128.49, 128.43, 128.39, 128.12, 128.09, 127.79, 126.17, 125.87, 111.67, 62.09, 60.33, 
53.16, 47.99, 39.15, 23.36. 
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